# EDGAR Filing Document

**Accession Number:** 0000895419
**File Stem:** 0000895419-23-000013
**Filing Date:** 2023-1
**Character Count:** 405944
**Document Hash:** 3e19bbcd408164613af9841d50a71166
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000895419-23-000013.hdr.sgml**: 20230126

**ACCESSION NUMBER**: 0000895419-23-000013

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 90

**CONFORMED PERIOD OF REPORT**: 20221225

**FILED AS OF DATE**: 20230126

**DATE AS OF CHANGE**: 20230126

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** WOLFSPEED, INC.
- **CENTRAL INDEX KEY:** 0000895419
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **IRS NUMBER:** 561572719
- **STATE OF INCORPORATION:** NC
- **FISCAL YEAR END:** 0625

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40863
- **FILM NUMBER:** 23557696

**BUSINESS ADDRESS:**
- **STREET 1:** 4600 SILICON DR
- **CITY:** DURHAM
- **STATE:** NC
- **ZIP:** 27703
- **BUSINESS PHONE:** 9194075300

**MAIL ADDRESS:**
- **STREET 1:** 4600 SILICON DR
- **CITY:** DURHAM
- **STATE:** NC
- **ZIP:** 27703-8475

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CREE, INC.
- **DATE OF NAME CHANGE:** 20190808

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CREE INC
- **DATE OF NAME CHANGE:** 20000103

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CREE RESEARCH INC /NC/
- **DATE OF NAME CHANGE:** 19940224

?xml version="1.0" ? wolf-20221225

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

(Mark One)

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the quarterly period ended December 25, 2022

or

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the transition period from <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> to <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

**Commission file number 001-40863**

__________________________________________

**WOLFSPEED, INC.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **North Carolina** | **North Carolina** | **56-1572719** |
| **(State or other jurisdiction of incorporation or organization)** | **(State or other jurisdiction of incorporation or organization)** | **(I.R.S. Employer Identification No.)** |
| **4600 Silicon Drive** | **4600 Silicon Drive** | |
| **Durham** | **North Carolina** | **27703** |
| **(Address of principal executive offices)** | **(Address of principal executive offices)** | **(Zip Code)** |

---

**(919) 407-5300**

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, $0.00125 par value | WOLF | New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☒

The number of shares outstanding of the registrant's common stock, par value $0.00125 per share, as of January 20, 2023, was 124,416,688.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**WOLFSPEED, INC.**

**FORM 10-Q**

For the Quarterly Period Ended December 25, 2022

**Table of Contents**

---

| | | |
|:---|:---|:---|
| <u>[Part I. Financial Information](#ibca995ad35aa487abdd08480b9f030b1_13)</u> | <u>[Part I. Financial Information](#ibca995ad35aa487abdd08480b9f030b1_13)</u> | |
| | <u>[Item 1. Financial Statements (Unaudited)](#ibca995ad35aa487abdd08480b9f030b1_16)</u> | <u>[3](#ibca995ad35aa487abdd08480b9f030b1_16)</u> |
| | <u>[Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](#ibca995ad35aa487abdd08480b9f030b1_91)</u> | <u>[33](#ibca995ad35aa487abdd08480b9f030b1_91)</u> |
| | <u>[Item 3. Quantitative and Qualitative Disclosures About Market Risk](#ibca995ad35aa487abdd08480b9f030b1_124)</u> | <u>[44](#ibca995ad35aa487abdd08480b9f030b1_124)</u> |
| | <u>[Item 4. Controls and Procedures](#ibca995ad35aa487abdd08480b9f030b1_127)</u> | <u>[44](#ibca995ad35aa487abdd08480b9f030b1_127)</u> |
| <u>[Part II. Other Information](#ibca995ad35aa487abdd08480b9f030b1_130)</u> | <u>[Part II. Other Information](#ibca995ad35aa487abdd08480b9f030b1_130)</u> | |
| | <u>[Item 1. Legal Proceedings](#ibca995ad35aa487abdd08480b9f030b1_133)</u> | <u>[45](#ibca995ad35aa487abdd08480b9f030b1_133)</u> |
| | <u>[Item 1A. Risk Factors](#ibca995ad35aa487abdd08480b9f030b1_136)</u> | <u>[46](#ibca995ad35aa487abdd08480b9f030b1_136)</u> |
| | <u>[Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](#ibca995ad35aa487abdd08480b9f030b1_139)</u> | <u>[60](#ibca995ad35aa487abdd08480b9f030b1_139)</u> |
| | <u>[Item 3. Defaults Upon Senior Securities](#ibca995ad35aa487abdd08480b9f030b1_142)</u> | <u>[60](#ibca995ad35aa487abdd08480b9f030b1_142)</u> |
| | <u>[Item 4. Mine Safety Disclosures](#ibca995ad35aa487abdd08480b9f030b1_145)</u> | <u>[60](#ibca995ad35aa487abdd08480b9f030b1_145)</u> |
| | <u>[Item 5. Other Information](#ibca995ad35aa487abdd08480b9f030b1_148)</u> | <u>[61](#ibca995ad35aa487abdd08480b9f030b1_148)</u> |
| | <u>[Item 6. Exhibits](#ibca995ad35aa487abdd08480b9f030b1_151)</u> | <u>[62](#ibca995ad35aa487abdd08480b9f030b1_151)</u> |

---

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**PART I - FINANCIAL INFORMATION**

**Item 1.&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements (Unaudited)**

---

| | |
|:---|:---|
| <u>[Consolidated Balance Sheets as of December 25, 2022 and June 26, 2022](#ibca995ad35aa487abdd08480b9f030b1_19)</u> | <u>[4](#ibca995ad35aa487abdd08480b9f030b1_19)</u> |
| <u>[Consolidated Statements of Operations for the three and six months ended December 25, 2022 and December 26, 2021](#ibca995ad35aa487abdd08480b9f030b1_22)</u> | <u>[5](#ibca995ad35aa487abdd08480b9f030b1_22)</u> |
| <u>[Consolidated Statements of Comprehensive Loss for the three and six months ended December 25, 2022 and December 26, 2021](#ibca995ad35aa487abdd08480b9f030b1_25)</u> | <u>[6](#ibca995ad35aa487abdd08480b9f030b1_25)</u> |
| <u>[Consolidated Statements of Shareholders' Equity for the six months ended December 25, 2022 and December 26, 2021](#ibca995ad35aa487abdd08480b9f030b1_28)</u> | <u>[7](#ibca995ad35aa487abdd08480b9f030b1_28)</u> |
| <u>[Consolidated Statements of Cash Flows for the six months ended December 25, 2022 and December 26, 2021](#ibca995ad35aa487abdd08480b9f030b1_31)</u> | <u>[9](#ibca995ad35aa487abdd08480b9f030b1_31)</u> |
| <u>[Notes to Unaudited Consolidated Financial Statements](#ibca995ad35aa487abdd08480b9f030b1_34)</u> | <u>[10](#ibca995ad35aa487abdd08480b9f030b1_34)</u> |

---

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**WOLFSPEED, INC.**

**UNAUDITED CONSOLIDATED BALANCE SHEETS**

---

| | | |
|:---|:---|:---|
| *in millions of U.S. Dollars, except share data in thousands* | **December 25, 2022** | **June 26, 2022** |
| **Assets** |  |  |
| Current assets: |  |  |
| Cash and cash equivalents | $1085.1 | $449.5 |
| Short-term investments | 1399.3 | 749.3 |
| &nbsp;&nbsp;&nbsp;Total cash, cash equivalents and short-term investments | 2484.4 | 1198.8 |
| Accounts receivable, net | 169.3 | 150.2 |
| Inventories | 266.6 | 227.0 |
| Income taxes receivable | 1.0 | 1.3 |
| Prepaid expenses | 28.0 | 32.1 |
| Other current assets | 133.4 | 151.4 |
| Current assets held for sale | 1.6 | 1.6 |
| **Total current assets** | 3084.3 | 1762.4 |
| Property and equipment, net | 1649.6 | 1481.1 |
| Goodwill | 359.2 | 359.2 |
| Intangible assets, net | 120.0 | 125.4 |
| Long-term receivables | 2.9 | 104.7 |
| Deferred tax assets | 1.0 | 1.0 |
| Other assets | 125.9 | 83.7 |
| **Total assets** | $5342.9 | $3917.5 |
| **Liabilities and Shareholders' Equity** |  |  |
| Current liabilities: |  |  |
| Accounts payable and accrued expenses | $389.1 | $307.7 |
| Accrued contract liabilities | 34.8 | 37.0 |
| Income taxes payable | 9.4 | 11.6 |
| Finance lease liabilities | 0.5 | 0.5 |
| Other current liabilities | 26.2 | 31.7 |
| **Total current liabilities** | 460.0 | 388.5 |
| Long-term liabilities: |  |  |
| Convertible notes, net | 3021.0 | 1021.6 |
| Deferred tax liabilities | 3.5 | 3.2 |
| Finance lease liabilities - long-term | 9.4 | 9.6 |
| Other long-term liabilities | 68.8 | 55.3 |
| **Total long-term liabilities** | 3102.7 | 1089.7 |
| Commitments and contingencies |  |  |
| Shareholders' equity: |  |  |
| Preferred stock, par value $0.01; 3,000 shares authorized at December 25, 2022 and June 26, 2022; none issued and outstanding |  |  |
| Common stock, par value $0.00125; 200,000 shares authorized at December 25, 2022 and June 26, 2022; 124,413 and 123,795 shares issued and outstanding at December 25, 2022 and June 26, 2022, respectively | 0.2 | 0.2 |
| Additional paid-in-capital | 3660.0 | 4228.4 |
| Accumulated other comprehensive loss | (28.6) | (25.3) |
| Accumulated deficit | (1851.4) | (1764.0) |
| **Total shareholders' equity** | 1780.2 | 2439.3 |
| **Total liabilities and shareholders' equity** | $5342.9 | $3917.5 |

---

*The accompanying notes are an integral part of the consolidated financial statements*

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**WOLFSPEED, INC.**

**UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Six months ended** | **Six months ended** |
| | **December 25, 2022** | **December 26, 2021** | **December 25, 2022** | **December 26, 2021** |
| *in millions of U.S. Dollars, except share data* |  |  |  |  |
| Revenue, net | $216.1 | $173.1 | $457.4 | $329.7 |
| Cost of revenue, net | 149.2 | 116.1 | 310.6 | 223.3 |
| Gross profit | 66.9 | 57.0 | 146.8 | 106.4 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 57.0 | 50.2 | 112.2 | 100.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales, general and administrative | 55.7 | 48.0 | 110.7 | 97.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization or impairment of acquisition-related intangibles | 2.8 | 3.6 | 5.7 | 7.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on disposal or impairment of other assets | 0.1 | 0.5 | 0.2 | 0.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other operating expense | 42.6 | 15.6 | 85.0 | 28.4 |
| Operating loss | (91.3) | (60.9) | (167.0) | (126.6) |
| Non-operating (income) expense, net | (0.8) | 27.8 | (50.5) | 31.9 |
| **Loss before income taxes** | (90.5) | (88.7) | (116.5) | (158.5) |
| Income tax expense | 0.4 | 8.0 | 0.6 | 8.3 |
| **Net loss** | ($90.9) | ($96.7) | ($117.1) | ($166.8) |
| **Basic and diluted loss per share** | ($0.73) | ($0.82) | ($0.94) | ($1.42) |
| **Weighted average shares - basic and diluted (in thousands)** | 124344 | 117218 | 124190 | 117068 |

---

*The accompanying notes are an integral part of the consolidated financial statements*

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**WOLFSPEED, INC.**

**UNAUDITED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Six months ended** | **Six months ended** |
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **December 26, 2021** | **December 25, 2022** | **December 26, 2021** |
| Net loss | ($90.9) | ($96.7) | ($117.1) | ($166.8) |
| Other comprehensive loss: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net unrealized gain (loss) on available-for-sale securities | 3.7 | (3.6) | (3.3) | (4.4) |
| Comprehensive loss | (87.2) | (100.3) | (120.4) | (171.2) |

---

*The accompanying notes are an integral part of the consolidated financial statements*

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**WOLFSPEED, INC.**

**UNAUDITED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Common Stock** | **Common Stock** | **Additional Paid-in Capital** | **Accumulated Deficit** | **Accumulated Other Comprehensive Income** | **Total Shareholders' Equity** |
| *(in millions of U.S. Dollars, except share data in thousands)* | **Number of Shares** | **Par Value** | **Additional Paid-in Capital** | **Accumulated Deficit** | **Accumulated Other Comprehensive Income** | **Total Shareholders' Equity** |
| **Balance at June 26, 2022** | **123795** | **$0.2** | **$4228.4** | **($1764.0)** | **($25.3)** | **$2439.3** |
| Net loss |  |  |  | (26.2) |  | (26.2) |
| Unrealized loss on available-for-sale securities |  |  |  |  | (7.0) | (7.0) |
| Comprehensive loss |  |  |  |  |  | (33.2) |
| Tax withholding on vested equity awards |  |  | (16.9) |  |  | (16.9) |
| Stock-based compensation |  |  | 23.2 |  |  | 23.2 |
| Exercise of stock options and issuance of shares | 415 |  | 0.5 |  |  | 0.5 |
| Adoption of ASU 2020-06 |  |  | (333.0) | 29.7 |  | (303.3) |
| **Balance at September 25, 2022** | **124210** | **$0.2** | **$3902.2** | **($1760.5)** | **($32.3)** | **$2109.6** |
| Net loss |  |  |  | (90.9) |  | (90.9) |
| Unrealized gain on available-for-sale securities |  |  |  |  | 3.7 | 3.7 |
| Comprehensive loss |  |  |  |  |  | (87.2) |
| Tax withholding on vested equity awards |  |  | (0.4) |  |  | (0.4) |
| Stock-based compensation |  |  | 21.4 |  |  | 21.4 |
| Exercise of stock options and issuance of shares | 203 |  | 10.7 |  |  | 10.7 |
| Capped call transactions related to the issuance of convertible notes due December 1, 2029 |  |  | (273.9) |  |  | (273.9) |
| **Balance at December 25, 2022** | **124413** | **$0.2** | **$3660.0** | **($1851.4)** | **($28.6)** | **$1780.2** |

---

*The accompanying notes are an integral part of the consolidated financial statements*

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**WOLFSPEED, INC.**

**UNAUDITED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Common Stock** | **Common Stock** | **Additional Paid-in Capital** | **Accumulated Deficit** | **Accumulated Other Comprehensive Income** | **Total Shareholders' Equity** |
| *(in millions of U.S. Dollars, except share data in thousands)* | **Number of Shares** | **Par Value** | **Additional Paid-in Capital** | **Accumulated Deficit** | **Accumulated Other Comprehensive Income** | **Total Shareholders' Equity** |
| **Balance at June 27, 2021** | **115691** | **$0.1** | **$3676.8** | **($1563.1)** | **$2.7** | **$2116.5** |
| Net loss |  |  |  | (70.1) |  | (70.1) |
| Unrealized loss on available-for-sale securities |  |  |  |  | (0.8) | (0.8) |
| Comprehensive loss |  |  |  |  |  | (70.9) |
| Tax withholding on vested equity awards |  |  | (22.5) |  |  | (22.5) |
| Stock-based compensation |  |  | 15.6 |  |  | 15.6 |
| Exercise of stock options and issuance of shares | 495 |  | 0.7 |  |  | 0.7 |
| **Balance at September 26, 2021** | **116186** | **$0.1** | **$3670.6** | **($1633.2)** | **$1.9** | **$2039.4** |
| Net loss |  |  |  | (96.7) |  | (96.7) |
| Unrealized loss on available-for-sale securities |  |  |  |  | (3.6) | (3.6) |
| Comprehensive loss |  |  |  |  |  | (100.3) |
| Tax withholding on vested equity awards |  |  | (2.8) |  |  | (2.8) |
| Stock-based compensation |  |  | 15.7 |  |  | 15.7 |
| Exercise of stock options and issuance of shares | 258 |  | 10.7 |  |  | 10.7 |
| Issuance of shares related to the extinguishment of convertible notes due September 1, 2023 | 7126 | 0.1 | 416.1 |  | **—** | 416.2 |
| **Balance at December 26, 2021** | **123570** | **$0.2** | **$4110.3** | **($1729.9)** | **($1.7)** | **$2378.9** |

---

*The accompanying notes are an integral part of the consolidated financial statements*

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**WOLFSPEED, INC.**

**UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS**

---

| | | |
|:---|:---|:---|
| | **Six months ended** | **Six months ended** |
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **December 26, 2021** |
| **Operating activities:** |  |  |
| Net loss | ($117.1) | ($166.8) |
| Adjustments to reconcile net loss to cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 77.1 | 67.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt issuance costs and discount, net of non-cash capitalized interest | 2.9 | 9.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on extinguishment of debt |  | 24.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 43.2 | 30.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on disposal or impairment of long-lived assets, including loss on disposal portion of factory optimization and start-up costs | 2.0 | 1.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of premium/discount on investments | 2.2 | 3.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Realized gain on sale of investments |  | (0.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | 0.3 | 0.4 |
| Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | (19.1) | (14.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | (38.2) | (41.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other assets | (1.8) | (5.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable, trade | 4.2 | 2.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued salaries and wages and other liabilities | (33.2) | (13.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued contract liabilities | (2.2) | 6.9 |
| **Cash used in operating activities** | (79.7) | (95.0) |
| **Investing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of property and equipment | (237.8) | (401.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of patent and licensing rights | (2.9) | (2.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of property and equipment, including insurance proceeds | 1.7 | 2.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of short-term investments | (814.1) | (29.8) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from maturities of short-term investments | 115.5 | 107.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of short-term investments | 43.1 | 189.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reimbursement of property and equipment purchases from long-term incentive agreement | 70.7 | 50.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of business resulting from the receipt of transaction related note receivable | 101.8 |  |
| **Cash used in investing activities** | (722.0) | (83.5) |
| **Financing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from long-term debt borrowings |  | 20.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments on long-term debt borrowings, including finance lease obligations | (0.3) | (20.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of common stock | 11.2 | 11.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tax withholding on vested equity awards | (17.3) | (25.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from convertible notes | 1750.0 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments of debt issuance costs | (31.4) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for capped call transactions | (273.9) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Commitment fees on long-term incentive agreement | (1.0) | (1.0) |
| **Cash provided by (used in) financing activities** | 1437.3 | (15.0) |
| Effects of foreign exchange changes on cash and cash equivalents |  | (0.1) |
| **Net change in cash and cash equivalents** | 635.6 | (193.6) |
| Cash and cash equivalents, beginning of period | 449.5 | 379.0 |
| **Cash and cash equivalents, end of period** | $1085.1 | $185.4 |

---

*The accompanying notes are an integral part of the consolidated financial statements*

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**WOLFSPEED, INC.**

**NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS**

---

| | | |
|:---|:---|:---|
| <u>[Note 1](#ibca995ad35aa487abdd08480b9f030b1_40)</u> | <u>[Basis of Presentation and New Accounting Standards](#ibca995ad35aa487abdd08480b9f030b1_40)</u> | <u>[11](#ibca995ad35aa487abdd08480b9f030b1_40)</u> |
| <u>[Note 2](#ibca995ad35aa487abdd08480b9f030b1_46)</u> | <u>[Discontinued Operations](#ibca995ad35aa487abdd08480b9f030b1_46)</u> | <u>[12](#ibca995ad35aa487abdd08480b9f030b1_46)</u> |
| <u>[Note 3](#ibca995ad35aa487abdd08480b9f030b1_52)</u> | <u>[Revenue Recognition](#ibca995ad35aa487abdd08480b9f030b1_52)</u> | <u>[13](#ibca995ad35aa487abdd08480b9f030b1_52)</u> |
| <u>[Note 4](#ibca995ad35aa487abdd08480b9f030b1_55)</u> | <u>[Leases](#ibca995ad35aa487abdd08480b9f030b1_55)</u> | <u>[14](#ibca995ad35aa487abdd08480b9f030b1_55)</u> |
| <u>[Note 5](#ibca995ad35aa487abdd08480b9f030b1_58)</u> | <u>[Financial Statement Details](#ibca995ad35aa487abdd08480b9f030b1_58)</u> | <u>[16](#ibca995ad35aa487abdd08480b9f030b1_58)</u> |
| <u>[Note 6](#ibca995ad35aa487abdd08480b9f030b1_61)</u> | <u>[Investments](#ibca995ad35aa487abdd08480b9f030b1_61)</u> | <u>[19](#ibca995ad35aa487abdd08480b9f030b1_61)</u> |
| <u>[Note 7](#ibca995ad35aa487abdd08480b9f030b1_64)</u> | <u>[Fair Value of Financial Instruments](#ibca995ad35aa487abdd08480b9f030b1_64)</u> | <u>[21](#ibca995ad35aa487abdd08480b9f030b1_64)</u> |
| <u>[Note 8](#ibca995ad35aa487abdd08480b9f030b1_67)</u> | <u>[Goodwill and Intangible Assets](#ibca995ad35aa487abdd08480b9f030b1_67)</u> | <u>[22](#ibca995ad35aa487abdd08480b9f030b1_67)</u> |
| <u>[Note 9](#ibca995ad35aa487abdd08480b9f030b1_70)</u> | <u>[Long-term Debt](#ibca995ad35aa487abdd08480b9f030b1_70)</u> | <u>[23](#ibca995ad35aa487abdd08480b9f030b1_70)</u> |
| <u>[Note 10](#ibca995ad35aa487abdd08480b9f030b1_76)</u> | <u>[Loss Per Share](#ibca995ad35aa487abdd08480b9f030b1_76)</u> | <u>[28](#ibca995ad35aa487abdd08480b9f030b1_76)</u> |
| <u>[Note 11](#ibca995ad35aa487abdd08480b9f030b1_79)</u> | <u>[Stock-Based Compensation](#ibca995ad35aa487abdd08480b9f030b1_79)</u> | <u>[28](#ibca995ad35aa487abdd08480b9f030b1_79)</u> |
| <u>[Note 12](#ibca995ad35aa487abdd08480b9f030b1_82)</u> | <u>[Income Taxes](#ibca995ad35aa487abdd08480b9f030b1_82)</u> | <u>[30](#ibca995ad35aa487abdd08480b9f030b1_82)</u> |
| <u>[Note 13](#ibca995ad35aa487abdd08480b9f030b1_85)</u> | <u>[Commitments and Contingencies](#ibca995ad35aa487abdd08480b9f030b1_85)</u> | <u>[31](#ibca995ad35aa487abdd08480b9f030b1_85)</u> |
| <u>[Note 14](#ibca995ad35aa487abdd08480b9f030b1_88)</u> | <u>[Restructuring](#ibca995ad35aa487abdd08480b9f030b1_88)</u> | <u>[32](#ibca995ad35aa487abdd08480b9f030b1_88)</u> |

---

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**Note 1 – Basis of Presentation and New Accounting Standards**

***Overview***

Wolfspeed, Inc. (the Company) is an innovator of wide bandgap semiconductors, focused on Silicon Carbide and gallium nitride (GaN) materials and devices for power and radio-frequency (RF) applications. The Company's product families include Silicon Carbide and GaN materials, power devices and RF devices targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense.

The Company's materials products and power devices are used in electric vehicles, motor drives, power supplies, solar and transportation applications. The Company's materials products and RF devices are used in military communications, radar, satellite and telecommunication applications.

The majority of the Company's products are manufactured at its production facilities located in North Carolina, California and Arkansas. The Company also uses contract manufacturers for certain products and aspects of product fabrication, assembly and packaging. Additionally, the Company recently opened its Silicon Carbide device fabrication facility in New York. The Company operates research and development facilities in North Carolina, California, Arkansas, Arizona and New York.

Wolfspeed, Inc. is a North Carolina corporation established in 1987, and its headquarters are in Durham, North Carolina.

***Basis of Presentation***

The consolidated financial statements presented herein have been prepared by the Company and have not been audited. In the opinion of management, all normal and recurring adjustments necessary to fairly state the consolidated financial position, results of operations, comprehensive loss, shareholders' equity and cash flows at December 25, 2022, and for all periods presented, have been made. All material intercompany accounts and transactions have been eliminated. The consolidated balance sheet at June 26, 2022 has been derived from the audited financial statements as of that date.

Certain prior period amounts in the accompanying consolidated financial statements and notes have been reclassified to conform to the current year presentation. These reclassifications had no effect on previously reported net loss or shareholders' equity.

These financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) for interim information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for annual financial statements. These financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended June 26, 2022 (fiscal 2022) (the 2022 Form 10-K). The results of operations for the three and six months ended December 25, 2022 are not necessarily indicative of the operating results that may be attained for the entire fiscal year ending June 25, 2023 (fiscal 2023).

***Recently Adopted Accounting Pronouncements***

*Convertible Debt Instruments*

In August 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity's Own Equity (Subtopic 815-40). This standard simplifies the accounting for convertible instruments by eliminating the cash conversion and the beneficial conversion accounting models. This update also amends the guidance for the derivatives scope exception for contracts in an entity's own equity. The update requires an entity to use the if-converted method for all convertible instruments in the diluted earnings per share calculation. An entity may use either a modified or full retrospective approach for adoption.

The Company adopted this standard on June 27, 2022, the first day of its 2023 fiscal year, under the modified retrospective approach. The adoption resulted in (i) a reduction of additional paid in capital by $333.0 million for the recombination of the equity conversion component of the convertible notes outstanding, which was initially separated and recorded in equity, (ii) an increase in the cumulative convertible note carrying value of $277.9 million as a result of removing previously recorded debt discounts, (iii) a decrease in property, plant and equipment for previously capitalized non-cash interest of $25.4 million and (iv) a decrease to beginning accumulated deficit as of June 27, 2022 of $29.7 million to recognize the cumulative gain on adoption. The Company did not recognize a discrete tax impact related to the opening deferred tax balances as of June 27, 2022 due to a full U.S. valuation allowance.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

*Government Assistance*

In November 2021, the FASB issued ASU 2021-10, Government Assistance (Topic 832) - Disclosures by Business Entities about Government Assistance. This standard will require entities to provide annual disclosures regarding government assistance. More specifically, the amendments in the standard improve financial reporting by requiring disclosures that increase the transparency of transactions with a government accounted for by applying a grant or contribution accounting model by analogy, including (1) the types of transactions; (2) the accounting for those transactions; and (3) the effect of those transactions on an entity's financial statements. An entity can apply the amendments prospectively or retrospectively. The Company adopted this standard on June 27, 2022 and will apply the amendments prospectively. The required disclosures will be reflected in the Company's Annual Report on Form 10-K for the fiscal year ending June 25, 2023.

***Accounting Pronouncements Pending Adoption***

None.

**Note 2 – Discontinued Operations**

On March 1, 2021, the Company completed the sale of certain assets and subsidiaries comprising its former LED Products segment to SMART Global Holdings, Inc. (SGH) and its wholly owned subsidiary CreeLED, Inc. (CreeLED and collectively with SGH, SMART) (the LED Business Divestiture) pursuant to the terms of the Asset Purchase Agreement (the LED Purchase Agreement), dated October 18, 2020, as amended. Pursuant to the LED Purchase Agreement, (i) the Company completed the sale to SMART of (a) certain equipment, inventory, intellectual property rights, contracts, and real estate comprising the Company's former LED Products segment, (b) all of the issued and outstanding equity interests of Cree Huizhou Solid State Lighting Company Limited (Cree Huizhou), a limited liability company organized under the laws of the People's Republic of China and an indirect wholly owned subsidiary of the Company, and (c) the Company's ownership interest in Cree Venture LED Company Limited., the Company's joint venture with San'an Optoelectronics Co., Ltd. (collectively, the LED Business); and (ii) SMART assumed certain liabilities related to the LED Business. The Company retained certain assets used in and pre-closing liabilities associated with the former LED Products segment.

The purchase price for the LED Business consisted of (i) a payment of $50 million in cash, subject to customary adjustments, (ii) an unsecured promissory note issued to the Company by SGH in the amount of $125 million (the Purchase Price Note), (iii) the potential to receive an earn-out payment between $2.5 million and $125 million based on the revenue and gross profit performance of the LED Business in the first four full fiscal quarters following the closing (the Earnout Period), also payable in the form of an unsecured promissory note (the Earnout Note), and (iv) the assumption of certain liabilities. The Purchase Price Note had a maturity date of August 15, 2023, and as explained further below, was prepaid by SGH in full pursuant to its terms, along with outstanding accrued and unpaid interest as of the payment date, in the third quarter of fiscal 2022. The Earnout Note was issued by CreeLED in the fourth quarter of 2022, had a maturity date of March 27, 2025 and as explained further below, was prepaid by CreeLED in full pursuant to its terms, in connection with the forgiveness by the Company of outstanding accrued and unpaid interest as of the payment date, in the first quarter of fiscal 2023. In fiscal 2021, the Company recognized a loss on sale of the LED Business of $29.1 million. The cost of selling the LED Business was $27.4 million, which was recognized throughout fiscal 2020 and 2021.

In connection with the closing of the LED Business Divestiture, the Company and CreeLED also entered into certain ancillary and related agreements, including (i) an Intellectual Property Assignment and License Agreement, which assigned to CreeLED certain intellectual property owned by the Company and its affiliates and licensed to CreeLED certain additional intellectual property owned by the Company, (ii) a Transition Services Agreement (LED TSA), (iii) a Wafer Supply and Fabrication Services Agreement (the Wafer Supply Agreement), pursuant to which the Company will supply CreeLED with certain Silicon Carbide materials and fabrication services for up to four years, and (iv) a Real Estate License Agreement (LED RELA), which will allow CreeLED to use certain premises owned by the Company to conduct the LED Business for a period of up to 24 months after closing.

In the third quarter of fiscal 2022, the Company received an early payment for the Purchase Price Note. The principal amount of $125.0 million was paid in full, along with outstanding accrued interest as of the payment date.

In the first quarter of fiscal 2023, the Company received an early payment for the Earnout Note. The principal amount of $101.8 million was paid in full and the Company agreed to forgo payment by CreeLED of the outstanding accrued interest as of the payment date.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

For the three and six months ended December 25, 2022, the Company recognized $0.9 million and $1.8 million in administrative fees related to the LED RELA, respectively, of which $0.3 million is included in accounts receivable, net in the consolidated balance sheet as of December 25, 2022. For the three and six months ended December 26, 2021, the Company recognized $0.9 million and $1.8 million in administrative fees related to the LED RELA, respectively. Fees related to the LED RELA were recorded as lease income, see Note 4, "Leases."

For the three and six months ended December 25, 2022, the Company recognized $1.8 million and $3.7 million in administrative fees related to the LED TSA, respectively, of which $0.6 million is included in accounts receivable, net in the consolidated balance sheet as of December 25, 2022. For the three and six months ended December 26, 2021, the Company recognized $2.4 million and $5.3 million in administrative fees related to the LED TSA, respectively. Fees related to the LED TSA were recorded as a reduction in expense within the line item in the consolidated statements of operations in which costs were incurred.

At the inception of the Wafer Supply Agreement, the Company recorded a supply agreement liability of $31.0 million, none of which was outstanding as of December 25, 2022.

For the three and six months ended December 25, 2022, the Company recognized a net loss of $2.6 million and $2.5 million, respectively, in non-operating income, net related to the Wafer Supply Agreement, of which a receivable of $1.6 million is included in other assets in the consolidated balance sheet as of December 25, 2022. For the three and six months ended December 26, 2021, the Company recognized a net loss of $0.1 million and $0.9 million, respectively, in non-operating income, net related to the Wafer Supply Agreement.

**Note 3 – Revenue Recognition**

The Company follows a five-step approach for recognizing revenue, consisting of the following: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when, or as, the entity satisfies a performance obligation.

Contract liabilities primarily include various rights of return and customer deposits, as well as a reserve on the Company's "ship and debit" program. Contract liabilities were $45.6 million as of December 25, 2022 and $47.8 million as of June 26, 2022. The decrease was primarily due to decreases in ship and debit reserves and product exchange reserves. Contract liabilities are recorded within accrued contract liabilities and other long-term liabilities on the consolidated balance sheets.

For the three and six months ended December 25, 2022, the Company did not recognize revenue that was included in contract liabilities as of June 26, 2022.

The Company conducts business in several geographic areas. Revenue is attributed to a particular geographic region based on the shipping address for the products. Disaggregated revenue from external customers by geographic area is as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Six months ended** | **Six months ended** | **Six months ended** | **Six months ended** |
| | **December 25, 2022** | **December 25, 2022** | **December 26, 2021** | **December 26, 2021** | **December 25, 2022** | **December 25, 2022** | **December 26, 2021** | **December 26, 2021** |
| *(in millions of U.S. Dollars)* | **Revenue** | **% of Revenue** | **Revenue** | **% of Revenue** | **Revenue** | **% of Revenue** | **Revenue** | **% of Revenue** |
| Europe | $63.6 | 29.4% | $61.7 | 35.6% | $139.3 | 30.5% | $119.8 | 36.3% |
| China | 52.0 | 24.1% | 49.7 | 28.7% | 118.0 | 25.8% | 92.6 | 28.1% |
| United States | 53.3 | 24.7% | 32.7 | 18.9% | 103.7 | 22.7% | 58.7 | 17.8% |
| Asia Pacific (excluding China) | 46.1 | 21.3% | 28.5 | 16.5% | 93.9 | 20.5% | 57.9 | 17.6% |
| Other | 1.1 | 0.5% | 0.5 | 0.3% | 2.5 | 0.5% | 0.7 | 0.2% |
| Total | $216.1 |  | $173.1 |  | $457.4 |  | $329.7 |  |

---

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**Note 4 – Leases**

The Company primarily leases manufacturing and office spaces. The Company also has a number of bulk gas leases. Lease agreements frequently include renewal provisions and require the Company to pay real estate taxes, insurance and maintenance costs. Variable costs include lease payments that were volume or usage-driven in accordance with the use of the underlying asset, as well as non-lease components incurred with respect to actual terms rather than contractually fixed amounts.

The Company's finance lease obligations primarily relate to contract manufacturing space in Malaysia and a 49-year ground lease on the Company's Silicon Carbide device fabrication facility in New York.

***Balance Sheet***

Lease assets and liabilities and the corresponding balance sheet classifications are as follows (in millions of U.S. Dollars):

---

| | | |
|:---|:---|:---|
| **Operating Leases:** | **December 25, 2022** | **June 26, 2022** |
| Right-of-use asset <sup>(1)</sup> | $58.1 | $48.5 |
| Current lease liability <sup>(2)</sup> | 5.3 | 4.6 |
| Non-current lease liability <sup>(3)</sup> | 57.3 | 43.6 |
| Total operating lease liabilities | $62.6 | $48.2 |
| **Finance Leases:** |  |  |
| Finance lease assets <sup>(4)</sup> | $10.0 | $10.3 |
| Current portion of finance lease liabilities | 0.5 | 0.5 |
| Finance lease liabilities, less current portion | 9.4 | 9.6 |
| Total finance lease liabilities | $9.9 | $10.1 |

---

<sup>(1)</sup> Within other assets on the consolidated balance sheets.

<sup>(2)</sup> Within other current liabilities on the consolidated balance sheets.

<sup>(3)</sup> Within other long-term liabilities on the consolidated balance sheets.

<sup>(4)</sup> Within property and equipment, net on the consolidated balance sheets.

***Statement of Operations***

Operating lease expense was $2.5 million and $4.7 million for the three and six months ended December 25, 2022, respectively, and $3.3 million and $4.8 million for the three and six months ended December 26, 2021, respectively.

Short-term lease expense, variable lease expense and sublease income were immaterial for the three and six months ended December 25, 2022 and December 26, 2021.

Finance lease amortization was $0.2 million and $0.4 million and interest expense was less than $0.1 million and $0.1 million for the three and six months ended December 25, 2022, respectively. Finance lease amortization was $0.3 million and $0.7 million and interest expense was $0.1 million and $0.2 million for the three and six months ended December 26, 2021, respectively.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

***Cash Flows***

Cash flow information consisted of the following <sup>(1)</sup>:

---

| | | |
|:---|:---|:---|
| | **Six months ended** | **Six months ended** |
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **December 26, 2021** |
| Cash (used in) provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for operating leases | ($2.7) | ($4.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash received from tenant improvement allowance on operating lease | 3.1 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for interest portion of financing leases | (0.1) | (0.1) |
| Cash used in financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for principal portion of finance leases | (0.3) | (0.2) |

---

<sup>(1)</sup> See Note 5, "Financial Statement Details," for non-cash activities related to leases.

***Lease Liability Maturities***

Maturities of operating and finance lease liabilities as of December 25, 2022 were as follows (in millions of U.S. Dollars):

---

| | | | |
|:---|:---|:---|:---|
| **Fiscal Year Ending** | **Operating Leases** | **Finance Leases** | **Total** |
| June 25, 2023 (remainder of fiscal 2023) | $3.4 | $0.4 | $3.8 |
| June 30, 2024 | 9.2 | 0.7 | 9.9 |
| June 29, 2025 | 9.9 | 0.7 | 10.6 |
| June 28, 2026 | 9.7 | 0.7 | 10.4 |
| June 27, 2027 | 8.4 | 0.4 | 8.8 |
| Thereafter | 67.1 | 14.2 | 81.3 |
| Total lease payments | 107.7 | 17.1 | 124.8 |
| Future tenant improvement allowances | (18.5) |  | (18.5) |
| Imputed lease interest | (26.6) | (7.2) | (33.8) |
| Total lease liabilities | $62.6 | $9.9 | $72.5 |

---

***Supplemental Disclosures***

---

| | | |
|:---|:---|:---|
| | **Operating Leases** | **Finance Leases** |
| Weighted average remaining lease term (in months) <sup>(1)</sup> | 134 | 556 |
| Weighted average discount rate <sup>(2)</sup> | 4.46% | 2.68% |

---

<sup>(1)</sup> Weighted average remaining lease term of finance leases excluding the 49-year ground lease is 47 months.

<sup>(2)</sup> Weighted average discount rate of finance leases excluding the 49-year ground lease is 3.49%.

***Lease Income***

As mentioned in Note 2, "Discontinued Operations", on March 1, 2021 and in connection with the sale of its LED Business, the Company entered into the LED RELA pursuant to which the Company leases to CreeLED approximately 58,000 square feet of the Company's property and certain facilities in Durham, North Carolina for a total of $3.6 million per year. The lease term is 24 months and expires on February 26, 2023. Subject to certain provisions in the LED RELA, CreeLED may terminate its rights or a portion of its rights under the agreement at any time with sixty days written notice. A notice of thirty days is permitted under certain circumstances as defined in the agreement. The agreement does not contain any renewal provisions.

The Company recognized lease income of $0.9 million and $1.8 million for the three and six months ended December 25, 2022, respectively. The Company recognized lease income of $0.9 million and $1.8 million for the three and six months ended December 26, 2021, respectively.

The Company did not recognize any variable lease income for the three and six months ended December 25, 2022 and December 26, 2021.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

Future minimum rental income relating to the LED RELA is $0.6 million for the remainder of fiscal 2023.

**Note 5 – Financial Statement Details**

***Accounts Receivable, net***

Accounts receivable, net consisted of the following:

---

| | | |
|:---|:---|:---|
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **June 26, 2022** |
| Billed trade receivables | $166.6 | $148.0 |
| Unbilled contract receivables | 2.6 | 2.7 |
| Royalties | 0.8 | 0.7 |
|  | 170.0 | 151.4 |
| Allowance for bad debts | (0.7) | (1.2) |
| Accounts receivable, net | $169.3 | $150.2 |

---

&nbsp;&nbsp;&nbsp;&nbsp;

Changes in the Company's allowance for bad debts were as follows:

---

| | |
|:---|:---|
| *(in millions of U.S. Dollars)* | **December 25, 2022** |
| Balance at beginning of period | $1.2 |
| Current period provision change | (0.5) |
| Write-offs, net of recoveries |  |
| Balance at end of period | $0.7 |

---

***Inventories***

Inventories consisted of the following:

---

| | | |
|:---|:---|:---|
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **June 26, 2022** |
| Raw material | $84.0 | $60.2 |
| Work-in-progress | 146.8 | 135.9 |
| Finished goods | 35.8 | 30.9 |
| Inventories | $266.6 | $227.0 |

---

***Other Current Assets***

Other current assets consisted of the following:

---

| | | |
|:---|:---|:---|
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **June 26, 2022** |
| Reimbursement receivable on long-term incentive agreement | $111.6 | $132.5 |
| Accrued interest receivable | 11.2 | 5.9 |
| Receivable on Wafer Supply Agreement | 1.6 | 2.7 |
| Inventory related to Wafer Supply Agreement | 2.8 | 3.9 |
| Deferred product costs | 0.3 | 2.5 |
| Other | 5.9 | 3.9 |
| Other current assets | $133.4 | $151.4 |

---

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

***Accounts Payable and Accrued Expenses***

Accounts payable and accrued expenses consisted of the following:

---

| | | |
|:---|:---|:---|
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **June 26, 2022** |
| Accounts payable, trade | $132.2 | $57.8 |
| Accrued salaries and wages | 54.9 | 80.6 |
| Accrued property and equipment | 156.8 | 132.1 |
| Accrued expenses and other | 45.2 | 37.2 |
| Accounts payable and accrued expenses | $389.1 | $307.7 |

---

***Other Operating Expense***

Other operating expense consisted of the following:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Six months ended** | **Six months ended** |
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **December 26, 2021** | **December 25, 2022** | **December 26, 2021** |
| Factory start-up costs | 37.6 | 11.0 | 76.0 | 19.6 |
| Project, transformation and transaction costs | 4.5 | 2.5 | 7.5 | 4.1 |
| Restructuring costs | 0.2 | 2.1 | 0.2 | 4.7 |
| Non-restructuring related executive severance | 0.3 |  | 1.3 |  |
| Other operating expense | $42.6 | $15.6 | $85.0 | $28.4 |

---

***Accumulated Other Comprehensive Loss, net of taxes***

Accumulated other comprehensive loss, net of taxes, consisted of $28.6 million and $25.3 million of net unrealized losses on available-for-sale securities as of December 25, 2022 and June 26, 2022, respectively. Amounts for both periods include a $2.4 million loss related to tax on unrealized loss on available-for-sale securities.

***Reclassifications Out of Accumulated Other Comprehensive Loss***

Reclassifications out of accumulated other comprehensive loss was a loss of less than $0.1 million for both the three and six months ended December 25, 2022 and a $0.1 million and $0.3 million gain for the three and six months ended December 26, 2021, respectively. Amounts were reclassified to non-operating (income) expense, net on the consolidated statements of operations.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

***Non-Operating (Income) Expense, net***

The following table summarizes the components of non-operating (income) expense, net:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Six months ended** | **Six months ended** |
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **December 26, 2021** | **December 25, 2022** | **December 26, 2021** |
| Gain on arbitration proceedings <sup>(1)</sup> | (0.9) |  | (50.3) |  |
| Loss on debt extinguishment <sup>(2)</sup> |  | 24.8 |  | 24.8 |
| Interest income | (11.6) | (2.4) | (15.9) | (5.0) |
| Interest expense, net of capitalized interest | 7.8 | 5.3 | 12.6 | 12.0 |
| Loss on Wafer Supply Agreement | 2.6 | 0.1 | 2.5 | 0.9 |
| Gain on sale of investments, net |  | (0.1) |  | (0.3) |
| Other, net | 1.3 | 0.1 | 0.6 | (0.5) |
| Non-operating (income) expense, net | ($0.8) | $27.8 | ($50.5) | $31.9 |

---

<sup>(1)</sup> In the first quarter of fiscal 2023, the Company received an arbitration award in relation to a former customer failing to fulfill contractual obligations to purchase a certain amount of product over a period of time. In the second quarter of fiscal 2023, a final payment, net of legal fees, was received. The arbitration award is recognized as non-operating income, net of legal fees incurred.

<sup>(2)</sup> As discussed further in Note 9, "Long-term Debt," in the second quarter of fiscal 2022, all outstanding 2023 Notes (as defined below) were surrendered for conversion, resulting in the settlement of all outstanding 2023 Notes in shares, with fractional shares paid in cash.

***Statements of Cash Flows - non-cash activities***

---

| | | |
|:---|:---|:---|
| | **Six months ended** | **Six months ended** |
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **December 26, 2021** |
| Lease asset and liability additions | $12.7 | $5.6 |
| Lease asset and liability modifications, net | 0.6 | 2.9 |
| Lease terminations |  | (0.2) |
| Settlement of 2023 Notes in shares of common stock <sup>(1)</sup> |  | 416.1 |
| Decrease in property, plant and equipment from investment tax credit receivables | 24.3 |  |
| Decrease in property, plant and equipment from long-term incentive related receivables | 49.8 | 81.1 |

---

<sup>(1)</sup> As discussed further in Note 9, "Long-term Debt," in the second quarter of fiscal 2022, all outstanding 2023 Notes were surrendered for conversion, resulting in the settlement of all outstanding 2023 Notes in shares, with fractional shares paid in cash.

Accrued property and equipment as of December 25, 2022 and December 26, 2021 was $156.8 million and $135.7 million, respectively.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**Note 6 – Investments**

Short-term investments consisted of the following (in millions of U.S. Dollars):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **December 25, 2022** | **December 25, 2022** | **December 25, 2022** | **December 25, 2022** | **December 25, 2022** |
| | **Amortized Cost** | **Gross Unrealized Gains** | **Gross Unrealized Losses** | **Credit Loss Allowance** | **Estimated Fair Value** |
| Corporate bonds | $618.2 | $0.1 | ($20.2) | $— | $598.1 |
| U.S. treasury securities | 251.2 |  | (1.1) |  | 250.1 |
| Certificates of deposit | 196.9 |  |  |  | 196.9 |
| Municipal bonds | 180.6 | 0.1 | (5.0) |  | 175.7 |
| Variable rate demand notes | 94.4 |  |  |  | 94.4 |
| Commercial paper | 64.0 |  |  |  | 64.0 |
| U.S. agency securities | 20.2 |  | (0.1) |  | 20.1 |
| Total short-term investments | $1425.5 | $0.2 | ($26.4) | $— | $1399.3 |
|  | **June 26, 2022** | **June 26, 2022** | **June 26, 2022** | **June 26, 2022** | **June 26, 2022** |
|  | **Amortized Cost** | **Gross Unrealized Gains** | **Gross Unrealized Losses** | **Credit Loss Allowance** | **Estimated Fair Value** |
| Corporate bonds | $465.8 | $— | ($17.8) | $— | $448.0 |
| Municipal bonds | 166.5 | 0.1 | (4.4) |  | 162.2 |
| U.S. treasury securities | 66.5 |  | (0.7) |  | 65.8 |
| Variable rate demand notes | 69.4 |  |  |  | 69.4 |
| U.S. agency securities | 4.0 |  | (0.1) |  | 3.9 |
| Total short-term investments | $772.2 | $0.1 | ($23.0) | $— | $749.3 |

---

All short-term investments are classified as available-for-sale. The Company did not have any long-term investments as of December 25, 2022 and June 26, 2022.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

The following tables present the gross unrealized losses and estimated fair value of the Company's short-term investments, aggregated by investment type and the length of time that individual securities have been in a continuous unrealized loss position (in millions of U.S. Dollars):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **December 25, 2022** | **December 25, 2022** | **December 25, 2022** | **December 25, 2022** | **December 25, 2022** | **December 25, 2022** |
| | **Less than 12 Months** | **Less than 12 Months** | **Greater than 12 Months** | **Greater than 12 Months** | **Total** | **Total** |
| | **Fair Value** | **Unrealized Loss** | **Fair Value** | **Unrealized Loss** | **Fair Value** | **Unrealized Loss** |
| Corporate bonds | $361.0 | ($12.1) | $146.4 | ($8.1) | $507.4 | ($20.2) |
| Municipal bonds | 108.5 | (3.2) | 35.7 | (1.8) | 144.2 | (5.0) |
| U.S. treasury securities | 133.6 | (1.1) |  |  | 133.6 | (1.1) |
| U.S. agency securities | 5.0 |  | 1.9 | (0.1) | 6.9 | (0.1) |
| Total | $608.1 | ($16.4) | $184.0 | ($10.0) | $792.1 | ($26.4) |
| Number of securities with an unrealized loss |  | 265 |  | 90 |  | 355 |
|  | **June 26, 2022** | **June 26, 2022** | **June 26, 2022** | **June 26, 2022** | **June 26, 2022** | **June 26, 2022** |
|  | **Less than 12 Months** | **Less than 12 Months** | **Greater than 12 Months** | **Greater than 12 Months** | **Total** | **Total** |
|  | **Fair Value** | **Unrealized Loss** | **Fair Value** | **Unrealized Loss** | **Fair Value** | **Unrealized Loss** |
| Corporate bonds | $431.1 | ($17.4) | $8.3 | ($0.4) | $439.4 | ($17.8) |
| Municipal bonds | 150.0 | (4.4) | 1.0 |  | 151.0 | (4.4) |
| U.S. treasury securities | 65.8 | (0.7) |  |  | 65.8 | (0.7) |
| U.S. agency securities | 3.9 | (0.1) |  |  | 3.9 | (0.1) |
| Total | $650.8 | ($22.6) | $9.3 | ($0.4) | $660.1 | ($23.0) |
| Number of securities with an unrealized loss |  | 346 |  | 5 |  | 351 |

---

Additionally, the Company held cash equivalent securities in unrealized loss positions as of December 25, 2022 and June 26, 2022. As of December 25, 2022, the Company held ten cash equivalent securities in unrealized loss positions with an aggregate fair value of $104.7 million and an aggregate unrealized loss of less than $0.1 million. As of June 26, 2022, the Company held six cash equivalent securities in unrealized loss positions with an aggregate fair value of $69.0 million and an aggregate unrealized loss of less than $0.1 million. All cash equivalents in unrealized loss positions as of December 25, 2022 and June 26, 2022 have been in unrealized loss positions for less than 12 months.

The Company does not include accrued interest in estimated fair values of short-term investments and does not record an allowance for credit losses on receivables related to accrued interest. Accrued interest receivable was $11.2 million and $5.9 million as of December 25, 2022 and June 26, 2022, respectively, and is recorded in other current assets on the consolidated balance sheets. When necessary, write-offs of noncollectable interest income are recorded as a reversal to interest income. There were no write-offs of noncollectable interest income during the three and six months ended December 25, 2022 and December 26, 2021.

The Company utilizes specific identification in computing realized gains and losses on the sale of investments. Realized gains and losses are included in non-operating (income) expense, net in the consolidated statements of operations. Unrealized gains and losses are included as a separate component of equity, net of tax, unless the Company determines there is an expected credit loss.

The Company evaluates its investments for expected credit losses. The Company believes it is able to and intends to hold each of the investments held with an unrealized loss as of December 25, 2022 until the investments fully recover in market value. No allowance for credit losses was recorded as of December 25, 2022.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

The contractual maturities of short-term investments as of December 25, 2022 were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| *(in millions of U.S. Dollars)* | **Within One Year** | **After One, Within Five Years** | **After Five, Within Ten Years** | **After Ten Years** | **Total** |
| Corporate bonds | $298.0 | $300.1 | $— | $— | $598.1 |
| U.S. treasury securities | 196.8 | 53.3 |  |  | 250.1 |
| Certificates of deposit | 196.9 |  |  |  | 196.9 |
| Municipal bonds | 66.1 | 109.6 |  |  | 175.7 |
| Variable rate demand notes |  |  | 14.7 | 79.7 | 94.4 |
| Commercial paper | 64.0 |  |  |  | 64.0 |
| U.S. agency securities | 15.1 | 5.0 |  |  | 20.1 |
| Total short-term investments | $836.9 | $468.0 | $14.7 | $79.7 | $1399.3 |

---

**Note 7 – Fair Value of Financial Instruments**

Under U.S. GAAP, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., the exit price) in an orderly transaction between market participants at the measurement date. In determining fair value, the Company uses various valuation approaches, including quoted market prices and discounted cash flows. U.S. GAAP also establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are obtained from independent sources and can be validated by a third party, whereas unobservable inputs reflect assumptions regarding what a third party would use in pricing an asset or liability. The fair value hierarchy is categorized into three levels based on the reliability of inputs as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1 - Valuations based on quoted prices in active markets for identical instruments that the Company is able to access. Because valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2 - Valuations based on quoted prices in active markets for instruments that are similar, or quoted prices in markets that are not active for identical or similar instruments, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

The financial assets for which the Company performs recurring fair value remeasurements are cash equivalents and short-term investments. As of December 25, 2022 and June 26, 2022, financial assets utilizing Level 1 inputs included U.S. treasury securities and money market funds. Financial assets utilizing Level 2 inputs included commercial paper, certificates of deposit, corporate bonds, municipal bonds, variable rate demand notes and U.S. agency securities. Level 2 assets are valued based on quoted prices in active markets for instruments that are similar or using a third-party pricing service's consensus price, which is a weighted average price based on multiple sources. These sources determine prices utilizing market income models which factor in, where applicable, transactions of similar assets in active markets, transactions of identical assets in infrequent markets, interest rates, bond or credit default swap spreads and volatility. The Company did not have any financial assets requiring the use of Level 3 inputs as of December 25, 2022 and June 26, 2022.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

The following table sets forth financial instruments carried at fair value within the U.S. GAAP hierarchy:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **December 25, 2022** | **December 25, 2022** | **December 25, 2022** | **June 26, 2022** | **June 26, 2022** | **June 26, 2022** |
| *(in millions of U.S. Dollars)* | **Level 1** | **Level 2** | **Total** | **Level 1** | **Level 2** | **Total** |
| Cash equivalents: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;U.S. treasury securities | $307.0 | $— | $307.0 | $69.0 | $— | $69.0 |
| &nbsp;&nbsp;&nbsp;Money market funds | 253.5 |  | 253.5 | 115.9 |  | 115.9 |
| &nbsp;&nbsp;&nbsp;Commercial paper |  | 67.6 | 67.6 |  | 59.4 | 59.4 |
| &nbsp;&nbsp;&nbsp;Certificates of deposit |  | 38.8 | 38.8 |  |  |  |
| &nbsp;&nbsp;&nbsp;Corporate bonds |  | 8.4 | 8.4 |  |  |  |
| &nbsp;&nbsp;&nbsp;Municipal bonds |  | 1.0 | 1.0 |  |  |  |
| **Total cash equivalents** | 560.5 | 115.8 | 676.3 | 184.9 | 59.4 | 244.3 |
| Short-term investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Corporate bonds |  | 598.1 | 598.1 |  | 448.0 | 448.0 |
| &nbsp;&nbsp;&nbsp;U.S. treasury securities | 250.1 |  | 250.1 | 65.8 |  | 65.8 |
| &nbsp;&nbsp;&nbsp;Certificates of deposit |  | 196.9 | 196.9 |  |  |  |
| &nbsp;&nbsp;&nbsp;Municipal bonds |  | 175.7 | 175.7 |  | 162.2 | 162.2 |
| &nbsp;&nbsp;&nbsp;Variable rate demand notes |  | 94.4 | 94.4 |  | 69.4 | 69.4 |
| &nbsp;&nbsp;&nbsp;Commercial paper |  | 64.0 | 64.0 |  |  |  |
| &nbsp;&nbsp;&nbsp;U.S. agency securities |  | 20.1 | 20.1 |  | 3.9 | 3.9 |
| **Total short-term investments** | 250.1 | 1149.2 | 1399.3 | 65.8 | 683.5 | 749.3 |
| **Total cash equivalents and short-term investments** | $810.6 | $1265.0 | $2075.6 | $250.7 | $742.9 | $993.6 |

---

**Note 8 – Goodwill and Intangible Assets**

***Goodwill***

There were no changes to goodwill during the six months ended December 25, 2022.

***Intangible Assets, net***

The following table presents the components of intangible assets, net:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **December 25, 2022** | **December 25, 2022** | **December 25, 2022** | **June 26, 2022** | **June 26, 2022** | **June 26, 2022** |
| *(in millions of U.S. Dollars)* | Gross | Accumulated Amortization | Net | Gross | Accumulated Amortization | Net |
| &nbsp;&nbsp;&nbsp;Customer relationships | $96.8 | ($34.3) | $62.5 | $96.8 | ($31.2) | $65.6 |
| &nbsp;&nbsp;&nbsp;Developed technology | 68.0 | (36.2) | 31.8 | 68.0 | (33.6) | 34.4 |
| &nbsp;&nbsp;&nbsp;Non-compete agreements | 12.2 | (12.2) |  | 12.2 | (12.2) |  |
| Acquisition related intangible assets | 177.0 | (82.7) | 94.3 | 177.0 | (77.0) | 100.0 |
| &nbsp;&nbsp;&nbsp;Patent and licensing rights | 64.1 | (38.4) | 25.7 | 65.5 | (40.1) | 25.4 |
| Total intangible assets | $241.1 | ($121.1) | $120.0 | $242.5 | ($117.1) | $125.4 |

---

Total amortization of acquisition-related intangibles assets was $2.8 million and $5.7 million for the three and six months ended December 25, 2022, respectively, and $3.6 million and $7.2 million for the three and six months ended December 26, 2021, respectively.

Total amortization of patents and licensing rights was $1.3 million and $2.5 million for the three and six months ended December 25, 2022, respectively, and $1.5 million and $2.8 million for the three and six months ended December 26, 2021, respectively.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

Total future amortization expense of intangible assets is estimated to be as follows:

---

| | | | |
|:---|:---|:---|:---|
| *(in millions of U.S. Dollars)*<br>**Fiscal Year Ending** | **Acquisition Related Intangibles** | **Patents** | **Total** |
| June 25, 2023 (remainder of fiscal 2023) | $5.5 | $2.3 | $7.8 |
| June 30, 2024 | 10.4 | 4.1 | 14.5 |
| June 29, 2025 | 10.4 | 3.1 | 13.5 |
| June 28, 2026 | 9.3 | 2.4 | 11.7 |
| June 27, 2027 | 9.3 | 1.9 | 11.2 |
| Thereafter | 49.4 | 11.9 | 61.3 |
| Total future amortization expense | $94.3 | $25.7 | $120.0 |

---

**Note 9 – Long-term Debt**

*Revolving Line of Credit*

As of December 25, 2022, the Company had a $125.0 million secured revolving line of credit (the Credit Agreement) under which the Company can borrow, repay and reborrow loans from time to time prior to its scheduled maturity date of January 9, 2026. The Credit Agreement requires the Company to maintain a ratio of certain cash equivalents and marketable securities to outstanding loans and letter of credit obligations greater than 1.25:1, with no other financial covenants.

The Company classifies balances outstanding under the Credit Agreement as long-term debt in the consolidated balance sheets. As of December 25, 2022, the Company had no outstanding borrowings under the Credit Agreement, $125.0 million in available commitments under the Credit Agreement and $125.0 million available for borrowing. For the three and six months ended December 25, 2022, the average interest rate was 0.00% due to no borrowings. As of December 25, 2022, the unused line fee on available borrowings is 25 basis points.

*2023 Convertible Notes*

On August 24, 2018, the Company sold $500.0 million aggregate principal amount of 0.875% convertible senior notes due September 1, 2023 to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the Securities Act), and an additional $75.0 million aggregate principal amount of such notes pursuant to the exercise in full of the over-allotment options of the underwriters (collectively, the 2023 Notes). The total net proceeds from the 2023 Notes offering was approximately $562.1 million. As discussed further below, the Company repurchased approximately $150.2 million aggregate principal amount of the 2023 Notes using a portion of net proceeds from the sale of an additional convertible note offering (the 2026 Notes, as defined and explained below) in April 2020.

On December 8, 2021 (the Redemption Notice Date), the Company issued a notice (the Redemption Notice) to holders of the 2023 Notes calling all outstanding 2023 Notes for redemption. The Redemption Notice designated December 23, 2021 as the redemption date (the Redemption Date). On the Redemption Date, the Redemption Price (as defined below) would have become due and payable on each of the 2023 Notes to be redeemed, and interest thereon would cease to accrue. However, any 2023 Notes called for redemption would not be redeemed if such note was converted before the Redemption Date. The Redemption Price for the 2023 Notes called for redemption was an amount in cash equal to the principal amount of such note plus accrued and unpaid interest on such note to, but excluding, the Redemption Date, which equated to a Redemption Price of $1,002.72222 per $1,000 principal amount of 2023 Notes (the Redemption Price).

As of the Redemption Notice Date, the conversion rate of the 2023 Notes was 16.6745 shares of the Company's common stock per $1,000 principal amount of such notes. However, in accordance with the Indenture, dated as of August 24, 2018, between the Company and U.S. Bank National Association, as trustee, which governed the terms of the 2023 Notes, the conversion rate for 2023 Notes that were converted after the Redemption Notice Date was increased to 16.7769 shares of the Company's common stock per $1,000 principal amount of such notes. Before the Redemption Date, all outstanding 2023 Notes were surrendered for conversion, resulting in the settlement of all outstanding 2023 Notes in approximately 7.1 million shares of the Company's common stock, with cash in lieu of any fractional shares. The fair value of shares issued upon conversion of all outstanding 2023 Notes was $788.0 million. The amount of cash paid for fractional shares was immaterial.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

*2026 Convertible Notes*

On April 21, 2020, the Company sold $500.0 million aggregate principal amount of 1.75% convertible senior notes due May 1, 2026 to qualified institutional buyers pursuant to Rule 144A under the Securities Act and an additional $75.0 million aggregate principal amount of such notes pursuant to the exercise in full of the over-allotment options of the underwriters (the 2026 Notes). The total net proceeds from the 2026 Notes offering was approximately $561.4 million.

The conversion rate will initially be 21.1346 shares of common stock per one thousand dollars in principal amount of 2026 Notes (equivalent to an initial conversion price of approximately $47.32 per share of common stock). The conversion rate will be subject to adjustment for some events, but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date, or following the Company's issuance of a notice of redemption, the Company will increase the conversion rate for a holder who elects to convert its 2026 Notes in connection with such a corporate event, or who elects to convert any 2026 Notes called for redemption during the related redemption period in certain circumstances. The Company may not redeem the 2026 Notes prior to May 1, 2023. The Company may redeem for cash all or any portion of the 2026 Notes, at its option, on a redemption date occurring on or after May 1, 2023 and on or before the 40th scheduled trading day immediately before the maturity date, if the last reported sales price of its common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive), including the trading day immediately preceding the date on which the Company provides a notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption. The redemption price will be 100% of the principal amount of the 2026 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company undergoes certain fundamental changes related to the Company's common stock, holders may require the Company to repurchase for cash all or any portions of their 2026 Notes at a fundamental repurchase price equal to 100% of the principal amount of the 2026 Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.

Holders may convert their 2026 Notes at their option at any time prior to the close of business on the business day immediately preceding November 3, 2025 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending June 30, 2020 (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any ten consecutive trading day period in which the trading price per $1.0 thousand principal amount of 2026 Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of its common stock and the conversion rate on each such trading day; (3) if the Company calls such 2026 Notes for redemption, at any time prior to the close of business on the second business day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events. On or after November 3, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their 2026 Notes at any time, regardless of the foregoing circumstances. Upon conversion, the Company will pay or deliver cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company's election.

The Company used approximately $144.3 million of the net proceeds from the sale of the 2026 Notes in April 2020 to repurchase approximately $150.2 million aggregate principal amount of the 2023 Notes, including approximately $0.2 million of accrued interest on such notes, in privately negotiated transactions.

*2028 Convertible Notes*

On February 3, 2022, the Company sold $650.0 million aggregate principal amount of 0.25% convertible senior notes due February 15, 2028 to qualified institutional buyers pursuant to Rule 144A under the Securities Act and an additional $100.0 million aggregate principal amount of such notes pursuant to the exercise in full of the over-allotment options of the underwriters (the 2028 Notes). The total net proceeds from the 2028 Notes offering was approximately $732.3 million.

The Company used approximately $108.2 million of the net proceeds from the 2028 Notes to fund the cost of entering into capped call transactions, as described below.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

The conversion rate will initially be 7.8602 shares of common stock per one thousand dollars in principal amount of 2028 Notes (equivalent to an initial conversion price of approximately $127.22 per share of common stock). The conversion rate will be subject to adjustment for some events, but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date, or following the Company's issuance of a notice of redemption, the Company will increase the conversion rate for a holder who elects to convert its 2028 Notes in connection with such a corporate event, or who elects to convert any 2028 Notes called for redemption during the related redemption period in certain circumstances. The Company may not redeem the 2028 Notes prior to February 18, 2025. The Company may redeem for cash all or any portion of the 2028 Notes, at its option, on a redemption date occurring on or after February 18, 2025 and on or before the 40th scheduled trading day immediately before the maturity date, if the last reported sales price of its common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive), including the trading day immediately preceding the date on which the Company provides a notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption. The redemption price will be 100% of the principal amount of the 2028 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company undergoes certain fundamental changes related to the Company's common stock, holders may require the Company to repurchase for cash all or any portions of their 2028 Notes at a fundamental repurchase price equal to 100% of the principal amount of the 2028 Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.

Holders may convert their 2028 Notes at their option at any time prior to the close of business on the business day immediately preceding August 16, 2027 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending March 31, 2022 (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any ten consecutive trading day period in which the trading price per $1.0 thousand principal amount of 2028 Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of its common stock and the conversion rate on each such trading day; (3) if the Company calls such 2028 Notes for redemption, at any time prior to the close of business on the second business day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events. On or after August 16, 2027 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their 2028 Notes at any time, regardless of the foregoing circumstances. Upon conversion, the Company will pay or deliver cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company's election.

*Capped Call Transactions in relation to the 2028 Notes*

On January 31, 2022, in connection with the pricing of the 2028 Notes, the Company entered into privately negotiated capped call transactions with certain of the initial purchasers or affiliates thereof (the 2028 Notes Capped Call Counterparties). In connection with the exercise by the initial purchasers of their option to purchase additional notes, the Company entered into additional privately negotiated capped call transactions (such transactions, collectively, the 2028 Notes Capped Call Transactions) with each of the 2028 Notes Capped Call Counterparties. The 2028 Notes Capped Call Transactions initially cover, subject to customary anti-dilution adjustments, the aggregate number of shares of the Company's common stock that initially underlie the 2028 Notes. The 2028 Notes Capped Call Transactions are expected generally to reduce the potential dilutive effect on the common stock upon any conversion of 2028 Notes and/or offset any potential cash payments the Company is required to make in excess of the principal amount of converted 2028 Notes, as the case may be, with such reduction and/or offset subject to a cap which initially is $212.04 per share, representing a premium of 125% over the last reported sale price per share of our common stock on January 31, 2022, subject to certain adjustments under the terms of the 2028 Notes Capped Call Transactions.

The 2028 Notes Capped Call Transactions are separate transactions entered into by the Company with each of the 2028 Notes Capped Call Counterparties, are not part of the terms of the 2028 Notes, and do not affect any holder's rights under the 2028 Notes. Holders of the 2028 Notes do not have any rights with respect to the 2028 Notes Capped Call Transactions.

*2029 Convertible Notes*

On November 21, 2022, the Company sold $1,525.0 million aggregate principal amount of 1.875% convertible senior notes due December 1, 2029 to qualified institutional buyers pursuant to Rule 144A under the Securities Act and an additional $225.0 million aggregate principal amount of such notes pursuant to the exercise in full of the over-allotment options of the underwriters (the 2029 Notes). The total net proceeds from the 2029 Notes offering was approximately $1,718.6 million.

The Company used approximately $273.9 million of the net proceeds from the 2029 Notes to fund the cost of entering into capped call transactions, as described below.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

The conversion rate will initially be 8.4118 shares of common stock per one thousand dollars in principal amount of 2029 Notes (equivalent to an initial conversion price of approximately $118.88 per share of common stock). The conversion rate will be subject to adjustment for some events, but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date, or following the Company's issuance of a notice of redemption, the Company will increase the conversion rate for a holder who elects to convert its 2029 Notes in connection with such a corporate event, or who elects to convert any 2029 Notes called for redemption during the related redemption period in certain circumstances. The Company may not redeem the 2029 Notes prior to December 4, 2026. The Company may redeem for cash all or any portion of the 2029 Notes, at its option, on a redemption date occurring on or after December 4, 2026 and on or before the 40th scheduled trading day immediately before the maturity date, if the last reported sales price of its common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive), including the trading day immediately preceding the date on which the Company provides a notice of redemption, during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption. The redemption price will be 100% of the principal amount of the 2029 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company undergoes certain fundamental changes related to the Company's common stock, holders may require the Company to repurchase for cash all or any portions of their 2029 Notes at a fundamental repurchase price equal to 100% of the principal amount of the 2029 Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.

Holders may convert their 2029 Notes at their option at any time prior to the close of business on the business day immediately preceding June 1, 2029 only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending March 31, 2023 (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any ten consecutive trading day period in which the trading price per $1.0 thousand principal amount of 2029 Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of its common stock and the conversion rate on each such trading day; (3) if the Company calls such 2029 Notes for redemption, at any time prior to the close of business on the second business day immediately preceding the redemption date; or (4) upon the occurrence of specified corporate events. On or after June 1, 2029 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their 2029 Notes at any time, regardless of the foregoing circumstances. Upon conversion, the Company will pay or deliver cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company's election.

*Capped Call Transactions in relation to the 2029 Notes*

On November 16, 2022, in connection with the pricing of the 2029 Notes, the Company entered into privately negotiated capped call transactions with certain of the initial purchasers or their affiliates and another financial institution (the 2029 Notes Capped Call Counterparties). In connection with the exercise by the initial purchasers of their option to purchase additional notes, the Company entered into additional privately negotiated capped call transactions (such transactions, collectively, the 2029 Notes Capped Call Transactions) with each of the 2029 Notes Capped Call Counterparties. The 2029 Notes Capped Call Transactions initially cover, subject to customary anti-dilution adjustments, the aggregate number of shares of the Company's common stock that initially underlie the 2029 Notes. The 2029 Notes Capped Call Transactions are expected generally to reduce the potential dilutive effect on the common stock upon any conversion of 2029 Notes and/or offset any potential cash payments the Company is required to make in excess of the principal amount of converted 2029 Notes, as the case may be, with such reduction and/or offset subject to a cap which initially is $202.538 per share, representing a premium of 130% over the last reported sale price per share of our common stock on November 16, 2022, subject to certain adjustments under the terms of the 2029 Notes Capped Call Transactions.

The 2029 Notes Capped Call Transactions are separate transactions entered into by the Company with each of the 2029 Notes Capped Call Counterparties, are not part of the terms of the 2029 Notes, and do not affect any holder's rights under the 2029 Notes. Holders of the 2029 Notes do not have any rights with respect to the 2029 Notes Capped Call Transactions.

*Accounting for 2023 Notes, 2026 Notes, 2028 Notes and 2029 Notes*

In accounting for the issuance of the 2023 Notes, 2026 Notes and 2028 Notes, the Company separated such notes into liability and equity components. The carrying amount of the equity component representing the conversion option was $110.6 million, $145.4 million and $187.6 million for the 2023 Notes, 2026 Notes and 2028 Notes, respectively. The amounts were determined by deducting the fair value of the liability component from the par value of each of the 2023 Notes, 2026 Notes and 2028 Notes. Due to the partial extinguishment of the 2023 Notes in connection with the issuance of the 2026 Notes, the equity component of the 2023 Notes was reduced by $27.7 million during the fourth quarter of fiscal 2020.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

As a result of the full conversion of all outstanding 2023 Notes, the Company remeasured the outstanding liability for the 2023 Notes using a market rate for debt without a conversion option (the Market Rate) as of the Redemption Notice Date. The Company performed a present value calculation using the Market Rate and determined the fair value of the debt as of the Redemption Notice Date was $416.1 million, $24.7 million higher than the carrying value of the 2023 Notes as of the Redemption Notice Date. As a result, the Company recorded a loss on extinguishment of $24.8 million, which included a $0.1 million loss on extinguishment expense related to third party fees. Additionally, the equity component of the 2023 Notes was reduced to zero.

Upon adoption of ASU 2020-06 on June 27, 2022, the first day of fiscal 2023, the unamortized discounts on the 2026 Notes and 2028 Notes were eliminated and the liability and equity components relating to the debt issuance costs for the 2026 Notes and 2028 Notes are now presented as a single liability.

Debt issuance costs in relation to the 2029 Notes were accounted for as a reduction of the principal balance and will be amortized over the term of the 2029 Notes.

The 2026 Notes, 2028 Notes and 2029 Notes (the Outstanding Notes) are equal in right of payment to any of the Company's unsecured indebtedness; senior in right of payment to the Company's existing and future indebtedness that is expressly subordinated in right of payment to the Outstanding Notes; effectively subordinated in right of payment of any of the Company's secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally subordinated to all indebtedness and other liabilities (including trade payables) of the Company's subsidiaries.

The net carrying amount of the liability component of the Outstanding Notes is as follows:

---

| | | |
|:---|:---|:---|
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **June 26, 2022** |
| Principal | $3075.0 | $1325.0 |
| Unamortized discount and issuance costs | (54.0) | (303.4) |
| Net carrying amount | $3021.0 | $1021.6 |

---

The net carrying amount of the equity component of the Outstanding Notes is as follows:

---

| | | |
|:---|:---|:---|
| *(in millions of U.S. Dollars)* | **December 25, 2022** <sup>(1)</sup> | **June 26, 2022** |
| Discount related to value of conversion option | $— | $341.1 |
| Debt issuance costs |  | (8.1) |
| Net carrying amount | $— | $333.0 |

---

<sup>(1)</sup> As discussed above, the equity components of the 2026 Notes and 2028 Notes were eliminated upon adoption of ASU 2020-06 on June 27, 2022, the first day of fiscal 2023.

The interest expense, net recognized related to the Outstanding Notes is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Six months ended** | **Six months ended** |
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **December 26, 2021** | **December 25, 2022** | **December 26, 2021** |
| Interest expense, net of capitalized interest | $5.7 | $0.8 | $8.7 | $1.9 |
| Amortization of discount and debt issuance costs, net of capitalized interest | 1.6 | 3.9 | 2.9 | 9.0 |
| Total interest expense, net | $7.3 | $4.7 | $11.6 | $10.9 |

---

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

The Company did not capitalize interest expense for the three and six months ended December 25, 2022. For the three and six months ended December 26, 2021, the Company capitalized $2.6 million and $4.9 million of interest expense, respectively, and $5.8 million and $11.2 million of amortization of discount and issuance costs, respectively, in connection with the building of a new Silicon Carbide device fabrication facility in New York.

The last reported sale price of the Company's common stock was greater than or equal to 130% of the applicable conversion price for the 2026 Notes for at least 20 trading days in the 30 consecutive trading days ended on December 31, 2022. As a result, the 2026 Notes are convertible at the option of the holders through March 31, 2023.

As of December 25, 2022, the if-converted value of the 2026 Notes exceeded their respective principal amounts by $303.3 million.

The estimated fair value of the Outstanding Notes is $3.3 billion as of December 25, 2022, as determined by a Level 2 valuation.

**Note 10 – Loss Per Share**

The details of the computation of basic and diluted loss per share are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Six months ended** | **Six months ended** |
| *(in millions of U.S. Dollars, except share data)* | **December 25, 2022** | **December 26, 2021** | **December 25, 2022** | **December 26, 2021** |
| Net loss | ($90.9) | ($96.7) | ($117.1) | ($166.8) |
| Weighted average shares - basic and diluted (in thousands) | 124344 | 117218 | 124190 | 117068 |
| Loss per share - basic and diluted | ($0.73) | ($0.82) | ($0.94) | ($1.42) |

---

Diluted net loss per share is the same as basic net loss per share for the periods presented due to potentially dilutive items being anti-dilutive given the Company's net loss.

For the three and six months ended December 25, 2022, 2.8 million and 2.8 million, respectively, of weighted average shares were excluded from the calculation of diluted loss per share because their effect would be anti-dilutive. For the three and six months ended December 26, 2021, 3.1 million and 3.3 million, respectively, of weighted average shares were excluded from the calculation of diluted loss per share because their effect would be anti-dilutive.

In addition, future earnings per share of the Company are also subject to dilution from conversion of the 2026 Notes, 2028 Notes and 2029 Notes under certain conditions as described in Note 9, "Long-term Debt."

**Note 11 – Stock-Based Compensation**

***Overview of Employee Stock-Based Compensation Plans***

The Company currently has one equity-based compensation plan, the 2013 Long-Term Incentive Compensation Plan (2013 LTIP), from which stock-based compensation awards can be granted to employees and directors. The 2013 LTIP provides for awards in the form of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares, performance units and other awards.

The Company's stock-based awards can be either service-based or performance-based. Performance-based conditions may be tied to future financial and/or operating performance of the Company, external based market metrics or internal performance metrics.

The Company also has an Employee Stock Purchase Plan (ESPP) that provides employees with the opportunity to purchase common stock at a discount. The ESPP limits employee contributions to 15% of each employee's compensation (as defined in the plan) and allows employees to purchase shares at a 15% discount to the fair market value of common stock on the purchase date two times per year. The ESPP provides for a twelve-month participation period, divided into two equal six-month purchase

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

periods, and also provides for a look-back feature. At the end of each six-month period in April and October, participants purchase the Company's common stock through the ESPP at a 15% discount to the fair market value of the common stock on the first day of the twelve-month participation period or the purchase date, whichever is lower. The plan also provides for an automatic reset feature to start participants on a new twelve-month participation period if the fair market value of common stock declines during the first six-month purchase period.

***Stock Option Awards***

A summary of stock option awards outstanding as of December 25, 2022 and changes during the six months then ended is as follows:

---

| | | |
|:---|:---|:---|
| *(shares in thousands)* | **Number of Shares** | **Weighted Average Exercise Price** |
| Outstanding at June 26, 2022 | 69 | $25.12 |
| Granted |  | $— |
| Exercised | (28) | $25.46 |
| Forfeited or expired | (1) | $26.07 |
| Outstanding at December 25, 2022 | 40 | $24.86 |

---

***Restricted Stock Units***

A summary of nonvested restricted stock unit awards (RSUs) outstanding as of December 25, 2022 and changes during the six months then ended is as follows:

---

| | | |
|:---|:---|:---|
| *(unit awards in thousands)* | **Number of RSUs** | **Weighted Average Grant-Date Fair Value** |
| Nonvested at June 26, 2022 | 1894 | $75.67 |
| Granted | 1225 | $88.41 |
| Vested | (629) | $66.52 |
| Forfeited | (156) | $71.44 |
| Nonvested at December 25, 2022 | 2334 | $84.25 |

---

***Stock-Based Compensation Valuation and Expense***

The Company accounts for its employee stock-based compensation plans using the fair value method. The fair value method requires the Company to estimate the grant-date fair value of its stock-based awards and amortize this fair value to compensation expense over the requisite service period or vesting term.

The Company uses the Black-Scholes option-pricing model to estimate the fair value of the Company's ESPP awards. The determination of the fair value of stock-based payment awards on the date of grant using an option-pricing model is affected by the Company's stock price as well as assumptions regarding a number of complex and subjective variables. These variables include the expected stock price volatility over the term of the awards, the risk-free interest rate and expected dividends. Due to the inherent limitations of option-valuation models, future events that are unpredictable and the estimation process utilized in determining the valuation of the stock-based awards, the ultimate value realized by award holders may vary significantly from the amounts expensed in the Company's financial statements.

For service-based RSUs and performance-based RSUs with internal metrics, the grant-date fair value is based upon the market price of the Company's common stock on the date of the grant. For performance-based RSUs, the Company reassesses the probability of the achievement of the performance condition at each reporting period and adjusts the compensation expense for subsequent changes in the estimate or actual outcome. This fair value is then amortized to compensation expense over the requisite service period or vesting term.

For performance-based awards with market conditions, the Company estimates the grant date fair value using the Monte Carlo valuation model and expenses the awards over the vesting period regardless of whether the market condition is ultimately satisfied.

Stock-based compensation expense is recognized net of estimated forfeitures such that expense is recognized only for those stock-based awards that are expected to vest. A forfeiture rate is estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from initial estimates.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

The Black-Scholes and Monte Carlo option pricing models require the input of highly subjective assumptions. These assumptions represent management's best estimates, but these estimates involve inherent uncertainties and the application of management judgment. As a result, if other assumptions had been used, recorded share-based compensation expense could have been materially different from that depicted below.

Total stock-based compensation expense was classified in the consolidated statements of operations as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Six months ended** | **Six months ended** |
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **December 26, 2021** | **December 25, 2022** | **December 26, 2021** |
| Cost of revenue, net | $5.8 | $4.2 | $11.9 | $7.3 |
| Research and development | 5.1 | 2.6 | 8.6 | 5.0 |
| Sales, general and administrative | 10.3 | 8.6 | 22.7 | 17.7 |
| Total stock-based compensation expense | $21.2 | $15.4 | $43.2 | $30.0 |

---

Stock-based compensation expense may differ from the impact of stock-based compensation to additional paid in capital due to manufacturing related stock-based compensation capitalized within inventory.

**Note 12 – Income Taxes**

In general, the variation between the Company's effective income tax rate and the U.S. statutory rate of 21% is primarily due to: (i) changes in the Company's valuation allowances against deferred tax assets in the U.S., (ii) projected income for the full year derived from international locations with differing tax rates than the U.S. and (iii) projected tax credits generated.

The Company assesses all available positive and negative evidence to estimate if sufficient future taxable income will be generated to utilize the existing deferred tax assets by jurisdiction. As of December 25, 2022, the Company has concluded that it is necessary to recognize a full valuation allowance against its U.S. deferred tax assets.

U.S. GAAP requires a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is cumulatively more than 50% likely to be realized upon ultimate settlement.

As of June 26, 2022, the Company's liability for unrecognized tax benefits was $7.2 million. During the six months ended December 25, 2022, the Company did not record any material movement in its unrecognized tax benefits. As a result, the total liability for unrecognized tax benefits as of December 25, 2022 was $7.2 million. If any portion of this $7.2 million is recognized, the Company will then include that portion in the computation of its effective tax rate. Although the ultimate timing of the resolution and/or closure of audits is highly uncertain, the Company believes it is reasonably possible that $1.7 million of gross unrecognized tax benefits will change in the next 12 months as a result of statutory requirements or settlement with tax authorities.

The Company files U.S. federal, U.S. state and foreign tax returns. For U.S. federal purposes, the Company is generally no longer subject to tax examinations for fiscal years prior to 2017. For U.S. state tax returns, the Company is generally no longer subject to tax examinations for fiscal years prior to 2018. For foreign purposes, the Company is generally no longer subject to examination for tax periods prior to 2012. Certain carryforward tax attributes generated in prior years remain subject to examination, adjustment and recapture.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**Note 13 – Commitments and Contingencies**

***Litigation***

The Company is currently a party to various legal proceedings, including the case described below. While management presently believes that the ultimate outcome of such proceedings, individually and in the aggregate, will not materially harm the Company's financial position, cash flows, or overall trends in results of operations, legal proceedings are subject to inherent uncertainties, and unfavorable rulings could occur. An unfavorable ruling could include monetary damages or, in matters for which injunctive relief or other conduct remedies may be sought, an injunction prohibiting the Company from selling one or more products at all or in particular ways. Were unfavorable final outcomes to occur, there exists the possibility of a material adverse impact on the Company's business, results of operations, financial position and overall trends. The outcomes in these matters are not reasonably estimable.

In October 2021, The Trustees of Purdue University (Purdue) filed a complaint against the Company in the U.S. District Court for the Middle District of North Carolina, alleging infringement of U.S. Patent Nos. 7,498,633 (the '633 Patent), entitled "High-voltage power semiconductor device," and 8,035,112 (the '112 Patent), entitled "SIC power DMOSFET with self-aligned source contact." In the complaint, Purdue also alleges willful infringement, and seeks unspecified monetary damages and attorneys' fees. In August 2022, Purdue voluntarily withdrew all allegations as to the '112 Patent after having disclaimed all rights to that patent. The Company denies Purdue's remaining allegations and has developed numerous defenses, including non-infringement, multiple invalidity grounds, and unenforceability due to inequitable conduct before the U.S. Patent & Trademark Office. The litigation with Purdue is in the early stages of fact discovery, and trial is currently scheduled to begin in August 2024. Due to the early stage of the case, the Company is unable to estimate the possible range of loss, if any, at this time.

***Grant Disbursement Agreement (GDA) with the State of New York***

The Company currently has a GDA with the State of New York Urban Development Corporation (doing business as Empire State Development). The GDA provides a potential total grant amount of $500.0 million to partially and fully reimburse the Company for certain property, plant and equipment costs related to the Company's construction of its Silicon Carbide device fabrication facility in Marcy, New York.

The GDA was signed in the fourth quarter of fiscal 2020 and requires the Company to satisfy a number of objectives for the Company to receive reimbursements through the span of the 13-year agreement. These objectives include maintaining a certain level of local employment, investing a certain amount in locally administered research and development activities and the payment of an annual commitment fee for the first six years. Additionally, the Company has agreed, under a separate agreement (the SUNY Agreement), to sponsor the creation of two endowed faculty chairs and fund a scholarship program at SUNY Polytechnic Institute.

The annual cost of satisfying the objectives of the GDA and the SUNY Agreement, excluding the direct and indirect costs associated with employment, varies from $2.7 million to $5.2 million per year through fiscal 2031.

As of December 25, 2022, the Company has reduced property and equipment, net by a total of $334.9 million as a result of GDA reimbursements, of which $220.4 million has been received in cash and an additional $114.5 million in receivables are recorded in other current assets and in other assets in the consolidated balance sheet. The Company started receiving cash reimbursements in the fourth quarter of fiscal 2021.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**Note 14 - Restructuring**

The Company has approved various operational plans that include restructuring costs. All restructuring costs are recorded in other operating expense on the consolidated statement of operations.

<u>Corporate Restructuring</u>

In January 2022, the Company commenced a plan to open a global IT shared services hub in Belfast, Northern Ireland in partnership with the Northern Ireland government. The Company recorded $0.2 million of severance-related costs relating to this plan for both the three and six months ended December 25, 2022 and has accrued $0.8 million as of December 25, 2022.

<u>Factory Optimization Restructuring</u>

In May 2019, the Company started a significant, multi-year factory optimization plan anchored by a state-of-the-art, automated 200mm capable Silicon Carbide and GaN fabrication facility in Marcy, New York to complement an expansion of the Company's Silicon Carbide materials production at its U.S. campus headquarters in Durham, North Carolina. As part of the plan, the Company incurred restructuring charges associated with the movement of equipment as well as disposals on certain long-lived assets.

The factory optimization restructuring plan concluded in fiscal 2022. For the three and six months ended December 26, 2021, the Company expensed and paid $1.8 million and $3.4 million, respectively, of restructuring charges associated with the movement of equipment related to the factory optimization plan. Additionally, the Company expensed and paid $0.3 million and $1.3 million of restructuring charges associated with disposals of certain long-lived assets for the three and six months ended December 26, 2021, respectively.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**Item 2.&nbsp;&nbsp;&nbsp;&nbsp; Management's Discussion and Analysis of Financial Condition and Results of Operations**

*Information set forth in this Quarterly Report on Form 10-Q contains various "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the Securities Act), and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act). All information contained in this report relative to future markets for our products and trends in and anticipated levels of revenue, gross margins and expenses, as well as other statements containing words such as "believe," "project," "may," "will," "anticipate," "target," "plan," "estimate," "expect" and "intend" and other similar expressions constitute forward-looking statements. These forward-looking statements are subject to business, economic and other risks and uncertainties, both known and unknown, and actual results may differ materially from those contained in the forward-looking statements. Any forward-looking statements we make are as of the date made, and except as required under the U.S. federal securities laws and the rules and regulations of the Securities and Exchange Commission (the SEC), we have no duty to update them if our views later change. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this Quarterly Report. Examples of risks and uncertainties that could cause actual results to differ materially from historical performance and any forward-looking statements include, but are not limited to, those described in "Risk Factors" in Part II, Item 1A of this Quarterly Report.*

***Executive Summary***

The following discussion is designed to provide a better understanding of our unaudited consolidated financial statements, including a brief discussion of our business and products, key factors that impacted our performance and a summary of our operating results. The following discussion should be read in conjunction with the unaudited consolidated financial statements and the notes thereto included in Part I, Item 1 of this Quarterly Report on Form 10-Q, and the audited consolidated financial statements and notes thereto and Management's Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report on Form 10-K for the fiscal year ended June 26, 2022 (the 2022 Form 10-K). Historical results and percentage relationships among any amounts in the financial statements are not necessarily indicative of trends in operating results for any future periods.

***Overview***

Wolfspeed, Inc. (Wolfspeed, we, our, or us) is an innovator of wide bandgap semiconductors, focused on Silicon Carbide and gallium nitride (GaN) materials and devices for power and radio-frequency (RF) applications. Our product families include Silicon Carbide and GaN materials, power devices and RF devices, and our products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense.

Our materials products and power devices are used in electric vehicles, motor drives, power supplies, solar and transportation applications. Our materials products and RF devices are used in military communications, radar, satellite and telecommunication applications.

The majority of our products are manufactured at our production facilities located in North Carolina, California and Arkansas. We also use contract manufacturers for certain products and aspects of product fabrication, assembly and packaging. We maintain captive lines at some of our contract manufacturers. Additionally, we recently opened a Silicon Carbide device fabrication facility in New York. We operate research and development facilities in North Carolina, California, Arkansas, Arizona and New York.

Wolfspeed, Inc. is a North Carolina corporation established in 1987, and our headquarters are in Durham, North Carolina. For further information about our consolidated revenue and earnings, please see our unaudited consolidated financial statements included in Part I, Item 1 of this Quarterly Report.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

***Industry Dynamics and Trends***

There are a number of industry factors that affect our business which include, among others:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Supply Constraints.* The semiconductor industry has experienced supply constraints for certain items. While we have successfully managed through challenges relating to obtaining certain necessary raw materials and production and processing equipment thus far, we expect the supply situation for these items to remain tight for at least the next few quarters. In addition, the ongoing military conflict between Russia and Ukraine may further exacerbate supply constraints. The current high demand for our products has also led to supply constraints for our customers. We are working closely with our customer base to best match our supply to their demand. We have taken steps to provide continuity to our customers to the extent possible, including entering into purchase agreements with suppliers to secure future supply, although we expect that constraints may continue to limit our shipments in the near term.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• Overall Demand for Products and Applications Using Our Wolfspeed Materials and Devices*. Our potential for growth depends significantly on the adoption of Silicon Carbide and GaN materials and device products in the power and RF markets, the continued use of silicon devices in the RF telecommunications market and our ability to win new designs for these applications. Demand also fluctuates based on various domestic and global economic and market cycles, continuously evolving industry supply chains, trade and tariff terms, and inflationary impacts, as well as evolving competitive dynamics in each of the respective markets. These uncertainties make demand difficult to forecast for us and our customers. For example, decreasing consumer or industrial demand as a result of an economic slowdown or recession may lead our customers to delay designing in our products. Recently, we have been seeing softening demand for our RF products but significantly higher demand for our power products. We believe the increased demand for our power products reflects the value that the industry places on a transition to Silicon Carbide materials and devices while also evidencing the growing global focus on adopting higher efficiency energy solutions, including electrical vehicle (EV) and related technologies. We believe these trends could have a significant positive impact on revenues in future periods as we increase capacity to meet this increased demand.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Intense and Constantly Evolving Competitive Environment.* Competition in the industries we serve is intense. Many companies have made significant investments in product development, production equipment and production facilities. To remain competitive, market participants must continuously increase product performance, reduce costs and develop improved ways to serve their customers. To address these competitive pressures, we have invested in research and development activities to support new product development, lower product costs and deliver higher levels of performance to differentiate our products in the market. In addition, we invest in systems, people and new processes to improve our ability to deliver a better overall experience for our customers. Market participants often undertake pricing strategies to gain or protect market share, increase the utilization of their production capacity and open new applications in the power and RF markets we serve.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*• COVID-19 Pandemic.* The global health crisis caused by COVID-19 and its resurgences has impacted and may continue to negatively impact global economic activity, which, despite the effectiveness of vaccines in preventing serious illnesses and hospitalizations, remains uncertain and cannot be predicted with confidence due to the continued emergence of variants and the likelihood that the protection conferred by existing vaccines wanes over time. The COVID-19 pandemic has affected us in a number of ways including, but not limited to, the impact on employees becoming ill, quarantined, or otherwise unable to work or travel due to illness or governmental restriction, the impact on customers and their related demand and/or purchases, the impact on our suppliers' and contract manufacturers' ability to fulfill our orders on a timely basis, and the overall impact of the aforementioned items that could cause output challenges and increased costs. The full extent to which the COVID-19 pandemic may impact our results of operations or liquidity remains uncertain. Our operations have experienced, and likely will continue to experience, supply, labor, demand and output challenges. We continue to monitor the impact that the COVID-19 pandemic is having on our business, the semiconductor industry, and the economies in which we operate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Governmental Trade and Regulatory Conditions*. Our potential for growth, as with most multi-national companies, depends on a balanced and stable trade, political, geopolitical, economic and regulatory environment among the countries where we do business. Changes in trade policy such as the imposition or extension of tariffs or export bans to specific customers or countries could reduce or limit demand for our products in certain markets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Technological Innovation and Advancement.* Innovations and advancements in materials, power, and RF technologies continue to expand the potential commercial application for our products. However, new technologies or standards could emerge or improvements could be made in existing technologies that could reduce or limit the demand for our products in certain markets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Intellectual Property Issues.* Market participants rely on patented and non-patented proprietary information relating to product development, manufacturing capabilities and other core competencies of their business. Protection of intellectual property is critical. Therefore, steps such as additional patent applications, confidentiality and non-

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

disclosure agreements, as well as other security measures are generally taken. To enforce or protect intellectual property rights, litigation or threatened litigation is common.

***Overview of the six months ended December 25, 2022***

The following is a summary of our financial results as of and for the six months ended December 25, 2022 compared to the six months ended December 26, 2021, unless otherwise stated.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Our revenue increased $127.7 million to $457.4 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Gross margin decreased to 32.1% from 32.3%. Gross profit increased to $146.8 million from $106.4 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Operating loss was $167.0 million compared to $126.6 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Diluted loss per share was $0.94 compared to $1.42.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Combined cash, cash equivalents and short-term investments was $2,484.4 million at December 25, 2022 and $1,198.8 million at June 26, 2022.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Convertible notes, net was $3,021.0 million at December 25, 2022 and $1,021.6 million at June 26, 2022. As discussed further below and in Note 9, "Long-term Debt," to our unaudited consolidated financial statements in Part I, Item 1 of this Quarterly Report, we sold $1,750.0 million aggregate principal amount of 1.875% convertible senior notes due December 1, 2029 in the second quarter of fiscal 2023.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Cash used in operating activities was $79.7 million compared to $95.0 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Purchases of property and equipment, net were $167.1 million (net of $70.7 million in reimbursements) compared to $350.8 million (net of $50.8 million in reimbursements).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Design-ins were $5.0 billion compared to $2.2 billion.

***Business Outlook***

We believe we are uniquely positioned as an innovator in the global semiconductor industry. The strength of our balance sheet provides us the ability to invest in our business, as indicated by our new state-of-the-art, automated 200mm Silicon Carbide device fabrication facility in Marcy, New York, where we continue to run qualification lots, an expansion of our materials factory at our U.S campus headquarters in Durham, North Carolina, and the recently announced plan to construct a new materials manufacturing facility in Siler City, North Carolina, all of which is expected to increase our production capacity. In fiscal 2022, we incurred $70.0 million of start-up and pre-production costs related to the ramping of production at the Marcy, New York facility. In fiscal 2023, we target approximately $125 million of start-up and underutilization costs primarily related to ramping of production at the Marcy, New York facility.

We are focused on investing in our business to expand the scale, further develop the technologies, and accelerate the growth opportunities of Silicon Carbide materials, Silicon Carbide power devices and modules, and GaN and silicon RF devices. We believe these efforts will support our goals of delivering higher revenue and shareholder returns over time.

In addition, we are focused on improving the number of usable items in a production cycle (yield) as our manufacturing technologies become more complex. Despite increased complexities in our manufacturing process, we believe we are in a position to improve yield levels to support our future growth, particularly as we transition to our new Silicon Carbide device fabrication facility in Marcy, New York.

We believe we have the ability to navigate the current environment while maintaining our capital expenditure plans to support future growth, including the continued build out of our new facility in New York and additional production capacity in North Carolina.

***Design-ins***

Design-ins are customer commitments to purchase our products and are one of the factors we use to forecast long-term demand and future revenue. To meet the qualification of a design-in, the customer provides us with documentation (e.g., a letter of intent, statement of work or developmental contract) that can include details such as the expected delivery timeline, estimated price, necessary capacity and required support. A design-in, even with a formal commitment, does not always convert to future revenue for a variety of reasons, including, but not limited to, the customer delaying or abandoning the project, capacity constraints, timeline challenges, and/or technology changes. Therefore, management uses the design-in amount as a guide to forecast future demand but it should not be taken as an absolute indicator of future revenue.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

***Results of Operations***

Selected consolidated statements of operations data for the three and six months ended December 25, 2022 and December 26, 2021 is as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Six months ended** | **Six months ended** | **Six months ended** | **Six months ended** |
| | **December 25, 2022** | **December 25, 2022** | **December 26, 2021** | **December 26, 2021** | **December 25, 2022** | **December 25, 2022** | **December 26, 2021** | **December 26, 2021** |
| *(in millions of U.S. Dollars, except share data)* | **Amount** | **% of Revenue** | **Amount** | **% of Revenue** | **Amount** | **% of Revenue** | **Amount** | **% of Revenue** |
| **Revenue, net** | **$216.1** | **100.0%** | **$173.1** | **100.0%** | **$457.4** | **100.0%** | **$329.7** | **100.0%** |
| Cost of revenue, net | 149.2 | 69.0 | 116.1 | 67.1 | 310.6 | 67.9 | 223.3 | 67.7 |
| **Gross profit** | **66.9** | **31.0** | **57.0** | **32.9** | **146.8** | **32.1** | **106.4** | **32.3** |
| Research and development | 57.0 | 26.4 | 50.2 | 29.0 | 112.2 | 24.5 | 100.1 | 30.4 |
| Sales, general and administrative | 55.7 | 25.8 | 48.0 | 27.7 | 110.7 | 24.2 | 97.0 | 29.4 |
| Amortization or impairment of acquisition-related intangibles | 2.8 | 1.3 | 3.6 | 2.1 | 5.7 | 1.2 | 7.2 | 2.2 |
| Loss on disposal or impairment of other assets | 0.1 |  | 0.5 | 0.3 | 0.2 |  | 0.3 | 0.1 |
| Other operating expense | 42.6 | 19.7 | 15.6 | 9.0 | 85.0 | 18.6 | 28.4 | 8.6 |
| **Operating loss** | **(91.3)** | **(42.2)** | **(60.9)** | **(35.2)** | **(167.0)** | **(36.5)** | **(126.6)** | **(38.4)** |
| Non-operating (income) expense, net | (0.8) | (0.4) | 27.8 | 16.1 | (50.5) | (11.0) | 31.9 | 9.7 |
| **Loss before income taxes** | **(90.5)** | **(41.9)** | **(88.7)** | **(51.2)** | **(116.5)** | **(25.5)** | **(158.5)** | **(48.1)** |
| Income tax expense | 0.4 | 0.2 | 8.0 | 4.6 | 0.6 | 0.1 | 8.3 | 2.5 |
| **Net loss** | **($90.9)** | **(42.1)** | **($96.7)** | **(55.9)** | **(117.1)** | **(25.6)** | **(166.8)** | **(50.6)** |
| **Basic and diluted loss per share** | ($0.73) |  | ($0.82) |  | ($0.94) |  | ($1.42) |  |

---

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

<u>Revenue</u>

Revenue was as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | | | **Six months ended** | **Six months ended** | | |
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **December 26, 2021** | **Change** | **Change** | **December 25, 2022** | **December 26, 2021** | **Change** | **Change** |
| Revenue | $216.1 | $173.1 | $43.0 | 25% | $457.4 | $329.7 | $127.7 | 39% |

---

Revenue for the three and six months ended December 25, 2022 compared to the three and six months ended December 26, 2021 increased due to increased demand across all of our product lines, as well as increased production capacity for our power and materials product lines to meet strong demand during the period and in future periods.

<u>Gross Profit and Gross Margin</u>

Gross profit and gross margin were as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | | | **Six months ended** | **Six months ended** | | |
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **December 26, 2021** | **Change** | **Change** | **December 25, 2022** | **December 26, 2021** | **Change** | **Change** |
| Gross profit | $66.9 | $57.0 | $9.9 | 17% | $146.8 | $106.4 | $40.4 | 38% |
| *Gross margin* | 31.0% | 32.9% |  |  | 32.1% | 32.3% |  |  |

---

The increases in gross profit for the three and six months ended December 25, 2022 compared to the three and six months ended December 26, 2021 were primarily due to increased revenues in the current periods.

The decrease in gross margin for the three months ended December 25, 2022 compared to the three months ended December 26, 2021 was primarily due to impacts from product mix, partially offset by impacts from increased revenues in the current period.

The decrease in gross margin for the six months ended December 25, 2022 compared to the six months ended December 26, 2021 was primarily due to the same factors for the three months ended December 25, 2022 compared to the three months ended December 26, 2021, partially offset by a gross margin improvement in the current period resulting from realizing the full impact of our early fiscal 2022 change in estimate to increase our expected useful lives of certain machinery and equipment assets to more closely reflect the estimated economic lives of those assets.\*

\* The change in our expected useful lives was applied in the first quarter of fiscal 2022 but had limited impact on that period's gross profit and gross margin because the majority of the impact in the first quarter of fiscal 2022 resulted in a reduction of inventory.

<u>Research and Development</u>

Research and development expenses include costs associated with the development of new products, enhancements of existing products and general technology research. These costs consisted primarily of employee salaries and related compensation costs, occupancy costs, consulting costs and the cost of development equipment and supplies. Research and development costs also include developing supporting technologies for expansion of our new Silicon Carbide device fabrication facility in Marcy, New York.

Research and development expenses were as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | | | **Six months ended** | **Six months ended** | | |
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **December 26, 2021** | **Change** | **Change** | **December 25, 2022** | **December 26, 2021** | **Change** | **Change** |
| Research and development | $57.0 | $50.2 | $6.8 | 14% | $112.2 | $100.1 | $12.1 | 12% |
| *Percent of revenue* | 26% | 29% |  |  | 25% | 30% |  |  |

---

The increase in research and development expenses was primarily due to our continued investment in our Silicon Carbide and GaN technologies, including the development of existing Silicon Carbide materials and fabrication technology for next generation platforms and expansion of our power and RF product portfolio.

Our research and development expenses vary significantly from year to year based on a number of factors, including the timing of new product introductions and the number and nature of our ongoing research and development activities.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

<u>Sales, General and Administrative</u>

Sales, general and administrative (SG&A) expenses are comprised primarily of costs associated with our sales and marketing personnel and our executive and administrative personnel (for example, finance, human resources, information technology and legal) and consist of salaries and related compensation costs; consulting and other professional services (such as litigation and other outside legal counsel fees, audit and other compliance costs); marketing and advertising expenses; facilities and insurance costs; and travel and other costs.

SG&A expenses were as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | | | **Six months ended** | **Six months ended** | | |
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **December 26, 2021** | **Change** | **Change** | **December 25, 2022** | **December 26, 2021** | **Change** | **Change** |
| Sales, general and administrative | $55.7 | $48.0 | $7.7 | 16% | $110.7 | $97.0 | $13.7 | 14% |
| *Percent of revenue* | 26% | 28% |  |  | 24% | 29% |  |  |

---

The increases in SG&A expenses for the three and six months ended December 25, 2022 compared to the three and six months ended December 26, 2021 were primarily due to increased salaries and benefits from increased headcount, including incentive based stock-based compensation, as well as small increases in travel costs and professional services.

<u>Amortization or Impairment of Acquisition-Related Intangibles</u>

As a result of our acquisitions, we have recognized various amortizable intangible assets, including customer relationships, developed technology and non-compete agreements.

Amortization of intangible assets related to our acquisitions was as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | | | **Six months ended** | **Six months ended** | | |
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **December 26, 2021** | **Change** | **Change** | **December 25, 2022** | **December 26, 2021** | **Change** | **Change** |
| Customer relationships | $1.6 | $1.6 | $— | —% | $3.1 | $3.1 | $— | —% |
| Developed technology | 1.2 | 1.2 |  | —% | 2.6 | 2.6 |  | —% |
| Non-compete agreements |  | 0.8 | (0.8) | (100)% |  | 1.5 | (1.5) | (100)% |
| Total amortization | $2.8 | $3.6 | ($0.8) | (22)% | $5.7 | $7.2 | ($1.5) | (21)% |

---

Amortization of acquisition-related intangible assets decreased due to an intangible asset relating to non-compete agreements reaching the end of its useful life in fiscal 2022. No other significant acquisition-related intangible activity or impairments occurred between the periods.

<u>Loss on Disposal or Impairment of Other Assets</u>

We operate a capital-intensive business. As such, we dispose of a certain level of our equipment in the normal course of business as our production processes change due to production improvement initiatives or product mix changes. Due to the risk of technological obsolescence or changes in our production process, we regularly review our long-lived assets and capitalized patent costs for possible impairment.

Loss on disposal or impairment of other assets were as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | | | **Six months ended** | **Six months ended** | | |
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **December 26, 2021** | **Change** | **Change** | **December 25, 2022** | **December 26, 2021** | **Change** | **Change** |
| Loss on disposal or impairment of other assets | $0.1 | $0.5 | ($0.4) | (80)% | $0.2 | $0.3 | ($0.1) | (33)% |

---

Loss on disposal or impairment of other assets primarily relate to proceeds from asset sales offset by write-offs of fixed asset projects, as well as the write-offs of impaired or abandoned patents.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

<u>Other Operating Expense</u>

Other operating expense was as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | | | **Six months ended** | **Six months ended** | | |
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **December 26, 2021** | **Change** | **Change** | **December 25, 2022** | **December 26, 2021** | **Change** | **Change** |
| Factory start-up costs | 37.6 | 11.0 | 26.6 | 242% | 76.0 | 19.6 | 56.4 | 288% |
| Project, transformation and transaction costs | 4.5 | 2.5 | 2.0 | 80% | 7.5 | 4.1 | 3.4 | 83% |
| Restructuring costs | 0.2 | 2.1 | (1.9) | (90)% | 0.2 | 4.7 | (4.5) | (96)% |
| Non-restructuring related executive severance | 0.3 |  | 0.3 | 100% | 1.3 |  | 1.3 | 100% |
| Other operating expense | $42.6 | $15.6 | $27.0 | 173% | $85.0 | $28.4 | $56.6 | 199% |

---

Factory start-up costs are costs related to expanding our production footprint to support expected growth.

Project, transformation and transaction costs primarily relate to professional services fees associated with completed and potential acquisitions and divestitures, as well as internal transformation programs focused on optimizing our administrative processes.

Restructuring costs relate to facility consolidations, disposals on certain long-lived assets, severance and other restructuring costs related to corporate restructuring plans. See Note 14, "Restructuring," to our unaudited consolidated financial statements in Part I, Item 1 of this Quarterly Report for additional information on our restructuring costs.

Other operating expense for the three and six months ended December 25, 2022 compared to the three and six months ended December 26, 2021 increased primarily due to increased start-up costs as we continue our expansion to a new Silicon Carbide device fabrication facility in Marcy, New York.

<u>Non-Operating (Income) Expense, net</u>

Non-operating (income) expense, net was comprised of the following:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | | | **Six months ended** | **Six months ended** | | |
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **December 26, 2021** | **Change** | **Change** | **December 25, 2022** | **December 26, 2021** | **Change** | **Change** |
| Gain on arbitration proceedings | ($0.9) | $— | ($0.9) | (100)% | ($50.3) | $— | ($50.3) | (100)% |
| Loss on debt extinguishment related to conversion of 2023 Notes |  | 24.8 | (24.8) | (100)% |  | 24.8 | (24.8) | (100)% |
| Interest income | (11.6) | (2.4) | (9.2) | 383% | (15.9) | (5.0) | (10.9) | 218% |
| Interest expense, net of capitalized interest | 7.8 | 5.3 | 2.5 | 47% | 12.6 | 12.0 | 0.6 | 5% |
| Loss on Wafer Supply Agreement | 2.6 | 0.1 | 2.5 | 2500% | 2.5 | 0.9 | 1.6 | 178% |
| Gain on sale of investments, net |  | (0.1) | 0.1 | (100)% |  | (0.3) | 0.3 | (100)% |
| Other, net | 1.3 | 0.1 | 1.2 | 1200% | 0.6 | (0.5) | 1.1 | (220)% |
| Non-operating (income) expense, net | ($0.8) | $27.8 | ($28.6) | (103)% | ($50.5) | $31.9 | ($82.4) | (258)% |

---

*Gain on arbitration proceedings*. In the first quarter of fiscal 2023, we received an arbitration award in relation to a former customer failing to fulfill contractual obligations to purchase a certain amount of product over a period of time. In the second quarter of fiscal 2023, a final payment was received. The gain recognized is net of legal fees incurred.

*Loss on debt extinguishment related to conversion of 2023 Notes.* In the second quarter of fiscal 2022, all of our outstanding 0.875% convertible senior notes due September 1, 2023 (the 2023 Notes) were converted into shares of our common stock, which resulted in a loss on extinguishment of $24.8 million. See Note 9, "Long-term Debt," to our unaudited consolidated financial statements in Part I, Item 1 of this Quarterly Report for additional information on this loss on debt extinguishment.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

*Interest income.* The increase in interest income in both periods was primarily driven by increased short-term investment balances, as well as increased returns on our short-term investments. Our short-term investment balances increased significantly in the second quarter of fiscal 2023 resulting from the net proceeds we received from the sale of our 1.875% convertible senior notes due December 1, 2029 (2029 Notes).

*Interest expense, net of capitalized interest*. The increase in interest expense in both periods related to interest from our 2028 Notes (as defined below) and the 2029 Notes, which were not outstanding as of December 26, 2021. In addition, interest expense increased from interest on our 1.75% convertible senior notes due May 1, 2026 (the 2026 Notes), the interest of which was fully capitalized in the three and six months ended December 26, 2021 but fully expensed in the three and six months ended December 25, 2022. These increases were partially offset by a decrease in interest expense from our 2023 Notes, which were converted in the second quarter of fiscal 2022.

*Loss on Wafer Supply Agreement.* In connection with the completed sale of our former LED Products business unit to SMART Global Holdings, Inc. (SGH) and its wholly owned subsidiary CreeLED, Inc. (CreeLED and collectively with SGH, SMART) in fiscal 2021, we entered into a Wafer Supply and Fabrication Services Agreement (the Wafer Supply Agreement), pursuant to which we supply CreeLED with certain Silicon Carbide materials and fabrication services for up to four years. We recognized a supply agreement liability in connection with this agreement, which reached full amortization in the second quarter of fiscal 2023.

<u>Income Tax Expense</u>

Income tax expense and our effective tax rate was as follows:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | | | **Six months ended** | **Six months ended** | | |
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **December 26, 2021** | **Change** | **Change** | **December 25, 2022** | **December 26, 2021** | **Change** | **Change** |
| Income tax expense | $0.4 | $8.0 | ($7.6) | (95)% | $0.6 | $8.3 | ($7.7) | (93)% |
| *Effective tax rate* | —% | (9)% |  |  | (1)% | (5)% |  |  |

---

The change in our effective tax rate was primarily due to $7.3 million of income tax expense recognized in the second quarter of fiscal 2022 related to the restructuring of our Luxembourg holding company.

In general, the variation between our effective income tax rate and the current U.S. statutory rate of 21.0% is primarily due to: (i) changes in our valuation allowances against deferred tax assets in the U.S., (ii) projected income derived from international locations with differing tax rates than the U.S., and (iii) tax credits generated.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

***Liquidity and Capital Resources***

<u>Overview</u>

We require cash to fund our operating expenses and working capital requirements, including the purchase of goods and services in the ordinary course of business such as raw materials, supplies and capital equipment, as well as outlays for research and development, strategic acquisitions and investments. Our principal sources of liquidity are cash on hand, marketable securities and, as described further below, availability under our line of credit.

Based on past performance and current expectations, we believe our current working capital, availability under our line of credit and anticipated cash flows from operations will be adequate to meet our cash needs for our daily operations and capital expenditures for at least the next 12 months. With the strength of our working capital position, we believe that we have the ability to continue to invest in the near-term expansion of our production capacity, further development of our products and, when necessary or appropriate, make selective acquisitions or other strategic investments to strengthen our product portfolio or secure key intellectual properties. However, even with our strong working capital position, we expect to need additional funding to fully complete our previously announced planned long-term capacity expansions.

<u>Sources of Liquidity</u>

The following table sets forth our cash, cash equivalents and short-term investments:

---

| | | | |
|:---|:---|:---|:---|
| *(in millions of U.S. Dollars)* | **December 25, 2022** | **June 26, 2022** | **Change** |
| Cash and cash equivalents | $1085.1 | $449.5 | $635.6 |
| Short-term investments | 1399.3 | 749.3 | 650.0 |
| Total cash, cash equivalents and short-term investments | $2484.4 | $1198.8 | $1285.6 |

---

The significant components of our working capital are liquid assets such as cash and cash equivalents, short-term investments, accounts receivable and inventories reduced by accounts payable and accrued expenses.

In the second quarter of fiscal 2022, all outstanding 2023 Notes were surrendered for conversion following our issuance on December 8, 2021 of a notice to holders of the 2023 Notes calling for the redemption of all outstanding 2023 Notes, resulting in the settlement of the previously outstanding $424.8 million aggregate principal amount of 2023 Notes in approximately 7.1 million shares of our common stock.

In the third quarter of fiscal 2022, we issued and sold a total of $750.0 million aggregate principal amount of 0.25% convertible senior notes due February 15, 2028 (the 2028 Notes), as discussed in Note 9, "Long-term Debt," in our consolidated financial statements included in Part I, Item 1 of this Quarterly Report. The total net proceeds of the 2028 Notes was $732.3 million, of which we used $108.2 million to fund the cost of entering into capped call transactions. We expect to use the remainder of the net proceeds for general corporate purposes.

In the second quarter of fiscal 2023, we issued and sold a total of $1,750.0 million aggregate principal amount of 2029 Notes, as discussed in Note 9, "Long-term Debt," in our consolidated financial statements included in Part I, Item 1 of this Quarterly Report. The total net proceeds of the 2029 Notes was $1,718.6 million, of which we used $273.9 million to fund the cost of entering into capped call transactions. We expect to use the remainder of the net proceeds for general corporate purposes.

In addition, we received early payments on two unsecured promissory notes issued to us in connection with the sale of certain assets and subsidiaries comprising our former LED Products segment (the LED Business) to SMART on March 1, 2021 (the LED Business Divestiture). In the third quarter of fiscal 2022, we received an early payment in the amount of $125.0 million, along with outstanding accrued and unpaid interest as of the payment date, relating to the unsecured promissory note issued with the completion of the transaction. In the first quarter of fiscal 2023, we received an early payment in the amount of $101.8 million in connection with the unsecured promissory note issued in the fourth quarter of fiscal 2022 as an earn-out payment.

We have a $125 million line of credit as discussed in Note 9, "Long-term Debt," in our consolidated financial statements included in Part I, Item 1 of this Quarterly Report, all of which was available for borrowing as of December 25, 2022. The purpose of this credit facility is to provide short-term flexibility to optimize returns on our cash and investment portfolio while funding capital expenditures and other general business needs.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

As of December 25, 2022, we had unrealized losses on our short-term investments of $26.4 million. All of our short-term investments had investment grade ratings, and any such investments that were in an unrealized loss position at December 25, 2022 were in such position due to interest rate changes, sector credit rating changes or company-specific rating changes. We evaluate our short-term investments for expected credit losses. We believe we are able to and we intend to hold each of the investments held with an unrealized loss as of December 25, 2022 until the investments fully recover in market value. No allowance for credit losses was recorded as of December 25, 2022.

From time to time, we evaluate strategic opportunities, including potential acquisitions, joint ventures, divestitures, spin-offs or investments in complementary businesses, and we have continued to make such evaluations. We may also access capital markets through the issuance of debt or additional shares of common stock, which we may use in connection with the acquisition of complementary businesses or other significant assets or for other strategic opportunities or general corporate purposes.

<u>Expected Uses of Liquidity</u>

We recently opened our new Silicon Carbide device fabrication facility in Marcy, New York, to expand capacity for production of our Silicon Carbide devices. We expect to invest approximately $2.0 billion, an increase from our previously expected $1.0 billion, in construction, equipment and other related costs for the new facility through fiscal 2024, of which approximately $500 million is expected to be reimbursed over time by the State of New York through a grant program administered by the State of New York Urban Development Corporation (doing business as Empire State Development). The increase is primarily due to capacity expansions at the site that have been pulled forward as a result of increased projected demand. As of December 25, 2022, we have spent approximately $800 million and received $220.4 million in reimbursements.

Additionally, we recently announced the intention to build a new materials manufacturing facility in Siler City, North Carolina. Starting in late fiscal 2023 and through fiscal 2024, we expect to invest approximately $1.3 billion in construction, equipment and other related costs for the new facility, net of estimated refundable federal investment tax credits and capital grants we expect to receive through the U.S. CHIPS and Science Act of 2022 (the CHIPS Act). The timing and amount of these estimated CHIPS Act incentives is uncertain. In addition, the facility is also further supported by an approximately $1.0 billion long-term incentive package from state, county and local governments, primarily in the form of property tax reimbursements and sales tax exemptions.

For fiscal 2023, we target approximately $1.0 billion of net capital investment, which is primarily related to capacity and infrastructure projects to support longer-term growth and strategic priorities. This target is highly dependent on the timing and overall progress on our new Silicon Carbide fabrication facility in New York and the construction of our new materials manufacturing facility in Siler City, North Carolina. Our target net capital investment figure is net of approximately $150 million of expected reimbursements from the State of New York Urban Development Corporation under the Grant Disbursement Agreement during the fiscal year.

In addition, we also intend to apply for and potentially sell tax credits as part of the Inflation Reduction Act to further fund our expansion initiatives.

Given our current cash position, we believe we will be able to fund daily operations for at least the next 12 months but we expect to need additional funding to fully complete our previously announced planned expansion initiatives described above. We believe we will be able to obtain the necessary funding and are exploring a variety of options, including, but not limited to, customer deposits, private funding, public markets, government reimbursements and selling transferable government tax credits.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

***Cash Flows***

In summary, our cash flows were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Six months ended** | **Six months ended** | | |
| | **December 25, 2022** | **December 26, 2021** | **Change** | **Change** |
| Cash used in operating activities | ($79.7) | ($95.0) | $15.3 | 16% |
| Cash used in investing activities | (722.0) | (83.5) | (638.5) | (765)% |
| Cash provided by (used in) financing activities | 1437.3 | (15.0) | 1452.3 | 9682% |
| Effect of foreign exchange changes |  | (0.1) | 0.1 | 100% |
| Net change in cash and cash equivalents | $635.6 | ($193.6) | $829.2 | 428% |

---

<u>Cash Flows from Operating Activities</u>

Net cash used in operating activities decreased primarily due to a decrease in net loss during the period, partially offset by increased working capital in the current period primarily related to decreased employee related accruals.

<u>Cash Flows from Investing Activities</u>

Our investing activities primarily relate to short-term investment transactions, purchases of property and equipment, and property related reimbursements.

Cash used in investing activities increased primarily due to an increase in net purchases of short-term investments of $922.7 million, partially offset by proceeds of an earnout payment related to the LED Business Divestiture of $101.8 million and a decrease in net property and equipment purchases of $183.7 million.

<u>Cash Flows from Financing Activities</u>

For the six months ended December 25, 2022, cash provided by financing activities primarily consisted of $1,718.6 million in net proceeds from the issuance of the 2029 Notes and $11.2 million of proceeds from the issuance of common stock, partially offset by $273.9 million in cash paid for capped call transactions in connection with the 2029 Notes and $17.3 million in tax withholdings on vested equity awards.

For the six months ended December 26, 2021, cash used in financing activities primarily consisted of $25.3 million in tax withholdings on vested equity awards, partially offset by $11.5 million of proceeds from the issuance of common stock.

***Off-Balance Sheet Arrangements***

We do not use off-balance sheet arrangements with unconsolidated entities or related parties, nor do we use any other forms of off-balance sheet arrangements. Accordingly, our liquidity and capital resources are not subject to off-balance sheet risks from unconsolidated entities. As of December 25, 2022, we did not have any off-balance sheet arrangements.

***Critical Accounting Policies and Estimates***

For information on critical accounting policies and estimates, see the "Critical Accounting Policies and Estimates" section of "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations" in the 2022 Form 10-K.

***Recent Accounting Pronouncements***

For a description of recent accounting pronouncements pending adoption, including the expected dates of adoption and the estimated effects, if any, on our consolidated financial statements, see Note 1, "Basis of Presentation and New Accounting Standards," to our unaudited consolidated financial statements in Part I, Item 1 of this Quarterly Report.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**Item 3.&nbsp;&nbsp;&nbsp;&nbsp; Quantitative and Qualitative Disclosures About Market Risk**

For quantitative and qualitative disclosures about our market risks, see "Part II. Item 7A. Quantitative and Qualitative Disclosures About Market Risk" of the 2022 Form 10-K. There have been no material changes to the amounts presented therein.

**Item 4.&nbsp;&nbsp;&nbsp;&nbsp; Controls and Procedures**

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this Form 10-Q. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this Form 10-Q, our disclosure controls and procedures are effective in that they provide reasonable assurances that the information we are required to disclose in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods required by the SEC's rules and forms and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

We routinely review our internal control over financial reporting and from time to time make changes intended to enhance the effectiveness of our internal control over financial reporting. We will continue to evaluate the effectiveness of our disclosure controls and procedures and internal control over financial reporting on an ongoing basis and will take action as appropriate.

In the second quarter of fiscal 2023, we completed the initial phase of our new enterprise resource planning (ERP) system implementation and migrated our general ledger and consolidation process onto the new system. In connection with this implementation, we modified certain internal control processes and procedures. Following the implementation, these changes to our control environment were validated according to our established processes. No other changes to our internal control over financial reporting were identified in management's evaluation pursuant to Rules 13a-15(d) and 15d-15(d) under the Exchange Act during the second quarter of fiscal 2023 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**PART II – OTHER INFORMATION**

**Item 1.&nbsp;&nbsp;&nbsp;&nbsp; Legal Proceedings**

The information required by this item is set forth under Note 13, "Commitments and Contingencies," to our unaudited financial statements in Part I, Item 1 of this Quarterly Report and is incorporated herein by reference.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**Item 1A. Risk Factors**

Described below are various risks and uncertainties that may affect our business. The descriptions below include any material changes to and supersede the description of the risk factors affecting our business previously disclosed in "Part I, Item 1A. Risk Factors" of the 2022 Form 10-K. If any of the risks described below actually occurs, our business, financial condition or results of operations could be materially and adversely affected.

Risk categories:

–Risks related to our global operations, including global macroeconomic and market risks

–Risks related to sales, product development and manufacturing

–Risks associated with our strategic transactions

–Risks associated with cybersecurity, intellectual property and litigation

–Risks related to the effects of COVID-19 and other potential future public health crises, pandemics or similar events

–Risks related to legal, regulatory, accounting, tax and compliance matters

–General risk factors

**<u>Risks related to our global operations, including global macroeconomic and market risks</u>**

***Our business may be adversely affected by the state of the global economy, uncertainties in global financial markets, our ability to access funding, and possible trade tariffs and trade restrictions.***

Our operations and performance depend significantly on worldwide economic and geopolitical conditions. Uncertainty about global economic conditions could result in customers postponing purchases of our products and services in response to tighter credit, unemployment, negative financial news and/or declines in income or asset values and other macroeconomic factors, which could have a material negative effect on demand for our products and services and, accordingly, on our business, results of operations or financial condition. For example, current global financial markets continue to reflect uncertainty, which has been affected by the COVID-19 pandemic and the ongoing military conflict between Russia and Ukraine. Given these uncertainties, there could be further disruptions to the global economy, financial markets and consumer confidence. If economic conditions deteriorate unexpectedly, our business and results of operations could be materially and adversely affected. For example, our customers, including our distributors and their customers, may experience difficulty obtaining the working capital and other financing necessary to support historical or projected purchasing patterns, which could negatively affect our results of operations.

Recent global economic slowdowns could continue and potentially result in certain economies dipping into economic recessions, including in the United States. Additionally, increased inflation around the world, including in the United States, applies pressure to our costs. Continued economic slowdowns or recessions and inflationary pressures could have a negative impact on our business, including decreased demand, increased costs, and other challenges. Government actions to address economic slowdowns and increased inflation, including increased interest rates, also could result in negative impacts to our growth.

General trade tensions between the United States and China have been escalating, and any economic and political uncertainty caused by the United States tariffs imposed on goods from China, among other potential countries, and any corresponding tariffs or currency devaluations from China or such other countries in response, has negatively impacted, and may in the future negatively impact, demand and/or increase the cost for our products. Additionally, Russia's invasion of Ukraine in early 2022 triggered significant sanctions from the U.S. and European countries. Resulting changes in U.S. trade policy could trigger retaliatory actions by Russia, its allies and other affected countries, including China, resulting in a potential trade war. Furthermore, if the conflict between Russia and Ukraine continues for a prolonged period of time, or if other countries, including the U.S., become involved in the conflict, we could face significant adverse effects to our business and financial condition. For example, if our supply or customer arrangements are disrupted due to expanded sanctions or involvement of countries where we have operations or relationships, our business could be materially disrupted. Further, the use of cyberattacks could expand as part of the conflict, which could adversely affect our ability to maintain or enhance our cyber-security and data protection measures.

Although we believe we have adequate liquidity and capital resources to fund our operations for at least the next 12 months, we expect to need additional funding to fully complete our intended expansion initiatives, which we may seek to obtain through, among other avenues, public or private equity offerings and debt financings. If unfavorable capital market conditions exist, we may not be able to raise sufficient capital on favorable terms and on a timely basis, if at all. If we issue equity or convertible debt securities to raise additional funds, our existing shareholders may experience dilution and the new equity or debt securities may have rights, preferences and privileges senior to those of our then-existing shareholders. If we incur additional debt, it may

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

impose financial and operating covenants that could restrict the operations of our business. In a rising interest rate environment, debt financing will become more expensive and may have higher transactional and servicing costs. In addition, our existing indebtedness may limit our ability to obtain additional financing in the future. The potential inability to obtain adequate funding from debt or capital sources in the future could force us to self-fund strategic initiatives or even forego certain opportunities, which in turn could potentially harm our performance.

***We are subject to risks related to international sales and purchases.***

We expect that revenue from international sales will continue to represent a significant portion of our total revenue. As such, a significant slowdown or instability in relevant foreign economies or lower investments in new infrastructure could have a negative impact on our sales. We also purchase a portion of the materials included in our products from overseas sources.

Our international sales and purchases are subject to numerous United States and foreign laws and regulations, including, without limitation, tariffs, trade sanctions, trade barriers, trade embargoes, regulations relating to import-export control, technology transfer restrictions, the International Traffic in Arms Regulation promulgated under the Arms Export Control Act, the Foreign Corrupt Practices Act and the anti-boycott provisions of the U.S. Export Administration Act. The U.S. Government has imposed, and in the future may impose, restrictions on shipments to some of our current customers. Government restrictions on sales to certain foreign customers will reduce company revenue and profit related to those customers in the short term and could have a potential long-term impact.

Our international sales are subject to variability as our selling prices become less competitive in countries with currencies that are declining in value against the U.S. Dollar and more competitive in countries with currencies that are increasing in value against the U.S. Dollar. In addition, our international purchases can become more expensive if the U.S. Dollar weakens against the foreign currencies in which we are billed. We may in the future enter into foreign currency derivative financial instruments in an effort to manage or hedge some of our foreign exchange rate risk. We may not be able to engage in hedging transactions in the future, and, even if we do, foreign currency fluctuations may still have a material adverse effect on our results of operations.

***Our operations in foreign countries expose us to certain risks inherent in doing business internationally, which may adversely affect our business, results of operations or financial condition.***

We have revenue, operations and contract manufacturing arrangements in foreign countries that expose us to certain risks. For example, fluctuations in exchange rates may affect our revenue, expenses and results of operations as well as the value of our assets and liabilities as reflected in our financial statements. We are also subject to other types of risks of doing business internationally, including the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• protection of intellectual property and trade secrets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• tariffs, customs, trade sanctions, trade embargoes and other barriers to importing/exporting materials and products in a cost-effective and timely manner, or changes in applicable tariffs or custom rules;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the burden of complying with and changes in United States or international taxation policies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• timing and availability of export licenses;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• rising labor costs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• disruptions in or inadequate infrastructure of the countries where we operate;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the impact of public health epidemics on employees and the global economy, such as COVID-19;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• difficulties in collecting accounts receivable;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• difficulties in staffing and managing international operations; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the burden of complying with foreign and international laws and treaties.

For example, the United States has imposed significant tariffs on Chinese-made goods, which the Biden administration has previously indicated will largely remain in place. The tariffs imposed on Chinese goods, among other potential countries and any corresponding tariffs from China or such other countries in response has, and may in the future, negatively impact demand and/or increase the costs for our products. In some instances, we have received and may continue to receive incentives from foreign governments to encourage our investment in certain countries, regions or areas outside of the United States. Government incentives may include tax rebates, reduced tax rates, favorable lending policies and other measures, some or all of which may be available to us due to our foreign operations. Any of these incentives could be reduced or eliminated by governmental authorities at any time or as a result of our inability to maintain minimum operations necessary to earn the incentives. Any reduction or elimination of incentives currently provided for our operations could adversely affect our business and results of operations. These same governments also may provide increased incentives to or require production processes that favor local companies, which could further negatively impact our business and results of operations.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

Changes in regulatory, geopolitical, social, economic, or monetary policies and other factors may have a material adverse effect on our business in the future, or may require us to exit a particular market or significantly modify our current business practices. Abrupt political change, terrorist activity and armed conflict pose a risk of general economic disruption in affected countries, which could also result in an adverse effect on our business and results of operations.

**<u>Risks related to sales, product development and manufacturing</u>**

***We face significant challenges managing our growth strategy.***

Our potential for growth depends significantly on the adoption of our products within the markets we serve and for other applications, and our ability to affect this rate of adoption. In order to manage our growth and business strategy effectively relative to the uncertain pace of adoption, we must continue to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• maintain, expand, construct and purchase adequate manufacturing facilities and equipment, as well as secure sufficient third-party manufacturing resources, to meet customer demand, including specifically the expansion of our Silicon Carbide capacity with the opening of a state-of-the-art, automated 200mm capable Silicon Carbide device fabrication facility, an expansion of our materials factory in Durham, North Carolina, and the future construction of a new materials manufacturing facility in Siler City, North Carolina;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• manage an increasingly complex supply chain (including managing the impacts of ongoing supply constraints in the semiconductor industry) that has the ability to supply an increasing number of raw materials, subsystems and finished products with the required specifications and quality, and deliver on time to our manufacturing facilities, our third-party manufacturing facilities, our logistics operations, or our customers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• expand the capability of our information systems to support a more complex business, such as our current implementation of a new company-wide enterprise resource planning (ERP) system;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• access capital markets to fund our growth initiatives, including our ongoing and planned capacity expansions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• be successful in securing design-ins across our end markets, including automotive applications;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• realize our expected local, state and federal government incentives, including capital investment reimbursements, property tax reimbursements and sales tax exemptions from state, county and local governments, refundable income tax credits and capital grants through the CHIPS Act, and the successful application, receipt and potential sale of any tax credits we may receive under the Inflation Reduction Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• expand research and development, sales and marketing, technical support, distribution capabilities, manufacturing planning and administrative functions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• safeguard confidential information and protect our intellectual property;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• manage organizational complexity and communication;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• expand the skills and capabilities of our current management team;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• add experienced senior level managers and executives;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• attract and retain qualified employees; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• execute, maintain and adjust the operational and financial controls that support our business.

While we intend to continue to focus on managing our costs and expenses, we expect to invest to support our growth and may have additional unexpected costs. Such investments take time to become fully operational, and we may not be able to expand quickly enough to exploit targeted market opportunities. In connection with our efforts to cost-effectively manage our growth, we have increasingly relied on contractors for production capacity, logistics support and certain administrative functions including hosting of certain information technology software applications. If our contract manufacturers (including those at which we maintain captive lines) or other service providers do not perform effectively, we may not be able to achieve the expected cost savings and may incur additional costs to correct errors or fulfill customer demand. Depending on the function involved, such errors may also lead to business disruption, processing inefficiencies, the loss of or damage to intellectual property through security breach, or an impact on employee morale. Our operations may also be negatively impacted if any of these contract manufacturers or other service providers do not have the financial capability to meet our growing needs.

There are also inherent execution risks in starting up a new factory or expanding production capacity, whether one of our own factories or that of our contract manufacturers, as well as risks to moving production to different contract manufacturers, that could increase costs and reduce our operating results. In the fourth quarter of fiscal 2022, we opened a new Silicon Carbide device fabrication facility in Marcy, New York to complement the materials factory expansion underway at our United States campus headquarters in Durham, North Carolina. We also commenced work on our new materials manufacturing facility in Siler City, North Carolina in the first quarter of fiscal 2023. The establishment and operation of a new manufacturing facility or expansion of an existing facility involves significant risks and challenges, including, but not limited to, the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• design and construction delays and cost overruns;

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• issues in installing and qualifying new equipment and ramping production;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• poor production process yields and reduced quality control; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• insufficient personnel with requisite expertise and experience to operate a Silicon Carbide device fabrication facility.

We are also increasingly dependent on information technology to enable us to improve the effectiveness of our operations and to maintain financial accuracy and efficiency. Allocation and effective management of the resources necessary to successfully implement, integrate, train personnel and sustain our information technology platforms will remain critical to ensure that we are not subject to transaction errors, processing inefficiencies, loss of customers, business disruptions or loss of or damage to intellectual property through a security breach in the near term. Additionally, we face these same risks if we fail to allocate and effectively manage the resources necessary to build, implement, upgrade, integrate and sustain appropriate technology infrastructure over the longer term.

***Variations in our production could impact our ability to reduce costs and could cause our margins to decline and our operating results to suffer.***

All of our products are manufactured using technologies that are highly complex. The number of usable items, or yield, from our production processes may fluctuate as a result of many factors, including but not limited to the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• variability in our process repeatability and control;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• contamination of the manufacturing environment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• equipment failure, power outages, fires, flooding, information or other system failures or variations in the manufacturing process;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• lack of consistency and adequate quality and quantity of piece parts, other raw materials and other bill of materials items;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• inventory shrinkage or human errors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• defects in production processes (including system assembly) either within our facilities or at our suppliers; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any transitions or changes in our production process, planned or unplanned.

In the past, we have experienced difficulties in achieving acceptable yields on certain products, which has adversely affected our operating results. We may experience similar problems in the future, and we cannot predict when they may occur or their severity.

In some instances, we may offer products for future delivery at prices based on planned yield improvements or increased cost efficiencies from other production advances. Failure to achieve these planned improvements or advances could have a significant impact on our margins and operating results.

In addition, our ability to convert volume manufacturing to larger diameter substrates can be an important factor in providing a more cost-effective manufacturing process. We continue to prepare for production using 200mm substrates and if we are unable to make this transition in a timely or cost-effective manner, our results could be negatively impacted.

***Our operating results are substantially dependent on the acceptance of new products.***

Our future success may depend on our ability to deliver new, higher performing and/or lower cost solutions for existing and new markets and for customers to accept those solutions. The development of new products is a highly complex process, and we have in some instances experienced delays in completing the development, introduction and qualification of new products which has impacted our results in the past. Our research and development efforts are aimed at solving increasingly complex problems, and we do not expect that all our projects will be successful. The successful development, introduction and acceptance of new products depend on a number of factors, including the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• qualification and acceptance of our new product and systems designs, specifically entering into automotive applications which require even more stringent levels of qualification and standards;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to effectively transfer increasingly complex products and technology from development to manufacturing, including the transition to 200mm substrates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to introduce new products in a timely and cost-effective manner;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to secure volume purchase orders related to new products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• achievement of technology breakthroughs required to make commercially viable products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to convert customer design-ins to sales of significant volume, and, if customer design-in activity does result in such sales, when such sales will ultimately occur and what the amount of such sales will be;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the accuracy of our predictions for market requirements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to predict, influence and/or react to evolving standards;

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• acceptance of new technology in certain markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to protect intellectual property developed in new products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the availability of qualified research and development personnel;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our timely completion of product designs and development;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to develop repeatable processes to manufacture new products in sufficient quantities, with the desired specifications and at competitive costs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our customers' ability to develop competitive products incorporating our products; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• market acceptance of our products and our customers' products.

If any of these or other similar factors becomes problematic, we may not be able to deliver and introduce new products in a timely or cost-effective manner.

***Our results of operations, financial condition and business could be harmed if we are unable to balance customer demand and capacity.***

As customer demand for our products changes, we must be able to adjust our production capacity to meet demand. We are continually taking steps to address our manufacturing capacity needs for our products. Currently, we are focusing on increasing production capacity. If we are not able to increase our production capacity at our targeted rate, if there are unforeseen costs associated with increasing our capacity levels, or if we are unable to obtain advanced semiconductor manufacturing equipment in a timely manner, we may not be able to achieve our financial targets. We may be unable to build or qualify new capacity on a timely basis to meet customer demand and customers may fulfill their orders with one of our competitors instead. In addition, as we introduce new products and change product generations, we must balance the production and inventory of prior generation products with the production and inventory of new generation products, whether manufactured by us or our contract manufacturers, to maintain a product mix that will satisfy customer demand and mitigate the risk of incurring cost write-downs on the previous generation products, related raw materials and tooling. Significant or prolonged shortages or delivery delays of our products to our customers could delay their manufacturing and negatively impact our relationships with these customers.

Due to the proportionately high fixed cost nature of our business (such as facility costs), if demand does not materialize at the rate forecasted, we may not be able to scale back our manufacturing expenses or overhead costs quickly enough to correspond to the lower than expected demand. This could result in lower margins and adversely impact our business and results of operations. Additionally, if product demand decreases or we fail to forecast demand accurately, our results may be adversely impacted due to higher costs resulting from lower factory utilization, causing higher fixed costs per unit produced. Further, we may be required to recognize impairments on our long-lived assets or recognize excess inventory write-off charges, or excess capacity charges, which would have a negative impact on our results of operations.

With the opening of our new Silicon Carbide device fabrication facility in Marcy, New York, we may experience increased pressure on margins during the period when production begins but before the facility is at full utilization. Additionally, our large upfront investment in the facility to increase capacity does not guarantee we will need the capacity and we may experience lower than expected capacity once the facility is in production, which could result in further margin pressures.

In addition, our efforts to improve quoted delivery lead-time performance may result in corresponding reductions in order backlog. A decline in backlog levels could result in more variability and less predictability in our quarter-to-quarter revenue and operating results.

***We face risks relating to our suppliers, including that we rely on a number of key sole source and limited source suppliers, are subject to high price volatility on certain commodity inputs, variations in parts quality, and raw material consistency and availability, and rely on independent shipping companies for delivery of our products.***

We depend on a number of sole source and limited source suppliers for certain raw materials, components, services and equipment used in manufacturing our products, including key materials and equipment used in critical stages of our manufacturing processes. Although alternative sources generally exist for these items, qualification of many of these alternative sources could take up to six months or longer. Where possible, we attempt to identify and qualify alternative sources for our sole and limited source suppliers.

We generally purchase these sole or limited source items with purchase orders, and we have limited guaranteed supply arrangements with such suppliers. Some of our sources can have variations in attributes and availability which can affect our ability to produce products in sufficient volume or quality. We do not control the time and resources that these suppliers devote to our business, and we cannot be sure that these suppliers will perform their obligations to us. Additionally, general shortages in the marketplace of certain raw materials or key components may adversely impact our business. In the past, we have

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

experienced decreases in our production yields when suppliers have varied from previously agreed upon specifications or made other modifications we do not specify, which impacted our cost of revenue.

Additionally, the inability of our suppliers to access capital efficiently could cause disruptions in their businesses, thereby negatively impacting ours. This risk may increase from unpredictable and unstable changes in economic conditions, including recession, inflation, or other changes, which may negatively affect key suppliers or a significant number of our other suppliers. Any delay in product delivery or other interruption or variation in supply from these suppliers could prevent us from meeting commercial demand for our products. If we were to lose key suppliers, if our key suppliers were unable to support our demand for any reason or if we were unable to identify and qualify alternative suppliers, our manufacturing operations could be interrupted or hampered significantly.

We rely on arrangements with independent shipping companies for the delivery of our products from vendors and to customers both in the United States and abroad. The failure or inability of these shipping companies to deliver products or the unavailability of shipping or port services, even temporarily, could have a material adverse effect on our business. We may also be adversely affected by an increase in freight surcharges due to rising fuel costs, oil costs and added security.

The risks mentioned above, including our sole source or limited source suppliers' ability to produce products and adequately access capital, and our ability to arrange effective shipping arrangements, have increased and may further increase due to the ongoing COVID-19 pandemic.

In our fabrication process, we consume a number of precious metals and other commodities, which are subject to high price volatility and the potential impacts of increased inflation. Our operating margins could be significantly affected if we are not able to pass along price increases to our customers. In addition, production could be disrupted by the unavailability of the resources used in production such as water, silicon, electricity and gases. Future environmental regulations could restrict supply or increase the cost of certain of those materials.

***We operate in industries that are subject to significant fluctuation in supply and demand and ultimately pricing, which affects our revenue and profitability.***

The industries we serve are in different stages of adoption and are characterized by constant and rapid technological change, rapid product obsolescence and price erosion, evolving standards and fluctuations in product supply and demand. The semiconductor industry is characterized by rapid technological change, high capital expenditures, short product life cycles and continuous advancements in process technologies and manufacturing facilities. As the markets for our products mature, additional fluctuations may result from variability and consolidations within the industry's customer base. These fluctuations have been characterized by lower product demand, production overcapacity, higher inventory levels and aggressive pricing actions by our competitors. These fluctuations have also been characterized by higher demand for key components and equipment used in, or in the manufacture of, our products resulting in longer lead times, supply delays and production disruptions. We have experienced these conditions in our business and may experience such conditions in the future, which could have a material negative impact on our business, results of operations or financial condition.

In addition, as we diversify our product offerings and as pricing differences in the average selling prices among our product lines widen, a change in the mix of sales among our product lines may increase volatility in our revenue and gross margin from period to period.

***The markets in which we operate are highly competitive and have evolving technical requirements.***

The markets for our products are highly competitive. In the semiconductor market, we compete with companies that have greater market share, name recognition, distribution and sales channels, and/or technical resources than we do. Competitors continue to offer new products with aggressive pricing, additional features and improved performance. Aggressive pricing actions by our competitors in our businesses could reduce margins if we are not able to reduce costs at an equal or greater rate than the sales price decline.

As competition increases, we need to continue to develop new products that meet or exceed the needs of our customers. Therefore, our ability to continually produce more efficient and lower cost power and RF products that meet the evolving needs of our customers will be critical to our success. Competitors may also try to align with some of our strategic customers. This could lead to lower prices for our products, reduced demand for our products and a corresponding reduction in our ability to recover development, engineering and manufacturing costs. Any of these developments could have an adverse effect on our business, results of operations or financial condition.

***We depend on a limited number of customers, including distributors, for a substantial portion of our revenue, and the loss of, or a significant reduction in purchases by, one or more of these customers could adversely affect our operating results.***

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

We receive a significant amount of our revenue from a limited number of customers and distributors, two of which individually represented more than 10% of our consolidated revenue in fiscal 2022. Many of our customer orders are made on a purchase order basis, which does not generally require any long-term customer commitments. Therefore, these customers may alter their purchasing behavior with little or no notice to us for various reasons, including developing, or, in the case of our distributors, their customers developing, their own product solutions; choosing to purchase or distribute product from our competitors; incorrectly forecasting end market demand for their products; or experiencing a reduction in their market share in the markets for which they purchase our products. If our customers alter their purchasing behavior, if our customers' purchasing behavior does not match our expectations or if we encounter any problems collecting amounts due from them, our financial condition and results of operations could be negatively impacted.

***Our revenue is highly dependent on our customers' ability to produce, market and sell more integrated products.***

Our revenue depends on getting our products designed into a larger number of our customers' products and in turn, our customers' ability to produce, market and sell their products. For example, we have current and prospective customers that create, or plan to create, power and RF products or systems using our substrates, die, components or modules. Even if our customers are able to develop and produce products or systems that incorporate our substrates, die, components or modules, there can be no assurance that our customers will be successful in marketing and selling these products or systems in the marketplace.

***Our results may be negatively impacted if customers do not maintain their favorable perception of our brands and products.***

Maintaining and continually enhancing the value of our brands is critical to the success of our business. Brand value is based in large part on customer perceptions. Success in promoting and enhancing brand value depends in large part on our ability to provide high-quality products. Brand value could diminish significantly due to a number of factors, including adverse publicity about our products (whether valid or not), a failure to maintain the quality of our products (whether perceived or real), the failure of our products to deliver consistently positive consumer experiences, the products becoming unavailable to consumers or consumer perception that we have acted in an irresponsible manner. Damage to our brand, reputation or loss of customer confidence in our brand or products could result in decreased demand for our products and have a negative impact on our business, results of operations or financial condition.

***If our products fail to perform or fail to meet customer requirements or expectations, we could incur significant additional costs, including costs associated with the recall of those items.***

The manufacture of our products involves highly complex processes. Our customers specify quality, performance and reliability standards that we must meet. If our products do not meet these standards, we may be required to replace or rework the products. In some cases, our products may contain undetected defects or flaws that only become evident after shipment and installation. Even if our products meet standard specifications, our customers may attempt to use our products in applications for which they were not designed or in products that were not designed or manufactured properly, resulting in product failures and creating customer satisfaction issues.

We have experienced product quality, performance or reliability problems from time to time and defects or failures may occur in the future. If failures or defects occur, they could result in significant losses or product recalls. A significant product recall could also result in adverse publicity, damage to our reputation and a loss of customer confidence in our products. We also may be the target of product liability lawsuits against us if the use of our products at issue is determined to have caused injury or contained a substantial product hazard.

We provide standard warranty periods of 90 days on our products, with longer periods under a limited number of customer contracts. Although we believe our reserves are appropriate, we are making projections about the future reliability of new products and technologies, and we may experience increased variability in warranty claims. Increased warranty claims could result in significant losses due to a rise in warranty expense and costs associated with customer support.

***If we are unable to effectively develop, manage and expand our sales channels for our products, our operating results may suffer.***

We sell a portion of our products to distributors, including a distributor that represented more than 10% of our revenue in fiscal 2022. We rely on distributors to develop and expand their customer base as well as to anticipate demand from their customers. If they are not successful, our growth and profitability may be adversely impacted. Distributors must balance the need to have enough products in stock in order to meet their customers' needs against their internal target inventory levels and the risk of potential inventory obsolescence. The risks of inventory obsolescence are especially relevant to technological products. The distributors' internal target inventory levels vary depending on market cycles and a number of factors within each distributor over which we have very little, if any, control. Distributors also have the ability to shift business to different manufacturers

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

within their product portfolio based on a number of factors, including new product availability and performance. Similarly, we have the ability to add, consolidate, or remove distributors.

We typically recognize revenue on products sold to distributors when the item is shipped and title passes to the distributor (sell-in method). Certain distributors have limited rights to return inventory under stock rotation programs and have limited price protection rights for which we make estimates. We evaluate inventory levels in the distribution channel, current economic trends and other related factors in order to account for these factors in our judgments and estimates. As inventory levels and product return trends change or we make changes to our distributor roster, we may have to revise our estimates and incur additional costs, and our gross margins and operating results could be adversely impacted.

***As a result of our continued expansion into new markets, we may compete with existing customers who may reduce their orders.***

We continue to expand into new markets and new market segments. Many of our existing customers who purchase our Silicon Carbide substrate materials develop and manufacture devices, die and components using those wafers that are offered in the same power and RF markets. As a result, some of our current customers perceive us as a competitor in these market segments. In response, our customers may reduce or discontinue their orders for our substrate materials. This reduction in or discontinuation of orders could occur faster than our sales growth in these new markets, which could adversely affect our business, results of operations or financial condition.

**<u>Risks associated with our strategic transactions</u>**

***If we fail to evaluate and execute strategic opportunities successfully, our business may suffer.***

From time to time, including the present, we evaluate strategic opportunities available to us for product, technology or business transactions, such as business acquisitions, investments or capacity expansions, joint ventures, divestitures, or spin-offs. If we choose to enter into such strategic transactions, we face certain risks including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the failure of an acquired business, investee or joint venture to meet our performance and financial expectations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• identification of additional liabilities relating to an acquired business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• loss of customers due to perceived conflicts or competition with such customers or due to regulatory actions taken by governmental agencies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• that we are not able to enter into acceptable contractual arrangements in connection with the transaction;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• difficulty integrating an acquired business's operations, personnel and financial and operating systems into our current business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• that we are not able to develop and expand customer bases and accurately anticipate demand from end customers, which can result in increased inventory and reduced orders if we experience wide fluctuations in supply and demand;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• diversion of management attention;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• difficulty separating the operations, personnel and financial and operating systems of a spin-off or divestiture from our current business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the possibility we are unable to complete the transaction and expend substantial resources without achieving the desired benefit;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the inability to obtain required regulatory agency approvals;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• reliance on a transaction counterparty for transition services for an extended period of time, which may result in additional expenses and delay the integration of the acquired business and realization of the desired benefit of the transaction;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• uncertainty of the financial markets or circumstances that cause conditions that are less favorable and/or different than expected; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• expenses incurred to complete a transaction may be significantly higher than anticipated.

We may not be able to adequately address these risks or any other problems that arise from our prior or future acquisitions, investments, joint ventures, divestitures or spin-offs. Any failure to successfully evaluate strategic opportunities and address risks or other problems that arise related to any such business transaction could adversely affect our business, results of operations or financial condition.

***We are subject to a number of risks associated with the sale of our former LED Products segment, and these risks could adversely impact our operations, financial condition and business.***

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

On March 1, 2021, we completed the sale of our former LED Products segment to SMART pursuant to the Asset Purchase Agreement dated October 18, 2020 (the LED Purchase Agreement). We are subject to a number of risks associated with this transaction, including risks associated with:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the restrictions on and obligations with respect to our business set forth in the transition services agreement and the Wafer Supply Agreement, in each case between us and CreeLED; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any required payments of indemnification obligations under the LED Purchase Agreement for retained liabilities and breaches of representations, warranties or covenants.

As a result of these risks, we may be unable to realize the anticipated benefits of the transaction. Our failure to realize the anticipated benefits of the transaction would adversely impact our operations, financial condition and business and could limit our ability to pursue additional strategic transactions.

***We are subject to risks associated with the sale of our former Lighting Products business unit, and these risks could adversely impact our financial condition.***

On May 13, 2019, we closed the sale of our former Lighting Products business unit to IDEAL Industries, Inc. (IDEAL). We are subject to risks associated with this transaction, including risks associated with any required payments of indemnification obligations under the Purchase Agreement with IDEAL for retained liabilities and breaches of representations, warranties or covenants.

As a result, we may be unable to realize the anticipated benefits of the transaction. Our failure to realize the anticipated benefits of the transaction would adversely impact our financial condition and could limit our ability to pursue additional strategic transactions.

**<u>Risks associated with cybersecurity, intellectual property and litigation</u>**

***We may be subject to confidential information theft or misuse, which could harm our business and results of operations.***

We face attempts by others to gain unauthorized access to our information technology systems on which we maintain proprietary and other confidential information and such attempts may increase in terms of frequency and severity in light of the sanctions imposed on Russia in response to its invasion of Ukraine. Our security measures may be breached as the result of industrial or other espionage actions of outside parties, employees, employee error, malfeasance or otherwise, and as a result, an unauthorized party may obtain access to our systems. The risk of a security breach or disruption, particularly through cyber-attacks, ransomware, or cyber intrusion, including by computer hackers, foreign governments, and cyber terrorists, has generally increased as cyber-attacks have become more prevalent and harder to detect and fight against. Additionally, outside parties may attempt to access our confidential information through other means, for example by fraudulently inducing our employees to disclose confidential information. We actively seek to prevent, detect and investigate any unauthorized access, which sometimes occurs and is usually not recognized until after it has occurred. To date, we do not believe that such unauthorized access has caused us any material damage. We might be unaware of any such access or unable to determine its magnitude and effects. We are also at risk of security breaches and disruptions occurring at third parties that we work with, including our customers and suppliers. In addition, these threats are constantly evolving, thereby increasing the difficulty of successfully defending against them or implementing adequate preventative measures. The theft and/or unauthorized use or publication of our trade secrets and other confidential business information as a result of such an incident could adversely affect our competitive position, result in a loss of confidence in the adequacy of our threat mitigation and detection processes and procedures, cause us to incur significant costs to remedy the damage caused by the incident, divert management's attention and other resources, and reduce the value of our investment in research and development. In addition, the increased prevalence of employees working from home may exacerbate the aforementioned cybersecurity risks. Our business could be subject to significant disruption and we could suffer monetary or other losses.

Our disclosure controls and procedures address cybersecurity and include elements intended to ensure that there is an analysis of potential disclosure obligations arising from security breaches. In addition, we are subject to data privacy, protection and security laws and regulations, including the European General Data Protection Act (GDPR) that governs personal information of European persons. We also maintain compliance programs to address the potential applicability of restrictions against trading while in possession of material, nonpublic information generally and in connection with a cyber-security breach. However, a breakdown in existing controls and procedures around our cyber-security environment may prevent us from detecting, reporting or responding to cyber incidents in a timely manner and could have a material adverse effect on our financial position and value of our stock.

***There are limitations on our ability to protect our intellectual property.***

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

Our intellectual property position is based in part on patents owned by us and patents licensed to us. We intend to continue to file patent applications in the future, where appropriate, and to pursue such applications with U.S. and certain foreign patent authorities.

Our existing patents are subject to expiration and re-examination and we cannot be sure that additional patents will be issued on any new applications around the covered technology or that our existing or future patents will not be successfully contested by third parties. Also, because issuance of a valid patent does not prevent other companies from using alternative, non-infringing technology, we cannot be sure that any of our patents, or patents issued to others and licensed to us, will provide significant commercial protection, especially as new competitors enter the market.

We periodically discover products that are counterfeit reproductions of our products or that otherwise infringe on our intellectual property rights. The actions we take to establish and protect trademarks, patents and other intellectual property rights may not be adequate to prevent imitation of our products by others, and therefore, may adversely affect our sales and our brand and result in the shift of customer preference away from our products. Further, the actions we take to establish and protect trademarks, patents and other intellectual property rights could result in significant legal expense and divert the efforts of our technical personnel and management, even if the litigation or other action results in a determination favorable to us.

We also rely on trade secrets and other non-patented proprietary information relating to our product development and manufacturing activities. We try to protect this information through appropriate efforts to maintain its secrecy, including requiring employees and third parties to sign confidentiality agreements. We cannot be sure that these efforts will be successful or that the confidentiality agreements will not be breached. We also cannot be sure that we would have adequate remedies for any breach of such agreements or other misappropriation of our trade secrets, or that our trade secrets and proprietary know-how will not otherwise become known or be independently discovered by others.

***Litigation could adversely affect our operating results and financial condition.***

We are often involved in litigation, primarily patent litigation. Defending against existing and potential litigation will likely require significant attention and resources and, regardless of the outcome, result in significant legal expenses, which could adversely affect our results unless covered by insurance or recovered from third parties. If our defenses are ultimately unsuccessful or if we are unable to achieve a favorable resolution, we could be liable for damage awards that could materially affect our results of operations and financial condition.

Where necessary, we may initiate litigation to enforce our patent or other intellectual property rights, which could adversely impact our relationship with certain customers. Any such litigation may require us to spend a substantial amount of time and money and could distract management from our day-to-day operations. Moreover, there is no assurance that we will be successful in any such litigation.

***Our business may be impaired by claims that we, or our customers, infringe the intellectual property rights of others.***

Vigorous protection and pursuit of intellectual property rights characterize our industry. These traits have resulted in significant and often protracted and expensive litigation. Litigation to determine the validity of patents or claims by third parties of infringement of patents or other intellectual property rights could result in significant legal expense and divert the efforts of our technical personnel and management, even if the litigation results in a determination favorable to us. In the event of an adverse result in such litigation, we could be required to pay substantial damages; indemnify our customers; stop the manufacture, use and sale of products found to be infringing; incur asset impairment charges; discontinue the use of processes found to be infringing; expend significant resources to develop non-infringing products or processes; or obtain a license to use third party technology.

There can be no assurance that third parties will not attempt to assert infringement claims against us, or our customers, with respect to our products. In addition, our customers may face infringement claims directed to the customer's products that incorporate our products, and an adverse result could impair the customer's demand for our products. We have also promised certain of our customers that we will indemnify them in the event they are sued by our competitors for infringement claims directed to the products we supply. Under these indemnification obligations, we may be responsible for future payments to resolve infringement claims against them.

From time to time, we receive correspondence asserting that our products or processes are or may be infringing patents or other intellectual property rights of others. If we believe the assertions may have merit or in other appropriate circumstances, we may take steps to seek to obtain a license or to avoid the infringement. We cannot predict, however, whether a license will be available; that we would find the terms of any license offered acceptable; or that we would be able to develop an alternative solution. Failure to obtain a necessary license or develop an alternative solution could cause us to incur substantial liabilities and costs and to suspend the manufacture of affected products.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**<u>Risks related to the effects of COVID-19 and other potential future public health crises, pandemics or similar events</u>**

***We may be subject to volatility and uncertainty in customer demand, supply chains, worldwide economies and financial markets resulting from the COVID-19 pandemic or other outbreak of infectious disease or similar public health threat.***

We have significant manufacturing operations in the United States and contract manufacturing agreements in Asia, which were affected by the COVID-19 pandemic and the measures to try to contain it. We initially experienced some limited disruptions in supply from some of our suppliers, although the disruptions to date have not been significant. At some of our contract manufacturers in Asia, which include captive lines and contract packaging facilities, we have experienced, and may experience in the future, some disruptions in supply from containment measures.

The emergence of fast-spreading variants and the potential waning effectiveness of vaccines have introduced renewed uncertainty into whether additional measures will be implemented to combat the spread of COVID-19. Restrictions on access to our manufacturing facilities or on our support operations or workforce, or similar limitations for our vendors and suppliers, and restrictions or disruptions of transportation, such as reduced availability of air transport, port closures, and increased border controls or closures, could limit our ability to meet customer demand, lead to increased costs and have a material adverse effect on our financial condition and results of operations.

The COVID-19 pandemic has significantly increased economic and demand uncertainty. These uncertainties also make it more difficult for us to assess the quality of our product order backlog and to estimate future financial results. The COVID-19 pandemic initially caused an economic slowdown, and the continued spread of COVID-19 and its variants could contribute to or exacerbate a global economic slowdown or recession, which could have a material adverse effect on demand for our products and on our financial condition and results of operations.

The spread of COVID-19 and its variants has caused us to modify our business practices. We may take further actions as may be required by government authorities or that we determine are in the best interests of our employees, customers, partners, and suppliers. There is no certainty that such measures will be sufficient to mitigate the risks posed by the virus and its variants, and our ability to perform critical functions could be harmed. In addition, in light of concerns about the spread of COVID-19 and its variants, our workforce has at times been operating at reduced levels at our manufacturing facilities and at the facilities of some of our contract manufacturers, which may continue to have an adverse impact on our ability to timely meet future customer orders.

The duration of the business disruption and related financial impact of the COVID-19 pandemic cannot be reasonably estimated at this time. However, it may materially affect our ability to obtain raw materials, manage input costs, manage customer credit risk, manufacture products or deliver inventory in a timely manner, and it also may impair our ability to meet customer demand for products, result in lost sales, additional costs, or penalties, or damage our reputation. The extent to which COVID-19, its variants or an outbreak of any other infectious disease will further impact our operations and results will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and its variants, the efficacy and effectiveness of vaccines, and the actions to contain the virus or treat its impact, among others.

**<u>Risks related to legal, regulatory, accounting, tax and compliance matters</u>**

***We may be required to recognize a significant charge to earnings if our goodwill or other assets become impaired.***

Goodwill and other assets are reviewed for impairment annually and when events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Factors that may indicate that the carrying value of our goodwill may not be recoverable include a significant decline in our stock price and market capitalization and slower growth rates in our industry. For other assets such as finite-lived intangible assets and fixed assets, we assess the recoverability of the asset balance when indicators of potential impairment are present. The recognition of a significant charge to earnings in our consolidated financial statements resulting from any impairment of our goodwill or other assets could adversely impact our results of operations.

***The adoption of or changes in government and/or industry policies, standards or regulations relating to the efficiency, performance, vehicle range or other aspects of our products and the products in which they are utilized could impact the demand for our products.***

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

The adoption of or changes in government and/or industry policies, standards or regulations relating to the efficiency, performance, vehicle range or other aspects of our products and the products in which they are utilized or integrated may impact the demand for our products. For example, efforts to change, eliminate or reduce industry or regulatory standards could negatively impact our business. These constraints may be eliminated or delayed by legislative action, which could have a negative impact on demand for our products. Our ability and the ability of our competitors to meet evolving government and/or industry requirements could impact competitive dynamics in the market.

***Changes in our effective tax rate may affect our results.***

Our future effective tax rates may be affected by a number of factors including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the jurisdiction in which profits are determined to be earned and taxed;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• potential changes in tax laws or alterations in the interpretation of such tax laws and changes in generally accepted accounting principles, for example interpretations and U.S. regulations issued as a result of the significant changes to the U.S. tax law included within the Tax Cuts and Jobs Act of 2017 (the TCJA) and the Coronavirus Aid, Relief and Economic Security Act of 2020;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the imposition of the proposed global corporate minimum tax rate;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the resolution of issues arising from tax audits with various authorities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in the valuation of our deferred tax assets and liabilities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the ongoing restructuring of our existing legal entities, including the restructuring of our Luxembourg holding company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• adjustments to estimated taxes upon finalization of various tax returns;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• increases in expenses not deductible for tax purposes, including impairment of goodwill in connection with acquisitions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in available tax credits;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the recognition and measurement of uncertain tax positions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• variations in realized tax deductions for certain stock-based compensation awards (such as non-qualified stock options and restricted stock) from those originally anticipated; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the repatriation of non-U.S. earnings for which we have not previously provided for taxes or any changes in legislation that may result in these earnings being taxed, regardless of our decision regarding repatriation of funds. For example, the TCJA included a one-time tax on deemed repatriated earnings of non-U.S. subsidiaries.

Any significant increase or decrease in our future effective tax rates could impact net (loss) income for future periods. In addition, the determination of our income tax provision requires complex estimations, significant judgments and significant knowledge and experience concerning the applicable tax laws. To the extent our income tax liability materially differs from our income tax provisions due to factors, including the above, which were not anticipated at the time we estimated our tax provision, our net (loss) income or cash flows could be affected.

***Failure to comply with applicable environmental laws and regulations worldwide could harm our business and results of operations.***

The manufacturing, assembling and testing of our products require the use of hazardous materials that are subject to a broad array of environmental, health and safety laws and regulations. Our failure to comply with any of these applicable laws or regulations could result in regulatory penalties, fines, legal liabilities and the forfeiture of certain tax benefits; suspension of production; alteration of our fabrication, assembly and test processes; and curtailment of our operations or sales.

In addition, our failure to manage the use, transportation, emission, discharge, storage, recycling or disposal of hazardous materials could subject us to significant costs or future liabilities. Existing and future environmental laws and regulations could also require us to acquire pollution abatement or remediation equipment, modify our product designs or incur other expenses, such as permit costs, associated with such laws and regulations. Many new materials that we are evaluating for use in our operations may be subject to regulation under existing or future environmental laws and regulations that may restrict our use of one or more of such materials in our manufacturing, assembly and test processes or products. Any of these restrictions could harm our business and results of operations by increasing our expenses or requiring us to alter our manufacturing processes.

New climate change laws and regulations could require us to change our manufacturing processes or procure substitute raw materials that may cost more or be more difficult to procure. Various jurisdictions in which we do business have implemented, or in the future could implement or amend, restrictions on emissions of carbon dioxide or other greenhouse gases, limitations or restrictions on water use, regulations on energy management and waste management, and other climate change-based rules and regulations, which may increase our expenses and adversely affect our operating results. We expect increased worldwide

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

regulatory activity relating to climate change in the future. Future compliance with these laws and regulations may adversely affect our business and results of operations.

***Our results could vary as a result of the methods, estimates and judgments that we use in applying our accounting policies, including changes in the accounting standards to be applied.***

The methods, estimates and judgments that we use in applying our accounting policies have a significant impact on our results (see "Critical Accounting Estimates" in Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our 2022 Annual Report). Such methods, estimates and judgments are, by their nature, subject to substantial risks, uncertainties and assumptions, and factors may arise over time that lead us to change our methods, estimates and judgments. Changes in those methods, estimates and judgments could significantly affect our results of operations or financial condition, such as the change in estimated useful lives of certain assets applied in the first quarter of fiscal 2022.

Likewise, our results may be impacted due to changes in the accounting standards to be applied, such as the changes in convertible debt recognition requirements.

***Regulations related to conflict-free minerals may force us to incur additional expenses.***

Rules adopted by the SEC under the Dodd-Frank Wall Street Reform and Consumer Protection Act impose annual disclosure and reporting requirements for those companies who may use "conflict" minerals mined from the Democratic Republic of Congo and adjoining countries in their products. We may face challenges with government regulators, our customers and our suppliers if we are unable to sufficiently verify that the metals used in our products are conflict free. Our most recent disclosure regarding our due diligence was filed on May 31, 2022 for calendar year 2021.

**<u>General risk factors</u>**

***Catastrophic events and disaster recovery may disrupt business continuity.***

A disruption or failure of our systems or operations in the event of a natural disaster or severe weather event, including, but not limited to, earthquakes, wildfires, droughts, flooding, tornadoes, hurricanes or tsunamis, health pandemic, such as an influenza outbreak within our workforce, or man-made catastrophic event could cause delays in completing sales, continuing production or performing other critical functions of our business, particularly if a catastrophic event were to occur at our primary manufacturing locations or our subcontractors' locations. Global climate change could result in certain natural disasters occurring more frequently or with greater intensity. Any of these events could severely affect our ability to conduct normal business operations and, as a result, our operating results could be adversely affected. There may also be secondary impacts that are unforeseeable as well, such as impacts to our customers, which could cause delays in new orders, delays in completing sales or even order cancellations.

***In order to compete, we must attract, motivate and retain key employees, and our failure to do so could harm our results of operations.***

Hiring and retaining qualified executives, scientists, engineers, technical staff, sales personnel and production personnel is critical to our business, and competition for experienced employees in our industry can be intense. As a global company, this issue is not limited to the United States, but includes our other locations such as Europe and Asia. For example, there is substantial competition for qualified and capable personnel, particularly experienced engineers and technical personnel, which may make it difficult for us to recruit and retain qualified employees. If we are unable to staff sufficient and adequate personnel at our facilities, we may experience lower revenue or increased manufacturing costs, which would adversely affect our results of operations.

To help attract, motivate and retain key employees, we use benefits such as stock-based compensation awards. If the value of such awards does not appreciate, as measured by the performance of the price of our common stock or if our stock-based compensation otherwise ceases to be viewed as a valuable benefit, our ability to attract, retain and motivate employees could be weakened, which could harm our business and results of operations.

***Our stock price may be volatile.***

Historically, our common stock has experienced substantial price volatility, particularly as a result of significant fluctuations in our revenue, earnings and margins over the past few years, and variations between our actual financial results and the published expectations of analysts. For example, the closing price per share of our common stock on the New York Stock Exchange ranged from a low of $58.67 to a high of $122.07 during the twelve months ended December 25, 2022. If our future operating results or margins are below the expectations of stock market analysts or our investors, our stock price will likely decline.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

Speculation and opinions in the press or investment community about our strategic position, financial condition, results of operations or significant transactions can also cause changes in our stock price. In particular, competition in some of the markets we address such as electric vehicles and 5G, the ramp up of our business, and the effect of tariffs or COVID-19 on our business, may have a dramatic effect on our stock price.

Additionally, actions taken by the option counterparties in the capped call transactions entered into in connection with the 2028 Notes and the 2029 Notes may affect our stock price, including the potential modifications of their hedge positions by entering into or unwinding various derivatives with respect to our common stock.

***We are exposed to fluctuations in the market value of our investment portfolio and in interest rates, and therefore, impairment of our investments or lower investment income could harm our earnings.***

We are exposed to market value and inherent interest rate risk related to our investment portfolio. We have historically invested portions of our available cash in fixed interest rate securities such as high-grade corporate debt, commercial paper, municipal bonds, certificates of deposit, government securities and other fixed interest rate investments. The primary objective of our cash investment policy is preservation of principal. However, these investments are generally not Federal Deposit Insurance Corporation insured and may lose value and/or become illiquid regardless of their credit rating.

From time to time, we have also made investments in public and private companies that engage in complementary businesses.

***We have outstanding debt which could materially restrict our business and adversely affect our financial condition, liquidity and results of operations.***

As of December 25, 2022, our indebtedness consisted of $575.0 million aggregate principal amount of the 2026 Notes, $750.0 million aggregate principal amount of the 2028 Notes and $1,750.0 million aggregate principal amount of the 2029 Notes (collectively, the Outstanding Notes) and potential borrowings from our revolving line of credit. Our ability to pay interest and repay the principal for any outstanding indebtedness under our line of credit and the Outstanding Notes is dependent upon our ability to manage our business operations and generate sufficient cash flows to service such debt. There can be no assurance that we will be able to manage any of these risks successfully.

The level of our outstanding debt may adversely affect our operating results and financial condition by, among other things:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• increasing our vulnerability to downturns in our business, to competitive pressures and to adverse general economic and industry conditions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• requiring the dedication of an increased portion of our expected cash flows from operations to service our indebtedness, thereby reducing the amount of expected cash flow available for other purposes, including capital expenditures, research and development and stock repurchases;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• limiting our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• placing us at a competitive disadvantage compared to our peers that may have less indebtedness than we have by limiting our ability to borrow additional funds needed to operate and grow our business; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• increasing our interest expense if interest rates increase.

Our line of credit requires us to maintain compliance with an asset coverage ratio. In addition, our line of credit contains certain restrictions that could limit our ability to, among other things: incur additional indebtedness, dispose of assets, create liens on assets, make acquisitions or engage in mergers or consolidations, and engage in certain transactions with our subsidiaries and affiliates. The Indentures governing the Outstanding Notes require us to repurchase the Outstanding Notes upon certain fundamental changes relating to our common stock, and also prohibit our consolidation, merger, or sale of all or substantially all of our assets except with or to a successor entity assuming our obligations under the Indentures. The restrictions imposed by our line of credit and by the Indentures governing the Outstanding Notes could limit our ability to plan for or react to changing business conditions, or could otherwise restrict our business activities and plans.

Our ability to comply with our loan covenants and the provisions of the Indentures governing the Outstanding Notes may also be affected by events beyond our control and if any of these restrictions or terms is breached, it could lead to an event of default under our line of credit or the Outstanding Notes. A default, if not cured or waived, may permit acceleration of our indebtedness. In addition, our lenders could terminate their commitments to make further extensions of credit under our line of credit. If our indebtedness is accelerated, we cannot be certain that we will have sufficient funds to pay the accelerated indebtedness or that we will have the ability to refinance accelerated indebtedness on terms favorable to us or at all.

***The capped call transactions may not prevent dilution of our common stock upon conversion of the 2028 Notes or the 2029 Notes.***

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

In connection with the pricing of the 2028 Notes and the 2029 Notes, we entered into privately negotiated capped call transactions with the option counterparties. The capped call transactions are expected generally to reduce the potential dilution to our common stock upon any conversion of the 2028 Notes and 2029 Notes and/or offset any potential cash payments we are required to make in excess of the principal amount of the converted 2028 Notes and 2029 Notes, as the case may be, upon conversion of the 2028 Notes and 2029 Notes. If, however, the market price per share of our common stock, as measured under the terms of the capped call transactions, exceeds the cap price of the capped call transactions (currently $212.04 for the 2028 Notes and $202.538 for the 2029 Notes), there would nevertheless be dilution and/or there would not be an offset of such potential cash payments, in each case, to the extent that such market price exceeds the cap price of the capped call transactions.

***Our amended and restated bylaws provide that, unless we consent in writing to the selection of an alternative forum, the state courts of North Carolina will be the sole and exclusive forum for substantially all disputes between us and our shareholders, which could limit our shareholders' ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees or agents.***

If a court were to find the choice of forum provision contained in our amended and restated bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, results of operations, and financial condition. Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to management and other employees.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds**

Not applicable.

**Item 3. Defaults Upon Senior Securities**

Not applicable.

**Item 4. Mine Safety Disclosures**

Not applicable.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**Item 5. Other Information**

On January 23, 2023, in connection with the new SEC rules regarding universal proxy cards and a periodic review of our bylaws, our Board of Directors adopted and approved amended and restated bylaws (the Amended and Restated Bylaws), which became effective the same day. Among other things, the Amended and Restated Bylaws:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• enhance the procedural mechanics and disclosure requirements in connection with shareholder nominations of directors and business proposals made in connection with meetings of shareholders by, among other things:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ requiring a shareholder delivering a nomination notice to comply in all respects with the requirements of Regulation 14A under the Exchange Act (including, without limitation, the requirements of new Rule 14a-19);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ providing that the chairman of the meeting has authority to determine whether a shareholder has satisfied applicable requirements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ expanding the amount of required information shareholders must provide;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ implementing a requirement that the shareholder must provide a written undertaking to solicit at least 67% of the voting power entitled to vote and adding a requirement to provide certain additional information about the shareholder; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ requiring us to disregard proxies that were solicited if the shareholder fails to comply with certain provisions of Rule 14a-19 or to appear in person or by proxy at the applicable meeting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• make various other updates, including technical, ministerial, and conforming changes related to recent amendments to the NCBCA, providing a definition of "close of business," and adopting gender-neutral language.

The foregoing description of the Amended and Restated Bylaws does not purport to be complete and is subject to and qualified in its entirety by the full text of the Amended and Restated Bylaws, copies of which are filed as Exhibits 3.1 (clean) and 3.2 (redlined) hereto and incorporated by reference herein.

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**Item 6. Exhibits**

The following exhibits are being filed herewith and are numbered in accordance with Item 601 of Regulation S-K:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | | Incorporated by Reference | Incorporated by Reference | Incorporated by Reference |
| Exhibit No. | Description | Filed Herewith | Form | Exhibit | Filing Date |
| <u>[3.1](exhibit31-amendedandrestat.htm)</u> | Amended and Restated Bylaws, dated January 23, 2023 (clean) | X |  |  |  |
| <u>[3.2](exhibit32-amendedandrestat.htm)</u> | Amended and Restated Bylaws, dated January 23, 2023 (redline) | X |  |  |  |
| <u>[4.1](http://www.sec.gov/Archives/edgar/data/895419/000119312522289993/d409300dex41.htm)</u> | Indenture, dated as of November 21, 2022, between the Company and U.S. Bank Trust Company, National Association |  | 8-K | 4.1 | 11/21/2022 |
| <u>[4.2](http://www.sec.gov/Archives/edgar/data/895419/000119312522289993/d409300dex41.htm)</u> | Form of 1.875% Convertible Senior Note due 2029 (included in Exhibit 4.1) |  | 8-K | 4.2 | 11/21/2022 |
| <u>[10.1](http://www.sec.gov/Archives/edgar/data/895419/000119312522289993/d409300dex101.htm)</u> | Form of Confirmation of Call Option Transactions related to 1.875% Convertible Senior Notes due 2029 |  | 8-K | 10.1 | 11/21/2022 |
| <u>[31.1](wolfspeed12252022ex311.htm)</u> | Certification by Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X |  |  |  |
| <u>[31.2](wolfspeed12252022ex312.htm)</u> | Certification by Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X |  |  |  |
| <u>[32.1](wolfspeed12252022ex321.htm)</u> | Certification by Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X |  |  |  |
| <u>[32.2](wolfspeed12252022ex322.htm)</u> | Certification by Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X |  |  |  |
| 101 | The following materials from Wolfspeed, Inc.'s Quarterly Report on Form 10-Q for the fiscal quarter ended December 25, 2022 formatted in Inline XBRL (eXtensible Business Reporting Language): (i) Consolidated Balance Sheets; (ii) Consolidated Statements of Operations; (iii) Consolidated Statements of Comprehensive Loss; (iv) Consolidated Statement of Shareholders' Equity; (v) Consolidated Statements of Cash Flows; and (vi) Notes to Consolidated Financial Statements | X |  |  |  |
| 104 | The cover page from Wolfspeed, Inc.'s Quarterly Report on Form 10-Q for the quarter ended December 25, 2022 formatted in Inline XBRL (included in Exhibit 101) | X |  |  |  |

---

------

<u>[**Table of Contents**](#ibca995ad35aa487abdd08480b9f030b1_10)</u>

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
| | WOLFSPEED, INC. |
| January 26, 2023 | |
| | /s/ Neill P. Reynolds |
| | Neill P. Reynolds |
| | Executive Vice President and Chief Financial Officer |
| | (Authorized Officer and Principal Financial and Chief Accounting Officer) |

---

## Exhibit 3.1

**Exhibit 3.1**

**BYLAWS OF**

**WOLFSPEED, INC.**

*As amended and restated effective January 23, 2023*

**<u>ARTICLE I</u>**

**<u>DEFINITIONS</u>**

In these bylaws, unless otherwise provided, the following terms shall have the following meanings:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)"Act" shall mean the North Carolina Business Corporation Act as codified in Chapter 55 of the North Carolina General Statutes effective July 1, 1990, and as amended from time to time;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)"Articles of Incorporation" shall mean the Corporation's articles of incorporation, including amended and restated articles of incorporation and articles of merger;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)"Corporation" shall mean Wolfspeed, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)"Distribution" shall mean a direct or indirect transfer of money or other property (except the Corporation's own shares) or incurrence of indebtedness by the Corporation to or for the benefit of its shareholders in respect of any of its shares. A distribution may be in the form of a declaration or payment of a dividend, a purchase, redemption, or other acquisition of shares, a distribution of indebtedness, or otherwise;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)"Emergency" shall mean a catastrophic event which prevents a quorum of the board of directors from being readily assembled;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)"Shares" shall mean the units into which the proprietary interests in the Corporation are divided; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7)"Voting group" shall mean all shares of one or more classes or series that under the Articles of Incorporation or the Act are entitled to vote and be counted together collectively on a matter at a meeting of shareholders. All shares entitled by the Articles of Incorporation or the Act to vote generally on a matter are for that purpose a single voting group.

**<u>ARTICLE II <br>OFFICES</u>**

**<u>SECTION 1. Principal Office</u>:** The principal office of the Corporation shall be located at 4600 Silicon Drive, Durham County, Durham, North Carolina 27703, or at such other place as may be determined from time to time by the board of directors.

**<u>SECTION 2. Registered Office</u>:** The registered office of the Corporation shall be maintained in the State of North Carolina, and may be, but not need be, identical with the principal office.

------

**<u>SECTION 3. Other Offices:</u>** The Corporation may have offices at such other places, either within or without the State of North Carolina, as the board of directors may from time to time determine, or as the affairs of the Corporation may require.

**<u>ARTICLE III</u>**

**<u>MEETINGS OF SHAREHOLDERS</u>**

**<u>SECTION 1. Place of Meetings</u>:** All meetings of shareholders shall be held at the principal office of the Corporation, or at such other place, either within or without the State of North Carolina, as shall be designated in the notice of the meeting or as may be agreed upon by a majority of the shareholders entitled to vote at the meeting.

**<u>SECTION 2. Participation by Remote Communication</u>:** The board of directors may authorize shareholders to participate in the meeting by means of remote communication, videoconference, teleconference, or other available technology, subject to any guidelines and procedures adopted by the board of directors. For any meeting in which shareholders participate by means of remote communication, the Corporation shall implement reasonable measures to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) verify that each person participating by remote communication is a shareholder; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) provide each shareholder participating by remote communication a reasonable opportunity to participate in the meeting and vote on matters submitted to the shareholders, including an opportunity to communicate, and read or hear the proceedings of the meeting in a substantially concurrent manner.

**<u>SECTION 3. Annual Meeting</u>:** The annual meeting of shareholders for the election of directors and the transaction of other business shall be held annually in any month on any day (except Saturday, Sunday or a legal holiday) as fixed by the board of directors.

**<u>SECTION 4. Substitute Annual Meeting</u>:** If the annual meeting shall not be held on the day designated by these bylaws, a substitute annual meeting may be called by the board of directors, the chair, the chief executive officer or the president. A meeting so called shall be designated and treated for all purposes as the annual meeting.

**<u>SECTION 5. Special Meetings</u>:** Special meetings of the shareholders may be called at any time by the board of directors of the Corporation or by the chair.

**<u>SECTION 6. Notice of Meeting</u>:** Written or printed notice stating the date, time and place of the meeting shall be delivered not less than ten (10) nor more than sixty (60) days before the date of any shareholders' meeting by any means of communication permitted under or authorized by the Act, including, without limitation, personally, by electronic means, or by mail or private carrier, by or at the direction of the chair of the board, the chief executive officer, the president, the secretary, or such other person calling the meeting, to each shareholder of record entitled to vote at such meeting. If mailed, such notice shall be deemed to be delivered when deposited in the United States mail, addressed to the shareholder at the address that appears on the record of the shareholders of the Corporation, with postage thereon prepaid. If the Board of Directors has authorized participation at the meeting by means of remote communication, the notice shall also describe the means of remote communication to be used.

------

In the case of a special meeting, the notice of meeting shall include a description of the purpose or purposes for which the meeting is called. In the case of an annual or substitute annual meeting, the notice of meeting need not specifically state the business to be transacted unless such a statement is required by the Act.

When an annual or special meeting is adjourned to a different date, time, and place, it is not necessary to give any notice of the adjourned meeting other than by announcement of the new date, time, place, if any, and means of remote communication, if applicable, at the meeting at which the adjournment is taken; *provided*, *however*, that if a new record date for the adjourned meeting is or must be set, notice of the adjourned meeting must be given to persons who are shareholders as of the new record date.

The record date for determining the shareholders entitled to notice of and to vote at an annual or special meeting shall be fixed as provided in Section 3 of Article VIII.

**<u>SECTION 7. Waiver of Notice</u>:** A shareholder may waive notice of any meeting either before or after such meeting. Such waiver shall be in writing, signed by the shareholder, and filed with the minutes or corporate records. A shareholder's attendance at a meeting in person or by proxy: (i) waives objection to lack of notice or defective notice of the meeting, unless the shareholder or such shareholder's proxy at the beginning of the meeting objects to holding the meeting or transacting business at the meeting; and (ii) waives objection to consideration of a particular matter at the meeting that is not within the purpose or purposes described in the meeting notice, unless the shareholder or such shareholder's proxy objects to considering the matter before it is voted upon.

**<u>SECTION 8. Shareholder List</u>:** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Commencing two (2) business days after notice of a meeting of shareholders is given and continuing through such meeting, the secretary of the Corporation shall maintain (i) at the principal office of the Corporation, or at a place identified in the meeting notice in the city where the meeting will be held or (ii) on a reasonably accessible electronic network, an alphabetical list of the shareholders entitled to vote at such meeting, arranged by voting group, with the address of and number of shares held by each. This list shall be subject to inspection by any shareholder or such shareholder's agent or attorney at any time during usual business hours and, subject to the requirements of Section 55-16-02(c) of the Act, may be copied at the shareholder's expense.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;If the meeting is to be held at a place, the shareholder list shall be made available at the meeting and any shareholder, or such shareholder's representative, may inspect the list at any time during the meeting or any adjournment thereof. If the meeting is to be held solely by means of remote communication, then the list shall also be open to inspection during the meeting on a reasonably accessible electronic network, and the information required to access the list shall be provided with the notice of the meeting.

**<u>SECTION 9. Quorum</u>:** A majority of the votes entitled to be cast on a matter by any voting group, represented in person or by proxy, shall constitute a quorum of that voting group for action on that matter. The shareholders present at a duly organized meeting may continue to transact business until adjournment, notwithstanding the withdrawal of enough shareholders to leave less than a quorum.

In the absence of a quorum at the opening of any meeting of shareholders, such meeting may be adjourned from time to time by a majority of the votes voting on the motion to adjourn; and at any

------

adjourned meeting at which a quorum is present, any business may be transacted which might have been transacted at the original meeting.

**<u>SECTION 10. Proxies</u>:** Shares may be voted either in person or by one or more agents authorized by a written proxy executed by the shareholder or by such shareholder's duly authorized attorney in fact. A proxy may take the form of a telegram, telex, facsimile or other form of wire or wireless communication which appears to have been transmitted by a shareholder. A proxy is effective when received by the secretary or other officer or agent authorized to tabulate votes. A proxy is not valid after the expiration of eleven (11) months from the date of its execution, unless the person executing it specifies therein the length of time for which it is to continue in force or limits its use to a particular meeting.

**<u>SECTION 11. Voting of Shares</u>:** Except as otherwise provided in the Articles of Incorporation and the Act, each outstanding share, regardless of class, shall be entitled to one vote on each matter submitted to a vote at a meeting of shareholders.

Except for the election of directors, which is governed by the provisions of Section 3 of Article IV, if a quorum is present, action on a matter by a voting group is approved if the votes cast within the voting group favoring the action exceed the votes cast against the action, unless the vote of a greater number is required by the Act, the Articles of Incorporation, or these bylaws.

Shares of the Corporation are not entitled to vote if: (i) absent special circumstances as determined under applicable law, they are owned, directly or indirectly, by a second corporation in which the Corporation owns a majority of the shares entitled to vote for directors of the second corporation, unless they are held in a fiduciary capacity; or (ii) they are redeemable shares and (x) notice of redemption has been given and (y) a sum sufficient to redeem the shares has been deposited with a bank, trust company, or other financial institution under an irrevocable obligation to pay the holders the redemption price upon surrender of the shares.

Either the board of directors or the chair of the meeting may appoint one or more voting inspectors, each of whom shall take an oath to execute such duties impartially and to the best of such inspector's ability. The voting inspectors shall, by majority vote, resolve all questions regarding voting of shares, including the number of shares outstanding, the voting power of each, the shares represented at the meeting, the qualification of voters, the validity of proxies, the existence of a quorum as to any voting group, and the acceptance, rejection and tabulation of votes.

**<u>SECTION 12. Informal Action by Shareholders</u>:** Any action which may be taken at a meeting of the shareholders may be taken without a meeting if a consent in writing, setting forth the action so taken, is signed by all of the persons who would be entitled to vote upon such action at a meeting and is delivered to the Corporation to be included in the minutes or to be kept as part of the corporate records. Such consent shall have the same force and effect as a unanimous vote of shareholders.

**<u>SECTION 13. Corporation's Acceptance of Votes</u>:** If the name signed on a vote, consent, waiver, or proxy appointment corresponds to the name of a shareholder, the Corporation is entitled to accept the vote, consent, waiver, or proxy appointment and to give it effect as the act of the shareholder.

If the name signed on a vote, consent, waiver, or proxy appointment does not correspond to the name of its shareholder, the Corporation is nevertheless entitled to accept the vote, consent, waiver, or proxy appointment and to give it effect as the act of the shareholder if: (i) the shareholder is an entity and the name signed purports to be that of an officer or agent of the entity; (ii) the name signed purports to be

------

that of an administrator, executor, guardian, or conservator representing the shareholder and, if the Corporation requests, evidence of fiduciary status acceptable to the Corporation has been presented with respect to the vote, consent, waiver, or proxy appointment; (iii) the name signed purports to be that of a receiver or trustee in bankruptcy of the shareholder and, if the Corporation requests, evidence of its status acceptable to the Corporation has been presented with respect to the vote, consent, waiver, or proxy appointment; (iv) the name signed purports to be that of a beneficial owner or attorney-in-fact of the shareholder and, if the Corporation requests, evidence acceptable to the Corporation of the signatory's authority to sign for the shareholder has been presented with respect to the vote, consent, waiver, or proxy appointment; or (v) two or more persons are the shareholder as co-tenants or fiduciaries and the name signed purports to be the name of at least one of the co-owners and the person signing appears to be acting on behalf of all the co-owners.

The Corporation is entitled to reject a vote, consent, waiver, or proxy appointment if the secretary or other officer or agent authorized to tabulate votes has a reasonable basis for doubt about the validity of the signature on it or about the signatory's authority to sign for the shareholder.

**<u>SECTION 14. Notice of Shareholder Business and Nominations:</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Annual Meetings of Shareholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Nominations of persons for election to the board of directors of the Corporation and the proposal of business to be considered by the shareholders may be made at an annual meeting of shareholders only: (A) pursuant to the notice of meeting delivered pursuant to Section 6 of Article III of these bylaws; (B) by or at the direction of the board of directors; or (C) by any shareholder of the Corporation who is a shareholder of record at the time of giving of notice provided for in this Section 14 of Article III, who is entitled to vote at the meeting and who complies with the notice procedures set forth in this bylaw. For the avoidance of doubt, the foregoing clause (C) shall be the exclusive means for a shareholder to make nominations or submit other business other than matters properly brought in accordance with Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the "Exchange Act").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) For nominations or other business to be properly brought before an annual meeting by a shareholder pursuant to clause (C) of paragraph (a)(i) of this bylaw, the shareholder must have (1) given timely notice thereof in writing to the secretary of the Corporation and such other business must otherwise be a proper matter for shareholder action, and (2) complied in all respects with the requirements of Regulation 14A under the Exchange Act, including, without limitation, the requirements of Rule 14a-19 (as such rule and regulations may be amended from time to time by the Securities and Exchange Commission (the "SEC"), including any SEC Staff interpretations relating thereto). The chair of the meeting shall determine that the shareholder has satisfied the requirements of this clause (2), including, without limitation, the satisfaction of any undertaking delivered under paragraph (C) of this Section 14(a)(ii) below. The number of nominees a shareholder may nominate for election at an annual meeting shall not exceed the number of directors to be elected at such annual meeting. To be timely, a shareholder's notice shall be received by the secretary at the principal executive offices of the Corporation, either in person or by United States certified mail, postage prepaid, not later than the close of business on the 90<sup>th</sup> calendar day nor earlier than the close of business on the 120<sup>th</sup> calendar day prior to the first anniversary of the preceding year's annual meeting; provided, however, that in the event that the date of the annual meeting is more than thirty (30) calendar days before or more than sixty (60) calendar days after such anniversary date, such notice by the shareholder must be so delivered not earlier than the close of business on the 120<sup>th</sup> calendar day prior to such annual meeting and not later than the close of business on the later of the 90<sup>th</sup> calendar day prior to such annual meeting or the 10<sup>th</sup> calendar

------

day following the calendar day on which public announcement of the date of such meeting is first made by the Corporation. In no event shall the public announcement of an adjournment of an annual meeting commence a new time period for the giving of a shareholder's notice as described above. Such shareholder's notice shall set forth:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)as to each person whom the shareholder proposes to nominate for election or reelection as a director (i) the name, age, business address and, if known, residence address of such person; (ii) the background and qualification of such person, including, without limitation, the principal occupation or employment of such person (at present and for the past five years); (iii) the class and number of shares of stock of the Corporation which are beneficially owned by such person; (iv) all information relating to such person that is required to be disclosed in solicitations of proxies for election of directors or is otherwise required by the rules and regulations of the Securities and Exchange Commission promulgated under the Exchange Act, including such person's written consent to (a) being named in any proxy statement as a nominee and any associated proxy card, (b) serving as a director if elected and (c) providing information that the Board requests to determine whether such person qualifies as an independent director under applicable rules, regulations and guidelines; and (v) a written and signed statement that such person (a) is not and will not become a party to (1) any agreement, arrangement or understanding with, and has not given any commitment or assurance to, any person or entity as to how such person, if elected as a director of the corporation, will act or vote on any issue or question (a "Voting Commitment") that has not been disclosed to the Corporation or (2) any Voting Commitment that could limit or interfere with such person's ability to comply, if elected as a director of the Corporation, with such person's fiduciary duties under applicable law, (b) is not and will not become a party to any agreement, arrangement or understanding with any person or entity other than the Corporation with respect to any direct or indirect compensation, reimbursement or indemnification in connection with service or action as a director of the Corporation that has not been disclosed in the notice required by this Section 14 of Article III, and (c) in such person's individual capacity and on behalf of any person, entity or group on whose behalf the nomination is being made, would be in compliance, if elected as a director of the Corporation, and will comply with all applicable publicly disclosed codes of ethics and conduct, corporate governance, conflict of interest, confidentiality and stock ownership and trading policies and guidelines of the Corporation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)as to any other business that the shareholder proposes to bring before the meeting, (i) a brief description of the business desired to be brought before the meeting, (ii) the text of the proposal or business (including the text of any resolutions proposed for consideration and in the event that such business includes a proposal to amend the articles of incorporation or bylaws of the Corporation, the language of the proposed amendment), (iii) the reasons for conducting such business at the meeting, (iv) any material interest in such business of such shareholder and any Shareholder Related Person (as defined below) and (v) a description of all agreements, arrangements and understandings between the shareholder and the Shareholder Related Person, if any, and any other person or persons (including the names of such persons) in connection with the proposal of such business by such shareholder; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C)as to the shareholder giving the notice and any Shareholder Related Person, if any, on whose behalf the nomination or proposal is made, (i) the name and address of such shareholder and any Shareholder Related Person, as they appear on the Corporation's books, (ii)(a) the class or series and number of shares of the Corporation which are directly or indirectly owned beneficially and of record by such shareholder and any Shareholder Related Person, (b) any option, warrant, convertible security, stock appreciation right, or similar right with an exercise or conversion privilege or a settlement payment or mechanism at a price related to any class or series of shares of the Corporation or with a value derived in whole or in part from the value of any class or series of shares of the

------

Corporation, whether or not such instrument or right shall be subject to settlement in the underlying class or series of capital stock of the Corporation or otherwise (a "Derivative Instrument") directly or indirectly owned beneficially by such shareholder and any Shareholder Related Person, and any other direct or indirect opportunity to profit or share in any profit derived from any increase or decrease in the value of shares of the Corporation, (c) any proxy, contract, arrangement, understanding, or relationship pursuant to which such shareholder or any Shareholder Related Person has a right to vote or has granted the right to vote any shares of any security of the Corporation, (d) any short interest in any security of the Corporation (for purposes of this by-law a person shall be deemed to have a short interest in a security if such person directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has the opportunity to profit or share in any profit derived from any decrease in the value of the subject security), (e) any rights to dividends on the shares of the Corporation owned beneficially by such shareholder or any Shareholder Related Person that are separated or separable from the underlying shares of the Corporation, (f) any proportionate interest in shares of the Corporation or Derivative Instruments held, directly or indirectly, by a general or limited partnership in which such shareholder or any Shareholder Related Person is a general partner or, directly or indirectly, beneficially owns an interest in a general partner and (g) any performance-related fees (other than an asset-based fee) that such shareholder or any Shareholder Related Person is entitled to based on any increase or decrease in the value of shares of the Corporation or Derivative Instruments, if any, including, without limitation, any such interests held by members of such shareholder's or Shareholder Related Person's immediate family sharing the same household, (iii) a representation that the shareholder or Shareholder Related Person is a holder of record of stock of the Corporation entitled to vote at such meeting and intends to appear in person or by proxy at the meeting to propose such business or nomination, (iv) a written undertaking by the shareholder or Shareholder Related Person that such shareholder or Shareholder Related Person will deliver to beneficial owners of shares representing at least 67% of the voting power of the stock entitled to vote generally in the election of directors either (a) at least 20 calendar days before the annual meeting, a copy of its definitive proxy statement for the solicitation of proxies for its director candidates or (b) at least 40 calendar days before the annual meeting a Notice of Internet Availability of Proxy Materials that would satisfy the requirements of Rule 14a-16(d) of the Exchange Act, (v) any proposal or nominations submitted on behalf of such shareholder or any Shareholder Related Person seeking to nominate directors at any other company's board of directors with a class of equity securities registered pursuant to Section 12 of the Exchange Act within the past 36 months (whether or not such proposal or nomination was publicly disclosed), (vi) any other information required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies or votes for, as applicable, the proposal and/or for the election of directors in an election contest pursuant to and in accordance with Section 14(a) of the Exchange Act and the rules and regulations promulgated thereunder, and (vii) a description of all agreements, arrangements and understandings between the shareholder and the Shareholder Related Person, if any, and any other person or persons (including the names of such persons) in connection with the proposal of such business by such shareholder. The Corporation may require any proposed nominee to furnish such other information as it may reasonably require to determine the eligibility of such proposed nominee to serve as a director of the Corporation. A "Shareholder Related Person" of any shareholder means (i) any person controlling, directly or indirectly, or acting in concert with, such shareholder, (ii) any beneficial owner of shares of stock of the Corporation owned of record or beneficially by such shareholder, and (iii) any person controlled by or under common control with such shareholder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(D)If any of the facts set forth in the notice provided pursuant to this Section 14(a)(ii) of Article III changes between the date that such notice is sent and the date of the annual meeting to which such notice pertains, the shareholder must deliver to the secretary of the Corporation, either in person or by United States certified mail, postage prepaid, and the Corporation must receive at its principal

------

executive officers by the earlier of (i) the close of business within five (5) calendar days of the event giving rise to such change, or (ii) the commencement of such annual meeting, a supplemental notice providing such revised information. For the avoidance of doubt, the obligation to supplement as set forth in this paragraph or any other section of these bylaws shall not (a) limit the Corporation's rights with respect to any deficiencies in any notice provided by a shareholder, (b) extend any applicable deadlines hereunder, or (c) enable or be deemed to permit a shareholder who has previously submitted notice hereunder to amend or update any proposal or to submit any new proposal, including by changing or adding nominees, matters, business or resolutions proposed to be brought before a meeting of the shareholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Special Meetings of Shareholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)Only such business shall be conducted at a special meeting of shareholders as shall have been brought before the meeting pursuant to the notice of meeting under Section 6 of Article III of these bylaws. If directors are to be elected at a special meeting of shareholders pursuant to the notice of meeting, nominations of persons for election to the board of directors at such meeting may be made (A) by or at the direction of the board of directors, or (B) by any shareholder of the Corporation who is a shareholder of record at the time of giving of notice provided for in this Section 14 of Article III, who is entitled to vote at the meeting and who complies with the notice procedures and information requirements set forth in Section 14(a) of these bylaws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)In the event a special meeting of shareholders is called for the purpose of electing one or more directors to the board of directors, any shareholder may, pursuant to clause (b)(i) above, nominate a person or persons (as the case may be) for election to such position(s) as specified in the notice of meeting, if the shareholder shall have delivered notice containing the information specified in paragraph (a)(ii) of this bylaw to the secretary at the principal executive offices of the Corporation not earlier than the close of business on the 120<sup>th</sup> calendar day prior to such special meeting and not later than the close of business on the later of the 90<sup>th</sup> calendar day prior to such special meeting or the 10<sup>th</sup> calendar day following the day on which public announcement is first made of the date of the special meeting and of the nominees proposed by the board of directors to be elected at such meeting. The number of nominees a stockholder may nominate for election at a special meeting shall not exceed the number of directors to be elected at such special meeting. For the avoidance of doubt, the obligation to supplement as set forth in this paragraph or any other section of these bylaws shall not limit the Corporation's rights with respect to any deficiencies in any notice provided by a shareholder, extend any applicable deadlines hereunder or enable or be deemed to permit a shareholder who has previously submitted notice hereunder to amend or update any proposal or to submit any new proposal, including by changing or adding nominees, matters, business or resolutions proposed to be brought before a meeting of the shareholders. In no event shall the public announcement of an adjournment of a special meeting commence a new time period for the giving of a shareholder's notice as described above.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) General.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)Only such persons who are nominated in accordance with the procedures set forth in this bylaw shall be eligible to serve as directors and only such business shall be conducted at a meeting of shareholders as shall have been brought before the meeting in accordance with the procedures set forth in this bylaw. Except as otherwise provided by law, the Articles of Incorporation or these bylaws, the chair of the meeting shall have the power and duty to determine whether a nomination or any business proposed to be brought before the meeting was made or proposed, as the case may be, in accordance with the procedures set forth in this bylaw and, if any proposed nomination or business is not in compliance with this bylaw, to declare that such defective proposal or nomination shall be disregarded. Without limiting

------

the foregoing, unless otherwise required by law, if a shareholder or Shareholder Related Person (A)(1) provides notice pursuant to this bylaw and Rule 14a-19(b) under the Exchange Act with respect to a nomination for election to the board of directors and (2) subsequently fails to comply with the requirements of Rule 14a-19(a)(2) and Rule 14a-19(a)(3) under the Exchange Act (or fails to timely provide reasonable evidence sufficient to satisfy the corporation that such shareholder or Shareholder Related Person has met the requirements of Rule 14a-19(a)(3)), or (B) does not appear in person or by proxy at the meeting to present the proposed business or nomination, then the Corporation shall disregard any proxies or votes solicited for any persons nominated by such shareholder or Shareholder Related Person. Upon request by the Corporation, if any shareholder or Shareholder Related Person provides notice pursuant to Rule 14a-19(b) promulgated under the Exchange Act, such shareholder or Shareholder Related Person shall deliver to the Corporation, no later than five (5) business days prior to the applicable meeting date, reasonable evidence that the shareholder or Shareholder Related Person has met the requirements of Rule 14a-19(a)(3) promulgated under the Exchange Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)For purposes of this bylaw, "public announcement" shall mean disclosure in a press release reported in a national news service or in a document publicly filed by the Corporation with the Securities and Exchange Commission pursuant to Section 13, 14 or 15(d) of the Exchange Act and "close of business" shall mean 5:00 p.m. local time at the principal executive offices of the Corporation on any calendar day, whether or not a business day.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)The requirements of this bylaw are separate from and in addition to the requirements of the Exchange Act, and a shareholder shall also comply with all applicable requirements of the Exchange Act and the rules and regulations thereunder with respect to the matters set forth in this bylaw. In addition to the provisions of this bylaw, a shareholder who seeks to have any proposal included in the Corporation's proxy statement also shall comply with the requirements of the Exchange Act, and the rules and regulations promulgated thereunder, including without limitation, Regulation 14A.

**<u>ARTICLE IV</u>**

**<u>BOARD OF DIRECTORS</u>**

**<u>SECTION 1. General Powers</u>:** All corporate powers shall be exercised by or under the authority of, and the business and affairs of the Corporation shall be managed under the direction of, its board of directors.

**<u>SECTION 2. Number, Term and Qualifications</u>:** The number of directors which shall constitute the board of directors shall be not less than five (5) nor more than ten (10). This range shall not be altered without shareholder approval. The exact number of directors shall be fixed from time to time within such range by resolution of the board of directors. Each director shall hold office until such director's death, resignation, retirement, removal, disqualification, or until such director's successor is elected and qualified. Directors need not be residents of the State of North Carolina or shareholders of the Corporation.

**<u>SECTION 3. Election of Directors</u>:** Except as provided in Section 6 of this Article, the directors shall be elected at the annual meeting of shareholders; and those persons who receive the highest number of votes shall be deemed to have been elected.

**<u>SECTION 4. No Cumulative Voting</u>:** Unless otherwise required by the Act, the shareholders of the Corporation shall have no right to cumulate their votes for the election of directors.

------

**<u>SECTION 5. Removal</u>:** Any director may be removed from office with or without cause by a vote of shareholders holding a majority of the outstanding shares entitled to vote at an election of directors. If a director is elected by a voting group of shareholders, only members of that voting group may participate in the vote to remove him. A director may not be removed by the shareholders at a meeting unless the notice of the meeting specifies such removal as one of its purposes. If any directors are removed, new directors may be elected at the same meeting.

**<u>SECTION 6. Vacancies</u>:** Any vacancy occurring in the board of directors, including, without limitation, a vacancy resulting from an increase in the authorized number of directors or from the failure by the shareholders to elect the full authorized number of directors, may be filled by the majority of the remaining directors. If the directors remaining in office constitute fewer than a quorum of the board, such vacancy may be filled by the affirmative vote of a majority of the remaining directors or by the sole remaining director. If the vacant office was held by a director elected by a voting group of shareholders, the remaining director or directors elected by that voting group are entitled to fill the vacancy. The shareholders may elect a director at any time, subject to the provisions of Section 14 of Article III, to fill a vacancy not filled by the directors. If the vacant office was held by a director elected by a voting group of shareholders, the holders of shares of that voting group may fill the vacancy not filled by the directors elected by such voting group. The term of a director elected to fill a vacancy shall expire at the next shareholders' meeting at which directors are elected.

**<u>SECTION 7. Chair of the Board</u>:** There may be a chair of the board of directors elected by the directors from their number at any meeting of the board. The chair of the board of directors may be, but is not required to be, an officer of the Corporation. The chair shall preside at all meetings of the board of directors and shareholders and perform such other board duties as may be directed by the board.

**<u>SECTION 8. Compensation</u>:** The board of directors may compensate directors for their services as such and may provide for the payment of all expenses incurred by directors in attending regular and special meetings of the board.

**<u>SECTION 9. Committees</u>:** The board of directors may create an executive committee and other committees of the board, each of which shall have one or more members, all of whom shall be directors. The creation of a committee and the appointment of members to it must be approved by a majority of all the directors in office when the action is taken. Each committee may, as specified by the board of directors, exercise some or all of the authority of the board except that a committee may not: (i) authorize distributions; (ii) approve or propose to shareholders action that the Act requires be approved by shareholders; (iii) fill vacancies on the board of directors or on any of its committees; (iv) amend the Articles of Incorporation; (v) adopt, amend, or repeal bylaws; or (vi) approve a plan of merger not requiring shareholder approval Any such committee, or any member thereof, may be discharged or removed by action of the majority of the board of directors. Any resolutions adopted or other action taken by any such committee within the scope of the authority delegated to it by the board of directors shall be deemed for all purposes to be adopted or taken by the board of directors. The provisions of Article V, which govern meetings of the board of directors, shall likewise apply to meetings of any committee of the board.

------

**<u>ARTICLE V</u>**

**<u>MEETINGS OF DIRECTORS</u>**

**<u>SECTION 1. Regular Meetings</u>:** Regular meetings of the board of directors shall be held at such time and place, within or without the State of North Carolina, as the board of directors shall fix by resolution.

**<u>SECTION 2. Special Meetings</u>:** Special meetings of the board of directors may be called by or at the request of the chair of the board, chief executive officer, president or any two directors. Such meetings may be held either within or without the State of North Carolina, as fixed by the person or persons calling the meeting.

**<u>SECTION 3. Notice of Meetings</u>:** Regular meetings of the board of directors may be held without notice. The person or persons calling a special meeting of the board of directors shall, at least two (2) days before the meeting, give notice of the meeting by any usual means of communication, including by electronic means, mail, or private carrier. Such notice need not specify the purpose for which the meeting is called and may be oral. Any duly convened regular or special meeting may be adjourned by the board of directors to a later time without further notice.

**<u>SECTION 4. Waiver of Notice</u>:** Any director may waive notice of any meeting either before or after such meeting. Such waiver shall be in writing, signed by the director, and filed with the minutes or corporate records; *provided*, *however*, that a director's attendance at or participation in a meeting waives any required notice to such director unless the director at the beginning of the meeting (or promptly upon such director's arrival) objects to holding the meeting or transacting business at the meeting and does not thereafter vote for or assent to action taken at the meeting.

**<u>SECTION 5. Quorum</u>:** The greater of (i) a majority of the directors in office and (ii) one-third of the number of directors fixed pursuant to Section 2 of Article IV shall constitute a quorum for the transaction of business at any meeting of the board of directors.

**<u>SECTION 6. Manner of Acting</u>:** The act of a majority of the directors present at a meeting at which a quorum is present shall be the act of the board of directors, unless a greater number is required by law, the Articles of Incorporation or these bylaws.

**<u>SECTION 7. Presumption of Assent</u>:** A director of the Corporation who is present at a meeting of the board of directors or a committee of the board of directors when corporate action is taken is deemed to have assented to the action taken unless: (i) such director objects at the beginning of the meeting (or promptly upon such director's arrival) to holding it or transacting business at the meeting; (ii) such director's dissent or abstention from the action taken is entered in the minutes of the meeting; or (iii) such director files written notice of such director's dissent or abstention with the presiding officer of the meeting before its adjournment or with the Corporation immediately after adjournment of the meeting. This right of dissent or abstention is not available to a director who votes in favor of the action taken.

**<u>SECTION 8. Participation in Meetings</u>:** Any or all of the directors may participate in a regular or special meeting by, or conduct the meeting through the use of, any means of communication by which all directors participating may simultaneously hear each other during the meeting.

**<u>SECTION 9. Action Without Meeting</u>:** Action which may be taken at a board of directors meeting or at a committee of the board of directors meeting may be taken without a meeting if the action

------

is taken by all members of the board or committee and is evidenced by one or more written consents signed by each director or committee member before or after such action, which describes the action taken and is included in the minutes or filed with the corporate records. A director's consent to action taken without a meeting or revocation thereof may be in electronic form and delivered by electronic means. Such action is effective when the last director or committee member signs the consent, unless the consent specifies a different effective date.

**<u>ARTICLE VI <br>OFFICERS</u>**

**<u>SECTION 1. Officers of the Corporation</u>:** The officers of the Corporation shall consist of a chief executive officer, president, chief financial officer, secretary, treasurer, and such vice presidents, assistant secretaries, assistant treasurers, and other officers as may be appointed from time to time in accordance with these bylaws. The board of directors may appoint the chair of the board, chosen from among the directors, as an officer of the Corporation. Any two or more offices may be held by the same person, but no officer may act in more than one capacity where action of two or more officers is required.

**<u>SECTION 2. Appointment and Term</u>:** The chair, the chief executive officer, the president and all executive vice presidents shall be appointed by the board of directors. The other officers of the Corporation may be appointed by the board of directors or by the chair or chief executive officer. A duly appointed officer may appoint one or more officers or assistant officers if authorized by the board of directors. The board of directors may appoint officers at any regular meeting or at any special meeting called for such purpose. Each officer shall hold office until such officer's death, resignation, retirement, removal, disqualification or until such officer's successor is appointed and qualified. The appointment of an officer does not itself create contract rights for either the officer or the Corporation.

**<u>SECTION 3. Compensation of Officers</u>:** The compensation of the chair, the chief executive officer, the president and any executive vice presidents of the Corporation shall be fixed by the board of directors or by a committee of the board authorized to act on its behalf with respect thereto. No officer shall receive compensation for serving the Corporation in any other capacity unless such additional compensation is authorized by the board of directors.

**<u>SECTION 4. Resignation and Removal</u>:** An officer may resign at any time by communicating such officer's resignation to the Corporation. A resignation is effective when it is communicated unless it specifies in writing a later date. If a resignation is made effective as of a later date and the Corporation accepts the future effective date, the board of directors may fill the pending vacancy before the effective date if the board provides that the successor does not take office until the effective date. An officer's resignation does not affect the Corporation's contract rights, if any, with the officer. Any officer may be removed at any time with or without cause by any of the following: (a) the board of directors, (b) the officer, including any successor, who appointed such officer being removed, unless otherwise provided by these bylaws or the board of directors; or (c) any other officer, if authorized by these bylaws or the board of directors. Such removal shall be without prejudice to the contract rights, if any, of the person so removed.

**<u>SECTION 5. Bonds</u>:** The board of directors may by resolution require any officer, agent, or employee of the Corporation to give bond to the Corporation, with sufficient sureties, conditioned on the faithful performance of the duties of such individual's respective office or position, and to comply with such other conditions as may from time to time be required by the board of directors.

------

**<u>SECTION 6. Chair</u>:** The chair of the Corporation, if also appointed as an officer, shall have such powers and perform such duties as may be assigned from time to time by the board of directors and shall be subject to the direction of the board of directors.

**<u>SECTION 7. Chief Executive Officer</u>:** Subject to the direction of the board of directors, the chief executive officer shall have general executive charge, management and control of the properties, businesses and operations of the Corporation with all such powers as may be reasonably incident to such responsibilities. The chief executive officer shall also serve as president if no other person is then serving as president. The chief executive officer may sign certificates for shares of capital stock of the Corporation and may agree upon and execute leases, contracts, evidences of indebtedness and other obligations in the name of the Corporation, and any deeds, mortgages, bonds or other instruments which may be lawfully executed on behalf of the Corporation, except where required by law to be otherwise signed or executed and except where the signing and execution thereof shall be delegated by the board of directors exclusively to some other officer or agent. Unless the board of directors otherwise determines, the chief executive officer shall, in the absence of or because of the inability to act of the chair, perform all duties of the chair and preside at all meetings of shareholders and (should the chief executive officer be a director) of the board of directors. The chief executive officer shall have such other powers and duties as from time to time may be assigned to such position by the board of directors.

**<u>SECTION 8. President</u>:** Subject to the direction of the chief executive officer, the president shall act in a general executive capacity and shall assist the chief executive officer in the administration and operation of the Corporation's business and general supervision of its policies and affairs. Unless the board of directors otherwise determines, the president shall have the authority to sign certificates for shares of capital stock of the Corporation and may agree upon and execute leases, contracts, evidences of indebtedness and other obligations in the name of the Corporation, and any deeds, mortgages, bonds or other instruments which may be lawfully executed on behalf of the Corporation, except where required by law to be otherwise signed or executed and except where the signing and execution thereof shall be delegated by the board of directors exclusively to some other officer or agent. Unless the board of directors otherwise determines, the president shall, in the absence of or because of the inability to act of the chair and the chief executive officer, perform all duties of the chair and chief executive officer and preside at all meetings of shareholders and (should the president be a director) of the board of directors. The president shall have such other powers and duties as from time to time maybe assigned to such position by the board of directors or the chief executive officer.

**<u>SECTION 9. Executive Vice Presidents</u>:** The executive vice presidents, in the order of their appointment unless otherwise determined by the board of directors, shall, in the absence or disability of the president, perform the duties and exercise the powers of that office. In addition, they shall perform such other duties and have such other powers as the board of directors or the chief executive officer or president shall prescribe.

**<u>SECTION 10. Chief Financial Officer</u>:** The chief financial officer, who shall be an executive vice president of the Corporation, shall keep full and accurate accounts of the finances of the Corporation and prepare quarterly and annual financial statements of such accounts, which statements may be consolidated or combined statements of the Corporation and one or more of its subsidiaries as appropriate, and shall be prepared on the basis of generally accepted accounting principles unless otherwise determined by the Board of Directors. The books of account shall at all reasonable times be open to inspection by any director for a purpose reasonably related to such director's position as a director. The chief financial officer shall, in general, perform all duties incident to such office and such other duties as may be assigned from time to time by the board of directors or the chief executive officer.

------

**<u>SECTION 11</u>**<u>.</u> **<u>Vice Presidents</u>:** The vice presidents shall perform such duties and have such powers as the board of directors or the chief executive officer shall prescribe.

**<u>SECTION 12. Secretary</u>:** The secretary shall keep accurate records of the acts and proceedings of all meetings of shareholders, directors and committees. The secretary shall give all notices required by law and by these bylaws. The secretary shall have general charge of the corporate books and records and of the corporate seal, and the secretary shall affix the corporate seal to any lawfully executed instrument requiring it. The secretary shall have general charge of the stock transfer books of the Corporation and shall keep, at the registered or principal office of the Corporation or at the offices of any transfer agent designated by the Corporation, a record of shareholders showing the name and address of each shareholder and the number and class of the shares held by each. The secretary shall sign such instruments as may require such individual's signature, and, in general, attest the signature or certify the incumbency or signature of any other officer of the Corporation and shall perform all duties incident to the office of secretary and such other duties as may be assigned from time to time by the board of directors, the chair or the chief executive officer.

**<u>SECTION 13. Treasurer</u>:** The treasurer shall have custody of all funds and securities belonging to the Corporation and shall receive, deposit or disburse the same under the direction of the chief financial officer. The treasurer shall, in general, perform all duties incident to such office and such other duties as may be assigned from time to time by the board of directors or the chief financial officer.

**<u>SECTION 14. Assistant Secretaries and Treasurers</u>:** The assistant secretaries and assistant treasurers shall, in the absence or disability of the secretary or the treasurer, perform the respective duties and exercise the respective powers of those offices, and they shall, in general, perform such other duties as shall be assigned to them by the board of directors or chair, or by the secretary or the treasurer, respectively.

**<u>SECTION 15. Action With Respect to Securities of Other Corporations</u>:** Unless otherwise directed by the board of directors, the chief executive officer shall have power to vote and otherwise act on behalf of the Corporation, in person or by proxy, at any meeting of security holders of or with respect to any action of security holders of any other corporation or entity in which this Corporation may hold securities and otherwise to exercise any and all rights and powers which this Corporation may possess by reason of its ownership of securities in such other corporation or entity.

**<u>ARTICLE VII</u>**

**<u>CONTRACTS, LOANS, CHECKS AND DEPOSITS</u>**

**<u>SECTION 1. Contracts</u>:** The board of directors may authorize any officer or agent to enter into any contract or to execute and deliver any instrument on behalf of the Corporation, and such authority may be general or confined to specific instances.

**<u>SECTION 2. Loans</u>:** No loans shall be contracted on behalf of the Corporation and no evidences of indebtedness shall be issued in its name unless authorized by a resolution of the board of directors. Such authority may be general or confined to specific instances.

**<u>SECTION 3. Checks and Drafts</u>:** All checks, drafts or other orders for payment of money issued in the name of the Corporation shall be signed by such officers or agents of the Corporation and in such manner as shall from time to time be determined by resolution of the board of directors.

------

**<u>SECTION 4. Deposits</u>:** All funds of the Corporation not otherwise employed shall be deposited from time to time to the credit of the Corporation in such depositories as the board of directors shall direct.

**<u>ARTICLE VIII</u>**

**<u>CERTIFICATES FOR SHARES AND THEIR TRANSFER</u>**

**<u>SECTION 1. Certificates for Shares</u>:** Shares may, but need not, be represented by certificates. If certificates are issued, they shall be in such form as the board of directors shall determine; *provided* that, at a minimum, each certificate shall be in such form as required by law. These certificates shall be signed, either manually or in facsimile, by the president, any vice president or any person who has been designated the chair or chief executive officer of the Corporation, and the secretary or any assistant secretary, the treasurer or any assistant treasurer. In case any officer who has signed or whose facsimile or other signature has been placed upon such certificate shall have ceased to be such officer before such certificate is issued, it may be issued by the Corporation with the same effect as if such person were such officer at the date of its issue. They shall be consecutively numbered or otherwise identified and the name and address of the persons to whom they are issued, with the number of shares and date of issue, shall be entered on the stock transfer books of the Corporation.

**<u>SECTION 2. Transfer of Shares</u>:** Transfer of shares of the Corporation shall be made only on the stock transfer books of the Corporation by the holder of record, by such holder's legal representative (who shall furnish proper evidence of authority to transfer) or by such holder's attorney (whose authority shall be evidenced by a power of attorney duly executed and filed with the secretary), and only upon surrender for cancellation of the certificates for such shares. All certificates surrendered for transfer shall be cancelled before new certificates for the transferred shares shall be issued.

**<u>SECTION 3. Fixing Record Date</u>:** For the purpose of determining shareholders entitled to receive notice of a meeting of shareholders, to demand a special meeting, to vote, to take any other action, or to receive payment, or for any other purpose, the board of directors may fix in advance a date as the record date for any such determination of shareholders, such record date in any case to be not more than seventy (70) days before the date on which the particular action requiring such determination of shareholders is to be taken.

When a determination of shareholders entitled to notice of or to vote at any meeting of shareholders has been made as provided in this section, such determination shall apply to any adjournment of such meeting unless the board of directors fixes a new record date, which it must do if the meeting is adjourned to a date more than 120 days after the date fixed for the original meeting.

**<u>SECTION 4. Lost Certificates</u>:** The board of directors may authorize the issuance of a new share certificate in place of a certificate claimed to have been lost or destroyed, upon receipt of an affidavit of such fact from the person claiming the loss or destruction. When authorizing the issuance of a new certificate, the board of directors may require the claimant to give the Corporation a bond in such sum as it may direct to indemnify the Corporation against loss from any claim with respect to the certificate claimed to have been lost or destroyed; or the board of directors may, by resolution reciting that the circumstances justify such action, authorize the issuance of the new certificate without requiring such a bond.

------

**<u>SECTION 5. Reacquired Shares</u>:** The Corporation may acquire its own shares and shares so acquired constitute authorized but unissued shares.

**<u>ARTICLE IX</u>**

**<u>GENERAL PROVISIONS</u>**

**<u>SECTION 1. Distributions</u>:** The board of directors may from time to time declare, and the Corporation may make, distributions on its outstanding shares in the manner and subject to the terms and conditions provided by the Act and by the Articles of Incorporation.

**<u>SECTION 2. Seal</u>:** The corporate seal of the Corporation shall consist of two concentric circles between which is the name of the Corporation and in the center of which is inscribed "1987" and which shall have such other characteristics as the board of directors may determine.

**<u>SECTION 3. Indemnification</u>:** Any person who at any time serves or has served as a director or officer of the Corporation, or at the request of the Corporation is or was serving as a director or officer for any other foreign or domestic corporation, partnership, limited liability company, joint venture, trust, employee benefit plan, or other enterprise, or as a trustee or administrator under any employee benefit plan of the Corporation or any wholly owned subsidiary thereof, shall be indemnified by the Corporation to the fullest extent from time to time permitted by law in the event such person is made, or is threatened to be made, a party to any threatened, pending or completed civil, criminal, administrative, investigative or arbitrative action, suit or proceeding and any appeal therein (and any inquiry or investigation that could lead to such action, suit or proceeding), whether or not brought by or on behalf of the Corporation, seeking to hold such person liable by reason of the fact that such person is or was acting in such capacity; *provided*, *however*, that the Corporation shall not indemnify any such person against liability or expenses such person may incur on account of such person's activities which were, at the time taken, known or believed by such person to be clearly in conflict with the best interests of the Corporation.

The rights of those receiving indemnification hereunder shall, to the fullest extent from time to time

permitted by law, cover (i) reasonable expenses, including without limitation all attorneys' fees actually and necessarily incurred by such person in connection with any such action, suit or proceeding, (ii) all reasonable payments made by such person in satisfaction of any judgment, money decree, fine (including an excise tax assessed with respect to an employee benefit plan), penalty, or settlement for which such person may have become liable in such action, suit or proceeding; and (iii) all reasonable expenses incurred in enforcing the indemnification rights provided herein.

The Corporation shall be entitled to pay expenses incurred by anyone entitled to receive indemnification under this section in defending a proceeding in advance of the final disposition of such proceeding as authorized by the board of directors in the specific case or as authorized or required under any provisions in the bylaws or by any applicable resolution or contract upon receipt of an undertaking by or on behalf of such person to repay such amount unless it shall ultimately be determined that such person is entitled to be indemnified by the Corporation against such expenses.

The provisions of this section shall not be deemed to preclude the Corporation, in its sole discretion, from indemnifying persons serving as agents or employees of the Corporation, or as agents, employees, partners or members at the request of the Corporation for any other or domestic corporation,

------

partnership, limited liability company, joint venture, trust, employee benefit plan, or other enterprise, to the extent permitted by law.

The board of directors of the Corporation shall take all such action as may be necessary or appropriate to authorize the Corporation to pay all amounts required by this bylaw, including without limitation, to the extent needed, (i) making a good faith evaluation of the manner in which the claimant for indemnity acted and of the reasonable amount of indemnity due him, (ii) making advances of costs and expenses, or (iii) giving notice to, or obtaining approval by, the shareholders of the Corporation. The board of directors may appoint a committee or special counsel to make such determination and evaluation.

Any person who at any time serves or has served in any of the aforesaid capacities for or on behalf of the Corporation shall be deemed to be doing or to have done so in reliance upon, and as consideration for, the right of indemnification provided herein. The rights to indemnification provided in this section are contract rights, and no repeal or modification of these indemnification provisions shall affect any rights or obligations existing at the time of such repeal or modification. The rights provided for herein shall inure to the benefit of the legal representatives of any such person and shall not be exclusive of any other rights to which such person may be entitled apart from the provisions of this bylaw.

The Corporation shall have the power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise or as a trustee or administrator under an employee benefit plan against any liability asserted against such person and incurred by such person in such capacity, or arising out of such person's status as such, whether or not the Corporation or other such enterprise would have the power to indemnify such person against such liability.

The rights granted herein shall not be limited by the provisions contained in Section 55-8-51 of the Act (or its successor) and shall not limit the power of the Corporation to agree to indemnify its directors, officers, employees or agents by contract or resolution to the fullest extent allowed by applicable law.

**<u>SECTION 4. Fiscal Year</u>:** The fiscal year of the Corporation shall be fixed by the board of directors.

**<u>SECTION 5. Amendments</u>:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The board of directors may amend or repeal these bylaws, except to the extent otherwise provided in the Articles of Incorporation, a bylaw adopted by the shareholders, or the Act, and except that a bylaw adopted, amended or repealed by the shareholders may be readopted, amended or repealed by the board of directors if the Articles of Incorporation, the Act or a bylaw adopted by the shareholders authorizes the board of directors to adopt, amend, or repeal that particular bylaw or the bylaws generally.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The board of directors shall have no power to adopt a bylaw:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Changing the statutory requirement for a quorum of directors or action by directors or changing the statutory requirement for a quorum of shareholders or action by shareholders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Providing for the management of the Corporation otherwise than by the board of directors or the committees thereof;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)Increasing or decreasing the number of directors; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)Classifying and staggering the election of directors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The Corporation's shareholders may adopt, amend, alter, change, or repeal any of these bylaws consistent with the provisions of Section 11 of Article III.

**<u>SECTION 6. Emergencies</u>:** In anticipation of or during an emergency, the board of directors may: (i) modify lines of succession to accommodate the incapacity of any director, officer, employee, or agent; and (ii) relocate the principal office or designate alternative principal or regional offices, or authorize the officers to do so.

During an emergency: (i) notice of a meeting of the board of directors need be given only to those directors whom it is practicable to reach and may be given in any practicable manner, including by publication and radio; and (ii) one or more officers present at a meeting of the board of directors may be deemed to be directors for the meeting, in order of rank and within the same rank in order of seniority, as necessary to achieve a quorum.

**<u>SECTION 7. Severability</u>:** Should any provision of these bylaws become ineffective or be declared to be invalid for any reason, such provision shall be severable from the remainder of these bylaws and all other provisions of these bylaws shall continue to be in full force and effect.

**<u>SECTION 8. Waiver of Notice</u>:** Whenever any notice is required to be given to any shareholder or director under the provisions of the Act or under the provisions of the Articles of Incorporation or bylaws of the Corporation, a waiver thereof in writing signed by the person or persons entitled to such notice, whether before or after the time stated therein, shall be equivalent to the giving of such notice.

**<u>SECTION 9. Time Periods</u>:** In applying any provision of these bylaws which requires an act to be done or not done a specified number of days prior to an event or that an act be done during a period of a specified number of days prior to an event, calendar days shall be used, the day of the doing of the act shall be excluded and the day of the event shall be included.

**<u>SECTION 10. Exclusive Forum</u>:** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) To the fullest extent provided by law, unless the Corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for all litigation relating to the internal affairs of the Corporation, including without limitation (i) any derivative action or proceeding brought on behalf of the Corporation, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Corporation to the Corporation or the shareholders of the Corporation, (iii) any action asserting a claim arising pursuant to any provision of the Act, the Articles of Incorporation or these Bylaws, (iv) any action to interpret, apply, enforce or determine the validity of the Corporation's articles of incorporation or these bylaws, or (v) any action asserting a claim governed by the internal affairs doctrine, shall be the state courts of North Carolina, or if such courts lack jurisdiction, a federal court located within the State of North Carolina, in all cases subject to the court's having personal jurisdiction over the indispensable parties named as defendants. Any such action filed in a North Carolina state court shall be designated by the party filing the action as a mandatory complex business case pursuant to Section 7A-45.4 of the North Carolina General Statutes. In any such action where the Act specifies the division or county wherein the action must be brought, the action shall be brought in such division or county.

------

the fullest extent permitted by law, be the exclusive forum for the resolution of any complaint asserting a cause of action against the Corporation or any director, officer, employee, or agent of the Corporation and arising under the Securities Act of 1933, as amended.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) To the fullest extent permitted by applicable law, any person or entity purchasing or otherwise acquiring any interest in shares of capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this Section 10 of Article IX.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) If any provision or provisions of Section 10 of Article IX shall be held to be invalid, illegal, or unenforceable as applied to any person or entity or circumstance for any reason whatsoever, then, to the fullest extent permitted by law, the validity, legality, and enforceability of such provisions in any other circumstance and of the remaining provisions of this Section 10 (including, without limitation, each portion of any sentence of this Section 10 containing any such provision held to be invalid, illegal, or unenforceable that is not itself held to be invalid, illegal, or unenforceable) and the application of such provision to other persons or entities and circumstances shall not in any way be affected or impaired thereby.

**<u>SECTION 11. Electronic Transactions</u>:** The Corporation may conduct any action or set of actions by any electronic means to the fullest extent permitted by applicable law.

## Exhibit 3.2

**Exhibit 3.2**

**BYLAWS OF**

**WOLFSPEED, INC.**

*As amended and restated effective October 25<u>January 23</u>, 2021<u>2023</u>*

**<u>ARTICLE I</u>**

**<u>DEFINITIONS</u>**

In these bylaws, unless otherwise provided, the following terms shall have the following meanings:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)"Act" shall mean the North Carolina Business Corporation Act as codified in Chapter 55 of the North Carolina General Statutes effective July 1, 1990, and as amended from time to time;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)"Articles of Incorporation" shall mean the Corporation's articles of incorporation, including amended and restated articles of incorporation and articles of merger;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)"Corporation" shall mean Wolfspeed, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)"Distribution" shall mean a direct or indirect transfer of money or other property (except the Corporation's own shares) or incurrence of indebtedness by the Corporation to or for the benefit of its shareholders in respect of any of its shares. A distribution may be in the form of a declaration or payment of a dividend, a purchase, redemption, or other acquisition of shares, a distribution of indebtedness, or otherwise;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)"Emergency" shall mean a catastrophic event which prevents a quorum of the board of directors from being readily assembled;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)"Shares" shall mean the units into which the proprietary interests in the Corporation are divided; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7)"Voting group" shall mean all shares of one or more classes or series that under the Articles of Incorporation or the Act are entitled to vote and be counted together collectively on a matter at a meeting of shareholders. All shares entitled by the Articles of Incorporation or the Act to vote generally on a matter are for that purpose a single voting group.

**<u>ARTICLE II <br>OFFICES</u>**

**<u>SECTION 1. Principal Office</u>:** The principal office of the Corporation shall be located at 4600 Silicon Drive, Durham County, Durham, North Carolina 27703, or at such other place as may be determined from time to time by the board of directors.

**<u>SECTION 2. Registered Office</u>:** The registered office of the Corporation shall be maintained in the State of North Carolina, and may be, but not need be, identical with the principal office.

------

**<u>SECTION 3. Other Offices</u>:** The Corporation may have offices at such other places, either within or without the State of North Carolina, as the board of directors may from time to time determine, or as the affairs of the Corporation may require.

**<u>ARTICLE III</u>**

**<u>MEETINGS OF SHAREHOLDERS</u>**

**<u>SECTION 1. Place of Meetings</u>:** All meetings of shareholders shall be held at the principal office of the Corporation, or at such other place, either within or without the State of North Carolina, as shall be designated in the notice of the meeting or as may be agreed upon by a majority of the shareholders entitled to vote at the meeting.

**<u>SECTION 2. Participation by Remote Communication</u>:** The board of directors may authorize shareholders to participate in the meeting by means of remote communication, videoconference, teleconference, or other available technology, subject to any guidelines and procedures adopted by the board of directors. For any meeting in which shareholders participate by means of remote communication, the Corporation shall implement reasonable measures to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) verify that each person participating by remote communication is a shareholder; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) provide each shareholder participating by remote communication a reasonable opportunity to participate in the meeting and vote on matters submitted to the shareholders, including an opportunity to communicate, and read or hear the proceedings of the meeting in a substantially concurrent manner.

**<u>SECTION 3. Annual Meeting</u>:** The annual meeting of shareholders for the election of directors and the transaction of other business shall be held annually in any month on any day (except Saturday, Sunday or a legal holiday) as fixed by the board of directors.

**<u>SECTION 4. Substitute Annual Meeting</u>:** If the annual meeting shall not be held on the day designated by these bylaws, a substitute annual meeting may be called by the board of directors, the chairman<u>chair</u>, the chief executive officer or the president. A meeting so called shall be designated and treated for all purposes as the annual meeting.

**<u>SECTION 5. Special Meetings</u>:** Special meetings of the shareholders may be called at any time by the board of directors of the Corporation or by the chairman<u>chair</u>.

**<u>SECTION 6. Notice of Meeting</u>:** Written or printed notice stating the date, time and place of the meeting shall be delivered not less than ten (10) nor more than sixty (60) days before the date of any shareholders' meeting by any means of communication permitted under or authorized by the Act, including, without limitation, personally, by electronic means, or by mail or private carrier, by or at the direction of the chairman<u>chair</u> of the board, the chief executive officer, the president, the secretary, or such other person calling the meeting, to each shareholder of record entitled to vote at such meeting. If mailed, such notice shall be deemed to be delivered when deposited in the United States mail, addressed to the shareholder at his<u>the</u> address as it<u>that</u> appears on the record of the shareholders of the Corporation, with postage thereon prepaid. <u>If the Board of Directors has authorized participation at the meeting by means of remote communication, the notice shall also describe the means of remote communication to be used.</u>

------

In the case of a special meeting, the notice of meeting shall include a description of the purpose or purposes for which the meeting is called. In the case of an annual or substitute annual meeting, the notice of meeting need not specifically state the business to be transacted unless such a statement is required by the Act.

When an annual or special meeting is adjourned to a different date, time, and place, it is not necessary to give any notice of the adjourned meeting other than by announcement <u>of the new date, time, place, if any, and means of remote communication, if applicable,</u> at the meeting at which the adjournment is taken; *provided*, *however*, that if a new record date for the adjourned meeting is or must be set, notice of the adjourned meeting must be given to persons who are shareholders as of the new record date.

The record date for determining the shareholders entitled to notice of and to vote at an annual or special meeting shall be fixed as provided in Section 3 of Article VIII.

**<u>SECTION 7. Waiver of Notice</u>:** A shareholder may waive notice of any meeting either before or after such meeting. Such waiver shall be in writing, signed by the shareholder, and filed with the minutes or corporate records. A shareholder's attendance at a meeting in person or by proxy: (i) waives objection to lack of notice or defective notice of the meeting, unless the shareholder or his<u>such shareholder's</u> proxy at the beginning of the meeting objects to holding the meeting or transacting business at the meeting; and (ii) waives objection to consideration of a particular matter at the meeting that is not within the purpose or purposes described in the meeting notice, unless the shareholder or his<u>such shareholder's</u> proxy objects to considering the matter before it is voted upon.

**<u>SECTION 8. Shareholder List</u>:** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)</u>&nbsp;&nbsp;&nbsp;&nbsp;Commencing two (2) business days after notice of a meeting of shareholders is given and continuing through such meeting, the secretary of the Corporation shall maintain <u>(i)</u> at the principal office of the Corporation, or at a place identified in the meeting notice in the city where the meeting will be held <u>or (ii) on a reasonably accessible electronic network</u>, an alphabetical list of the shareholders entitled to vote at such meeting, arranged by voting group, with the address of and number of shares held by each. This list shall be subject to inspection by any shareholder or his<u>such shareholder's</u> agent or attorney at any time during usual business hours and<u>, subject to the requirements of Section 55-16-02(c) of the Act,</u> may be copied at the shareholder's expense. This

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)</u>&nbsp;&nbsp;&nbsp;&nbsp;<u>If the meeting is to be held at a place, the shareholder</u> list shall be made available at the meeting and any shareholder, or his<u>such shareholder's</u> representative, may inspect the list at any time during the meeting or any adjournment thereof. <u>If the meeting is to be held solely by means of remote communication, then the list shall also be open to inspection during the meeting on a reasonably accessible electronic network, and the information required to access the list shall be provided with the notice of the meeting.</u>

**<u>SECTION 9. Quorum</u>:** A majority of the votes entitled to be cast on a matter by any voting group, represented in person or by proxy, shall constitute a quorum of that voting group for action on that matter. The shareholders present at a duly organized meeting may continue to transact business until adjournment, notwithstanding the withdrawal of enough shareholders to leave less than a quorum.

In the absence of a quorum at the opening of any meeting of shareholders, such meeting may be adjourned from time to time by a majority of the votes voting on the motion to adjourn; and at any

------

adjourned meeting at which a quorum is present, any business may be transacted which might have been transacted at the original meeting.

**<u>SECTION 10. Proxies</u>:** Shares may be voted either in person or by one or more agents authorized by a written proxy executed by the shareholder or by his<u>such shareholder's</u> duly authorized attorney in fact. A proxy may take the form of a telegram, telex, facsimile or other form of wire or wireless communication which appears to have been transmitted by a shareholder. A proxy is effective when received by the secretary or other officer or agent authorized to tabulate votes. A proxy is not valid after the expiration of eleven (11) months from the date of its execution, unless the person executing it specifies therein the length of time for which it is to continue in force or limits its use to a particular meeting.

**<u>SECTION 11. Voting of Shares</u>:** Except as otherwise provided in the Articles of Incorporation and the Act, each outstanding share, regardless of class, shall be entitled to one vote on each matter submitted to a vote at a meeting of shareholders.

Except for the election of directors, which is governed by the provisions of Section 3 of Article IV, if a quorum is present, action on a matter by a voting group is approved if the votes cast within the voting group favoring the action exceed the votes cast against the action, unless the vote of a greater number is required by the Act, the Articles of Incorporation, or these bylaws.

Shares of the Corporation are not entitled to vote if: (i) absent special circumstances as determined under applicable law, they are owned, directly or indirectly, by a second corporation in which the Corporation owns a majority of the shares entitled to vote for directors of the second corporation, unless they are held in a fiduciary capacity; or (ii) they are redeemable shares and (x) notice of redemption has been given and (y) a sum sufficient to redeem the shares has been deposited with a bank, trust company, or other financial institution under an irrevocable obligation to pay the holders the redemption price upon surrender of the shares.

Either the board of directors or the Chairman<u>chair</u> of the meeting may appoint one or more voting inspectors, each of whom shall take an oath to execute his<u>such</u> duties impartially and to the best of his<u>such inspector's</u> ability. The voting inspectors shall, by majority vote, resolve all questions regarding voting of shares, including the number of shares outstanding, the voting power of each, the shares represented at the meeting, the qualification of voters, the validity of proxies, the existence of a quorum as to any voting group, and the acceptance, rejection and tabulation of votes.

**<u>SECTION 12. Informal Action by Shareholders</u>:** Any action which may be taken at a meeting of the shareholders may be taken without a meeting if a consent in writing, setting forth the action so taken, is signed by all of the persons who would be entitled to vote upon such action at a meeting and is delivered to the Corporation to be included in the minutes or to be kept as part of the corporate records. Such consent shall have the same force and effect as a unanimous vote of shareholders.

**<u>SECTION 13. Corporation's Acceptance of Votes</u>:** If the name signed on a vote, consent, waiver, or proxy appointment corresponds to the name of a shareholder, the Corporation is entitled to accept the vote, consent, waiver, or proxy appointment and to give it effect as the act of the shareholder.

If the name signed on a vote, consent, waiver, or proxy appointment does not correspond to the name of its shareholder, the Corporation is nevertheless entitled to accept the vote, consent, waiver, or proxy appointment and to give it effect as the act of the shareholder if: (i) the shareholder is an entity and the name signed purports to be that of an officer or agent of the entity; (ii) the name signed purports to be

------

that of an administrator, executor, guardian, or conservator representing the shareholder and, if the Corporation requests, evidence of fiduciary status acceptable to the Corporation has been presented with respect to the vote, consent, waiver, or proxy appointment; (iii) the name signed purports to be that of a receiver or trustee in bankruptcy of the shareholder and, if the Corporation requests, evidence of its status acceptable to the Corporation has been presented with respect to the vote, consent, waiver, or proxy appointment; (iv) the name signed purports to be that of a beneficial owner or attorney-in-fact of the shareholder and, if the Corporation requests, evidence acceptable to the Corporation of the signatory's authority to sign for the shareholder has been presented with respect to the vote, consent, waiver, or proxy appointment; or (v) two or more persons are the shareholder as co-tenants or fiduciaries and the name signed purports to be the name of at least one of the co-owners and the person signing appears to be acting on behalf of all the co-owners.

The Corporation is entitled to reject a vote, consent, waiver, or proxy appointment if the secretary or other officer or agent authorized to tabulate votes has a reasonable basis for doubt about the validity of the signature on it or about the signatory's authority to sign for the shareholder.

**<u>SECTION 14. Notice of Shareholder Business and Nominations:</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Annual Meetings of Shareholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Nominations of persons for election to the board of directors of the Corporation and the proposal of business to be considered by the shareholders may be made at an annual meeting of shareholders <u>only</u>: (A) pursuant to the notice of meeting delivered pursuant to Section 6 of Article III of these bylaws; (B) by or at the direction of the board of directors; or (C) by any shareholder of the Corporation who is a shareholder of record at the time of giving of notice provided for in this Section 14 of Article III, who is entitled to vote at the meeting and who complies with the notice procedures set forth in this bylaw. <u>For the avoidance of doubt, the foregoing clause (C) shall be the exclusive means for a shareholder to make nominations or submit other business other than matters properly brought in accordance with Rule 14a-8 under the Securities Exchange Act</u> <u>of 1934, as amended (the "Exchange Act")</u><u>.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) For nominations or other business to be properly brought before an annual meeting by a shareholder pursuant to clause (C) of paragraph (a)(i) of this bylaw, the shareholder must have <u>(1)</u> given timely notice thereof in writing to the secretary of the Corporation and such other business must otherwise be a proper matter for shareholder action<u>, and (2) complied in all respects with the requirements of Regulation 14A under the Exchange Act, including, without limitation, the requirements of Rule 14a-19 (as such rule and regulations may be amended from time to time by the Securities and Exchange Commission (the "SEC"), including any SEC Staff interpretations relating thereto). The chair of the meeting shall determine that the shareholder has satisfied the requirements of this clause (2), including, without limitation, the satisfaction of any undertaking delivered under paragraph (C) of this Section 14(a)(ii) below. The number of nominees a shareholder may nominate for election at an annual meeting shall not exceed the number of directors to be elected at such annual meeting</u>. To be timely, a shareholder's notice shall be received by the secretary at the principal executive offices of the Corporation, either in person or by United States certified mail, postage prepaid, not later than the close of business on the 90<sup>th</sup> calendar day nor earlier than the close of business on the 120<sup>th</sup> calendar day prior to the first anniversary of the preceding year's annual meeting; provided, however, that in the event that the date of the annual meeting is more than thirty (30) calendar days before or more than sixty (60) calendar days after such anniversary date, such notice by the shareholder must be so delivered not earlier than the close of business on the 120<sup>th</sup> calendar day prior to such annual meeting and not later than the close of business on the later of the 90<sup>th</sup> calendar day prior to such annual meeting or the 10<sup>th</sup> calendar

------

day following the calendar day on which public announcement of the date of such meeting is first made by the Corporation. In no event shall the public announcement of an adjournment of an annual meeting commence a new time period for the giving of a shareholder's notice as described above. Such shareholder's notice shall set forth:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)as to each person whom the shareholder proposes to nominate for election or reelection as a director (i) the name, age, business address and, if known, residence address of such person; (ii) the background and qualification of such person, including<u>,</u> without limitation, the principal occupation or employment of such person <u>(at present and for the past five years)</u>; (iii) the class and number of shares of stock of the Corporation which are beneficially owned by such person; (iv) all information relating to such person that is required to be disclosed in solicitations of proxies for election of directors or is otherwise required by the rules and regulations of the Securities and Exchange Commission promulgated under the Securities Exchange Act, of 1934, as amended (the "Exchange Act"), including such person's written consent to (a) being named in the<u>any</u> proxy statement as a nominee <u>and any associated proxy card</u>, (b) serving as a director if elected and (c) providing information that the Board requests to determine whether such person qualifies as an independent director under applicable rules, regulations and guidelines; and (v) a written and signed statement that such person (a) is not and will not become a party to (1) any agreement, arrangement or understanding with, and has not given any commitment or assurance to, any person or entity as to how such person, if elected as a director of the corporation, will act or vote on any issue or question (a "Voting Commitment") that has not been disclosed to the Corporation or (2) any Voting Commitment that could limit or interfere with such person's ability to comply, if elected as a director of the Corporation, with such person's fiduciary duties under applicable law, (b) is not and will not become a party to any agreement, arrangement or understanding with any person or entity other than the Corporation with respect to any direct or indirect compensation, reimbursement or indemnification in connection with service or action as a director of the Corporation that has not been disclosed in the notice required by this Section 14 of Article III, and (c) in such person's individual capacity and on behalf of any person, entity or group on whose behalf the nomination is being made, would be in compliance, if elected as a director of the Corporation, and will comply with all applicable publicly disclosed codes of ethics and conduct, corporate governance, conflict of interest, confidentiality and stock ownership and trading policies and guidelines of the Corporation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)as to any other business that the shareholder proposes to bring before the meeting, (i) a brief description of the business desired to be brought before the meeting, (ii) the text of the proposal or business (including the text of any resolutions proposed for consideration and in the event that such business includes a proposal to amend the articles of incorporation or bylaws of the Corporation, the language of the proposed amendment), (iii) the reasons for conducting such business at the meeting and<u>,</u> (iv) any material interest in such business of such shareholder and any Shareholder Related Person (as defined below); and <u>and (v) a description of all agreements, arrangements and understandings between the shareholder and the</u> <u>Shareholder Related Person, if any,</u> <u>and any other person or persons (including the names of such persons) in connection with</u> <u>the proposal of such</u> <u>business by such shareholder; and</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C)as to the shareholder giving the notice and any Shareholder Related Person, if any, on whose behalf the nomination or proposal is made, (i) the name and address of such shareholder and any Shareholder Related Person, as they appear on the Corporation's books, and (ii)(a) the class or series and number of shares of the Corporation which are directly or indirectly owned beneficially and of record by such shareholder and any Shareholder Related Person, (b) any option, warrant, convertible security, stock appreciation right, or similar right with an exercise or conversion privilege or a settlement payment or mechanism at a price related to any class or series of shares of the

------

Corporation or with a value derived in whole or in part from the value of any class or series of shares of the Corporation, whether or not such instrument or right shall be subject to settlement in the underlying class or series of capital stock of the Corporation or otherwise (a "Derivative Instrument") directly or indirectly owned beneficially by such shareholder and any Shareholder Related Person, and any other direct or indirect opportunity to profit or share in any profit derived from any increase or decrease in the value of shares of the Corporation, (c) any proxy, contract, arrangement, understanding, or relationship pursuant to which such shareholder or any Shareholder Related Person has a <u>right to vote or has granted the</u> right to vote any shares of any security of the Corporation, (d) any short interest in any security of the Corporation (for purposes of this by-law a person shall be deemed to have a short interest in a security if such person directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has the opportunity to profit or share in any profit derived from any decrease in the value of the subject security), (e) any rights to dividends on the shares of the Corporation owned beneficially by such shareholder or any Shareholder Related Person that are separated or separable from the underlying shares of the Corporation, (f) any proportionate interest in shares of the Corporation or Derivative Instruments held, directly or indirectly, by a general or limited partnership in which such shareholder or any Shareholder Related Person is a general partner or, directly or indirectly, beneficially owns an interest in a general partner and (g) any performance-related fees (other than an asset-based fee) that such shareholder or any Shareholder Related Person is entitled to based on any increase or decrease in the value of shares of the Corporation or Derivative Instruments, if any, including<u>,</u> without limitation<u>,</u> any such interests held by members of such shareholder's or Shareholder Related Person's immediate family sharing the same household, (iii) a representation that the shareholder or Shareholder Related Person is a holder of record of stock of the Corporation entitled to vote at such meeting and intends to appear in person or by proxy at the meeting to propose such business or nomination, and (iv) a representation whether<u>written undertaking by</u> the shareholder, the beneficial owner or any Shareholder Related Person, if any, intends or is part of a group which intends (a) to deliver a proxy statement and/or form of proxy to holders of at least the percentage of the Corporation's outstanding capital stock required to approve or adopt the proposal or elect the nominee and/or (b) otherwise to solicit proxies from shareholders in support of such proposal or nomination <u>or Shareholder Related Person that such shareholder or Shareholder Related Person will deliver to beneficial owners of shares representing at least 67% of the voting power of the stock entitled to vote generally in the election of directors either (a) at least 20 calendar days before the annual meeting, a copy of its definitive proxy statement for the solicitation of proxies for its director candidates</u> <u>or (b)</u> <u>at least 40 calendar days before the annual meeting a Notice of Internet Availability of Proxy Materials that would satisfy the requirements of Rule 14a-16(d) of the Exchange Act, (v) any proposal or nominations submitted on behalf of such shareholder or any Shareholder Related Person seeking to nominate directors at any other company's board of directors with a class of equity securities registered pursuant to Section 12 of the Exchange Act within the past 36 months (whether or not such proposal or nomination was publicly disclosed), (vi) any other information required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies or votes for, as applicable, the proposal and/or for the election of directors in an election contest pursuant to and in accordance with Section 14(a) of the Exchange Act and the rules and regulations promulgated thereunder, and (vii) a description of all agreements, arrangements and understandings between the shareholder and the Shareholder Related Person, if any, and any other person or persons (including the names of such persons) in connection with the proposal of such business by such shareholder</u>. The Corporation may require any proposed nominee to furnish such other information as it may reasonably require to determine the eligibility of such proposed nominee to serve as a director of the Corporation. A "Shareholder Related Person" of any shareholder means (i) any person controlling, directly or indirectly, or acting in concert with, such shareholder, (ii) any beneficial owner of shares of stock of the Corporation owned of record or

------

beneficially by such shareholder, and (iii) any person controlled by or under common control with such shareholder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(D)If any of the facts set forth in the notice provided pursuant to this Section 14(a)(ii) of Article III changes between the date that such notice is sent and the date of the annual meeting to which such notice pertains, the shareholder must deliver to the secretary of the Corporation, either in person or by United States certified mail, postage prepaid, and the Corporation must receive at its principal executive officers by the earlier of (a<u>i</u>) the close of business within five (5) calendar days of the event giving rise to such change, or (b<u>ii</u>) the commencement of such annual meeting, a supplemental notice providing such revised information. <u>For the avoidance of doubt, the obligation to supplement as set forth in this paragraph or any other section of these bylaws shall not (a) limit the Corporation's rights with respect to any deficiencies in any notice provided by a shareholder, (b) extend any applicable deadlines hereunder, or (c) enable or be deemed to permit a shareholder who has previously submitted notice hereunder to amend or update any proposal or to submit any new proposal, including by changing or adding nominees, matters, business or resolutions proposed to be brought before a meeting of the shareholders.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Special Meetings of Shareholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)Only such business shall be conducted at a special meeting of shareholders as shall have been brought before the meeting pursuant to the notice of meeting under Section 6 of Article III of these bylaws. If directors are to be elected at a special meeting of shareholders pursuant to the notice of meeting, nominations of persons for election to the board of directors at such meeting may be made (a<u>A</u>) by or at the direction of the board of directors, or (b<u>B</u>) by any shareholder of the Corporation who is a shareholder of record at the time of giving of notice provided for in this Section 14 of Article III, who is entitled to vote at the meeting and who complies with the notice procedures <u>and information requirements</u> set forth in this bylaw<u>Section 14(a) of these bylaws</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)In the event a special meeting of shareholders is called for the purpose of electing one or more directors to the board of directors, any shareholder may, pursuant to clause (b)(i) above, nominate a person or persons (as the case may be) for election to such position(s) as specified in the notice of meeting, if the shareholder shall have delivered notice containing the information specified in paragraph (a)(ii) of this bylaw to the secretary at the principal executive offices of the Corporation not earlier than the close of business on the 120<sup>th</sup> calendar day prior to such special meeting and not later than the close of business on the later of the 90<sup>th</sup> calendar day prior to such special meeting or the 10<sup>th</sup> calendar day following the day on which public announcement is first made or<u>of</u> the date of the special meeting and of the nominees proposed by the board of directors to be elected at such meeting. <u>The number of nominees a stockholder may nominate for election at a special meeting shall not exceed the number of directors to be elected at such special meeting. For the avoidance of doubt, the obligation to supplement as set forth in this paragraph or any other section of these bylaws shall not limit the Corporation's rights with respect to any deficiencies in any notice provided by a shareholder, extend any applicable deadlines hereunder or enable or be deemed to permit a shareholder who has previously submitted notice hereunder to amend or update any</u> <u>proposal or</u> <u>to submit any new proposal, including by changing or adding nominees, matters, business or resolutions proposed to be brought before a meeting of the shareholders.</u> In no event shall the public announcement of an adjournment of a special meeting commence a new time period for the giving of a shareholder's notice as described above.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) General.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)Only such persons who are nominated in accordance with the procedures set forth in this bylaw shall be eligible to serve as directors and only such business shall be conducted at a meeting of shareholders as shall have been brought before the meeting in accordance with the procedures set forth in this bylaw. Except as otherwise provided by law, the Articles of Incorporation or these bylaws, the chairman<u>chair</u> of the meeting shall have the power and duty to determine whether a nomination or any business proposed to be brought before the meeting was made or proposed, as the case may be, in accordance with the procedures set forth in this bylaw and, if any proposed nomination or business is not in compliance with this bylaw, to declare that such defective proposal or nomination shall be disregarded. <u>Without limiting the foregoing, unless otherwise required by law, if a shareholder or Shareholder Related Person (A)(1) provides notice pursuant to this bylaw and Rule 14a-19(b) under the Exchange Act with respect to a nomination for election to the board of directors and (2) subsequently fails to comply with the requirements of Rule 14a-19(a)(2) and Rule 14a-19(a)(3) under the Exchange Act (or fails to timely provide reasonable evidence sufficient to satisfy the corporation that such shareholder or Shareholder Related Person has met the requirements of Rule 14a-19(a)(3)), or (B) does not appear in person or by proxy at the meeting to present the proposed business or nomination, then the Corporation shall disregard any proxies or votes solicited for any persons nominated by such shareholder or Shareholder Related Person. Upon request by the Corporation, if any shareholder or Shareholder Related Person provides notice pursuant to Rule 14a-19(b) promulgated under the Exchange Act, such shareholder or Shareholder Related Person shall deliver to the Corporation, no later than five (5) business days prior to the applicable meeting date, reasonable evidence that the shareholder or Shareholder Related Person has met the requirements of Rule 14a-19(a)(3) promulgated under the Exchange Act.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)For purposes of this bylaw, "public announcement" shall mean disclosure in a press release reported in a national news service or in a document publicly filed by the Corporation with the Securities and Exchange Commission pursuant to Section 13, 14 or 15(d) of the Exchange Act. <u>and "close of business" shall mean 5:00 p.m. local time at the principal executive offices of the Corporation on any calendar day, whether or not a business day.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)The requirements of this bylaw are separate from and in addition to the requirements of the Exchange Act, and a shareholder shall also comply with all applicable requirements of the Exchange Act and the rules and regulations thereunder with respect to the matters set forth in this bylaw. In addition to the provisions of this bylaw, a shareholder who seeks to have any proposal included in the Corporation's proxy statement also shall comply with the requirements of the Exchange Act, and the rules and regulations promulgated thereunder, including without limitation, Regulation 14A.

**<u>ARTICLE IV</u>**

**<u>BOARD OF DIRECTORS</u>**

**<u>SECTION 1. General Powers</u>:** All corporate powers shall be exercised by or under the authority of, and the business and affairs of the Corporation shall be managed under the direction of, its board of directors.

**<u>SECTION 2. Number, Term and Qualifications</u>:** The number of directors which shall constitute the board of directors shall be not less than five (5) nor more than ten (10). This range shall not be altered without shareholder approval. The exact number of directors shall be fixed from time to time within such range by resolution of the board of directors. Each director shall hold office until his<u>such director's</u> death, resignation, retirement, removal, disqualification, or until his<u>such director's</u> 

------

successor is elected and qualified. Directors need not be residents of the State of North Carolina or shareholders of the Corporation.

**<u>SECTION 3. Election of Directors</u>:** Except as provided in Section 6 of this Article, the directors shall be elected at the annual meeting of shareholders; and those persons who receive the highest number of votes shall be deemed to have been elected.

**<u>SECTION 4. No Cumulative Voting</u>:** Unless otherwise required by the Act, the shareholders of the Corporation shall have no right to cumulate their votes for the election of directors.

**<u>SECTION 5. Removal</u>:** Any director may be removed from office with or without cause by a vote of shareholders holding a majority of the outstanding shares entitled to vote at an election of directors. If a director is elected by a voting group of shareholders, only members of that voting group may participate in the vote to remove him. A director may not be removed by the shareholders at a meeting unless the notice of the meeting specifies such removal as one of its purposes. If any directors are removed, new directors may be elected at the same meeting.

**<u>SECTION 6. Vacancies</u>:** Any vacancy occurring in the board of directors, including, without limitation, a vacancy resulting from an increase in the authorized number of directors or from the failure by the shareholders to elect the full authorized number of directors, may be filled by the majority of the remaining directors. If the directors remaining in office constitute fewer than a quorum of the board, such vacancy may be filled by the affirmative vote of a majority of the remaining directors or by the sole remaining director. If the vacant office was held by a director elected by a voting group of shareholders, the remaining director or directors elected by that voting group are entitled to fill the vacancy. The shareholders may elect a director at any time, subject to the provisions of Section 14 of Article III, to fill a vacancy not filled by the directors. If the vacant office was held by a director elected by a voting group of shareholders, the holders of shares of that voting group may fill the vacancy not filled by the directors elected by such voting group. The term of a director elected to fill a vacancy shall expire at the next shareholders' meeting at which directors are elected.

**<u>SECTION 7.</u> <u>Chairman</u><u>Chair</u> <u>of the Board</u>:** There may be a chairman<u>chair</u> of the board of directors elected by the directors from their number at any meeting of the board. The chairman<u>chair</u> of the board of directors may be, but is not required to be, an officer of the Corporation. The chairman<u>chair</u> shall preside at all meetings of the board of directors and shareholders and perform such other board duties as may be directed by the board.

**<u>SECTION 8. Compensation</u>:** The board of directors may compensate directors for their services as such and may provide for the payment of all expenses incurred by directors in attending regular and special meetings of the board.

**<u>SECTION 9. Committees</u>:** The board of directors may create an executive committee and other committees of the board, each of which shall have one or more members, all of whom shall be directors. The creation of a committee and the appointment of members to it must be approved by a majority of all the directors in office when the action is taken. Each committee may, as specified by the board of directors, exercise some or all of the authority of the board except that a committee may not: (i) authorize distributions; (ii) approve or propose to shareholders action that the Act requires be approved by shareholders; (iii) fill vacancies on the board of directors or on any of its committees; (iv) amend the Articles of Incorporation; (v) adopt, amend, or repeal bylaws; or (vi) approve a plan of merger not requiring shareholder approval Any such committee, or any member thereof, may be discharged or removed by action of the majority of the board of directors. Any resolutions adopted or other action

------

taken by any such committee within the scope of the authority delegated to it by the board of directors shall be deemed for all purposes to be adopted or taken by the board of directors. The provisions of Article V, which govern meetings of the board of directors, shall likewise apply to meetings of any committee of the board.

**<u>ARTICLE V</u>**

**<u>MEETINGS OF DIRECTORS</u>**

**<u>SECTION 1. Regular Meetings</u>:** Regular meetings of the board of directors shall be held at such time and place, within or without the State of North Carolina, as the board of directors shall fix by resolution.

**<u>SECTION 2. Special Meetings</u>:** Special meetings of the board of directors may be called by or at the request of the chairman<u>chair</u> of the board, chief executive officer, president or any two directors. Such meetings may be held either within or without the State of North Carolina, as fixed by the person or persons calling the meeting.

**<u>SECTION 3. Notice of Meetings</u>:** Regular meetings of the board of directors may be held without notice. The person or persons calling a special meeting of the board of directors shall, at least two (2) days before the meeting, give notice of the meeting by any usual means of communication, including by electronic means, mail, or private carrier. Such notice need not specify the purpose for which the meeting is called and may be oral. Any duly convened regular or special meeting may be adjourned by the board of directors to a later time without further notice.

**<u>SECTION 4. Waiver of Notice</u>:** Any director may waive notice of any meeting either before or after such meeting. Such waiver shall be in writing, signed by the director, and filed with the minutes or corporate records; *provided*, *however*, that a director's attendance at or participation in a meeting waives any required notice to him<u>such director</u> unless the director at the beginning of the meeting (or promptly upon his

<u>such director's</u> arrival) objects to holding the meeting or transacting business at the meeting and does not thereafter vote for or assent to action taken at the meeting.

**<u>SECTION 5. Quorum</u>:** The greater of (i) a majority of the directors in office and (ii) one-third of the number of directors fixed pursuant to Section 2 of Article IV shall constitute a quorum for the transaction of business at any meeting of the board of directors.

**<u>SECTION 6. Manner of Acting</u>:** The act of a majority of the directors present at a meeting at which a quorum is present shall be the act of the board of directors, unless a greater number is required by law, the Articles of Incorporation or these bylaws.

**<u>SECTION 7. Presumption of Assent</u>:** A director of the Corporation who is present at a meeting of the board of directors or a committee of the board of directors when corporate action is taken is deemed to have assented to the action taken unless: (i) he<u>such director</u> objects at the beginning of the meeting (or promptly upon his<u>such director's</u> arrival) to holding it or transacting business at the meeting; (ii) his<u>such director's</u> dissent or abstention from the action taken is entered in the minutes of the meeting; or (iii) he<u>such director</u> files written notice of his<u>such director's</u> dissent or abstention with the presiding officer of the meeting before its adjournment or with the Corporation immediately after adjournment of

------

the meeting. This right of dissent or abstention is not available to a director who votes in favor of the action taken.

**<u>SECTION 8. Participation in Meetings</u>:** Any or all of the directors may participate in a regular or special meeting by, or conduct the meeting through the use of, any means of communication by which all directors participating may simultaneously hear each other during the meeting.

**<u>SECTION 9. Action Without Meeting</u>:** Action which may be taken at a board of directors meeting or at a committee of the board of directors meeting may be taken without a meeting if the action is taken by all members of the board or committee and is evidenced by one or more written consents signed by each director or committee member before or after such action, which describes the action taken and is included in the minutes or filed with the corporate records. A director's consent to action taken without a meeting or revocation thereof may be in electronic form and delivered by electronic means. Such action is effective when the last director or committee member signs the consent, unless the consent specifies a different effective date.

**<u>ARTICLE VI <br>OFFICERS</u>**

**<u>SECTION 1. Officers of the Corporation</u>:** The officers of the Corporation shall consist of a chief executive officer, president, chief financial officer, secretary, treasurer, and such vice presidents, assistant secretaries, assistant treasurers, and other officers as may be appointed from time to time in accordance with these bylaws. The board of directors may appoint the chairman<u>chair</u> of the board, chosen from among the directors, as an officer of the Corporation. Any two or more offices may be held by the same person, but no officer may act in more than one capacity where action of two or more officers is required.

**<u>SECTION 2. Appointment and Term</u>:** The chairman<u>chair</u>, the chief executive officer, the president and all executive vice presidents shall be appointed by the board of directors. The other officers of the Corporation may be appointed by the board of directors or by the chairman<u>chair</u> or chief executive officer. A duly appointed officer may appoint one or more officers or assistant officers if authorized by the board of directors. The board of directors may appoint officers at any regular meeting or at any special meeting called for such purpose. Each officer shall hold office until his<u>such officer's</u> death, resignation, retirement, removal, disqualification or until his<u>such officer's</u> successor is appointed and qualifies<u>qualified</u>. The appointment of an officer does not itself create contract rights for either the officer or the Corporation.

**<u>SECTION 3. Compensation of Officers</u>:** The compensation of the chairman<u>chair</u>, the chief executive officer, the president and any executive vice presidents of the Corporation shall be fixed by the board of directors or by a committee of the board authorized to act on its behalf with respect thereto. No officer shall receive compensation for serving the Corporation in any other capacity unless such additional compensation is authorized by the board of directors.

**<u>SECTION 4. Resignation and Removal</u>:** An officer may resign at any time by communicating his<u>such officer's</u> resignation to the Corporation. A resignation is effective when it is communicated unless it specifies in writing a later date. If a resignation is made effective as of a later date and the Corporation accepts the future effective date, the board of directors may fill the pending vacancy before the effective date if the board provides that the successor does not take office until the effective date. An

------

officer's resignation does not affect the Corporation's contract rights, if any, with the officer. Any officer may be removed at any time with or without cause by any of the following: (a) the board of directors, (b) the officer, including any successor, who appointed such officer being removed, unless otherwise provided by these bylaws or the board of directors; or (c) any other officer, if authorized by these bylaws or the board of directors. Such removal shall be without prejudice to the contract rights, if any, of the person so removed.

**<u>SECTION 5. Bonds</u>:** The board of directors may by resolution require any officer, agent, or employee of the Corporation to give bond to the Corporation, with sufficient sureties, conditioned on the faithful performance of the duties of his<u>such individual's</u> respective office or position, and to comply with such other conditions as may from time to time be required by the board of directors.

**<u>SECTION 6.</u> <u>Chairman</u><u>Chair</u>:** The chairman<u>chair</u> of the Corporation, if also appointed as an officer, shall have such powers and perform such duties as may be assigned from time to time by the board of directors and shall be subject to the direction of the board of directors.

**<u>SECTION 7. Chief Executive Officer</u>:** Subject to the direction of the board of directors, the chief executive officer shall have general executive charge, management and control of the properties, businesses and operations of the Corporation with all such powers as may be reasonably incident to such responsibilities. The chief executive officer shall also serve as president if no other person is then serving as president. The chief executive officer may sign certificates for shares of capital stock of the Corporation and may agree upon and execute leases, contracts, evidences of indebtedness and other obligations in the name of the Corporation, and any deeds, mortgages, bonds or other instruments which may be lawfully executed on behalf of the Corporation, except where required by law to be otherwise signed or executed and except where the signing and execution thereof shall be delegated by the board of directors exclusively to some other officer or agent. Unless the board of directors otherwise determines, the chief executive officer shall, in the absence of or because of the inability to act of the chairman<u>chair</u>, perform all duties of the chairman<u>chair</u> and preside at all meetings of shareholders and (should he<u>the chief executive officer</u> be a director) of the board of directors. He<u>The chief executive officer</u> shall have such other powers and duties as from time to time may be assigned to him<u>such position</u> by the board of directors.

**<u>SECTION 8. President</u>:** Subject to the direction of the chief executive officer, the president shall act in a general executive capacity and shall assist the chief executive officer in the administration and operation of the Corporation's business and general supervision of its policies and affairs. Unless the board of directors otherwise determines, the president shall have the authority to sign certificates for shares of capital stock of the Corporation and may agree upon and execute leases, contracts, evidences of indebtedness and other obligations in the name of the Corporation, and any deeds, mortgages, bonds or other instruments which may be lawfully executed on behalf of the Corporation, except where required by law to be otherwise signed or executed and except where the signing and execution thereof shall be delegated by the board of directors exclusively to some other officer or agent. Unless the board of directors otherwise determines, the president shall, in the absence of or because of the inability to act of the chairman<u>chair</u> and the chief executive officer, perform all duties of the chairman<u>chair</u> and chief executive officer and preside at all meetings of shareholders and (should he<u>the president</u> be a director) of the board of directors. He<u>The president</u> shall have such other powers and duties as from time to time maybe assigned to him<u>such position</u> by the board of directors or the chief executive officer.

**<u>SECTION 9. Executive Vice Presidents</u>:** The executive vice presidents, in the order of their appointment unless otherwise determined by the board of directors, shall, in the absence or disability of the president, perform the duties and exercise the powers of that office. In addition, they shall perform

------

such other duties and have such other powers as the board of directors or the chief executive officer or president shall prescribe.

**<u>SECTION 10. Chief Financial Officer</u>:** The chief financial officer, who shall be an executive vice president of the Corporation, shall keep full and accurate accounts of the finances of the Corporation and prepare quarterly and annual financial statements of such accounts, which statements may be consolidated or combined statements of the Corporation and one or more of its subsidiaries as appropriate, and shall be prepared on the basis of generally accepted accounting principles unless otherwise determined by the Board of Directors. The books of account shall at all reasonable times be open to inspection by any director for a purpose reasonably related to his<u>such director's</u> position as a director. The chief financial officer shall, in general, perform all duties incident to such office and such other duties as may be assigned from time to time by the board of directors or the chief executive officer.

**<u>SECTION 11</u>**<u>.</u> **<u>Vice Presidents</u>:** The vice presidents shall perform such duties and have such powers as the board of directors or the chief executive officer shall prescribe.

**<u>SECTION 12. Secretary</u>:** The secretary shall keep accurate records of the acts and proceedings of all meetings of shareholders, directors and committees. He<u>The secretary</u> shall give all notices required by law and by these bylaws. He<u>The secretary</u> shall have general charge of the corporate books and records and of the corporate seal, and he<u>the secretary</u> shall affix the corporate seal to any lawfully executed instrument requiring it. He<u>The secretary</u> shall have general charge of the stock transfer books of the Corporation and shall keep, at the registered or principal office of the Corporation or at the offices of any transfer agent designated by the Corporation, a record of shareholders showing the name and address of each shareholder and the number and class of the shares held by each. He<u>The secretary</u> shall sign such instruments as may require his<u>such individual's</u> signature, and, in general, attest the signature or certify the incumbency or signature of any other officer of the Corporation and shall perform all duties incident to the office of secretary and such other duties as may be assigned from time to time by the board of directors, the chairman<u>chair</u> or the chief executive officer.

**<u>SECTION 13. Treasurer</u>:** The treasurer shall have custody of all funds and securities belonging to the Corporation and shall receive, deposit or disburse the same under the direction of the chief financial officer. The treasurer shall, in general, perform all duties incident to such office and such other duties as may be assigned from time to time by the board of directors or the chief financial officer.

**<u>SECTION 14. Assistant Secretaries and Treasurers</u>:** The assistant secretaries and assistant treasurers shall, in the absence or disability of the secretary or the treasurer, perform the respective duties and exercise the respective powers of those offices, and they shall, in general, perform such other duties as shall be assigned to them by the board of directors or chairman<u>chair</u>, or by the secretary or the treasurer, respectively.

**<u>SECTION 15. Action With Respect to Securities of Other Corporations</u>:** Unless otherwise directed by the board of directors, the chief executive officer shall have power to vote and otherwise act on behalf of the Corporation, in person or by proxy, at any meeting of security holders of or with respect to any action of security holders of any other corporation or entity in which this Corporation may hold securities and otherwise to exercise any and all rights and powers which this Corporation may possess by reason of its ownership of securities in such other corporation or entity.

------

**<u>ARTICLE VII</u>**

**<u>CONTRACTS, LOANS, CHECKS AND DEPOSITS</u>**

**<u>SECTION 1. Contracts</u>:** The board of directors may authorize any officer or agent to enter into any contract or to execute and deliver any instrument on behalf of the Corporation, and such authority may be general or confined to specific instances.

**<u>SECTION 2. Loans</u>:** No loans shall be contracted on behalf of the Corporation and no evidences of indebtedness shall be issued in its name unless authorized by a resolution of the board of directors. Such authority may be general or confined to specific instances.

**<u>SECTION 3. Checks and Drafts</u>:** All checks, drafts or other orders for payment of money issued in the name of the Corporation shall be signed by such officers or agents of the Corporation and in such manner as shall from time to time be determined by resolution of the board of directors.

**<u>SECTION 4. Deposits</u>:** All funds of the Corporation not otherwise employed shall be deposited from time to time to the credit of the Corporation in such depositories as the board of directors shall direct.

**<u>ARTICLE VIII</u>**

**<u>CERTIFICATES FOR SHARES AND THEIR TRANSFER</u>**

**<u>SECTION 1. Certificates for Shares</u>:** Shares may, but need not, be represented by certificates. If certificates are issued, they shall be in such form as the board of directors shall determine; *provided* that, at a minimum, each certificate shall be in such form as required by law. These certificates shall be signed, either manually or in facsimile, by the president, any vice president or any person who has been designated the chairman<u>chair</u> or chief executive officer of the Corporation, and the secretary or any assistant secretary, the treasurer or any assistant treasurer. In case any officer who has signed or whose facsimile or other signature has been placed upon such certificate shall have ceased to be such officer before such certificate is issued, it may be issued by the Corporation with the same effect as if he<u>such person</u> were such officer at the date of its issue. They shall be consecutively numbered or otherwise identified and the name and address of the persons to whom they are issued, with the number of shares and date of issue, shall be entered on the stock transfer books of the Corporation.

**<u>SECTION 2. Transfer of Shares</u>:** Transfer of shares of the Corporation shall be made only on the stock transfer books of the Corporation by the holder of record, by his<u>such holder's</u> legal representative (who shall furnish proper evidence of authority to transfer) or by his<u>such holder's</u> attorney (whose authority shall be evidenced by a power of attorney duly executed and filed with the secretary), and only upon surrender for cancellation of the certificates for such shares. All certificates surrendered for transfer shall be cancelled before new certificates for the transferred shares shall be issued.

**<u>SECTION 3. Fixing Record Date</u>:** For the purpose of determining shareholders entitled to receive notice of a meeting of shareholders, to demand a special meeting, to vote, to take any other action, or to receive payment, or for any other purpose, the board of directors may fix in advance a date as the record date for any such determination of shareholders, such record date in any case to be not

------

more than seventy (70) days before the date on which the particular action requiring such determination of shareholders is to be taken.

When a determination of shareholders entitled to notice of or to vote at any meeting of shareholders has been made as provided in this section, such determination shall apply to any adjournment of such meeting unless the board of directors fixes a new record date, which it must do if the meeting is adjourned to a date more than 120 days after the date fixed for the original meeting.

**<u>SECTION 4. Lost Certificates</u>:** The board of directors may authorize the issuance of a new share certificate in place of a certificate claimed to have been lost or destroyed, upon receipt of an affidavit of such fact from the person claiming the loss or destruction. When authorizing the issuance of a new certificate, the board of directors may require the claimant to give the Corporation a bond in such sum as it may direct to indemnify the Corporation against loss from any claim with respect to the certificate claimed to have been lost or destroyed; or the board of directors may, by resolution reciting that the circumstances justify such action, authorize the issuance of the new certificate without requiring such a bond.

**<u>SECTION 5. Reacquired Shares</u>:** The Corporation may acquire its own shares and shares so acquired constitute authorized but unissued shares.

**<u>ARTICLE IX</u>**

**<u>GENERAL PROVISIONS</u>**

**<u>SECTION 1. Distributions</u>:** The board of directors may from time to time declare, and the Corporation may make, distributions on its outstanding shares in the manner and subject to the terms and conditions provided by the Act and by the Articles of Incorporation.

**<u>SECTION 2. Seal</u>:** The corporate seal of the Corporation shall consist of two concentric circles between which is the name of the Corporation and in the center of which is inscribed "1987" and which shall have such other characteristics as the board of directors may determine.

**<u>SECTION 3. Indemnification</u>:** Any person who at any time serves or has served as a director or officer of the Corporation, or at the request of the Corporation is or was serving as a director or officer for any other foreign or domestic corporation, partnership, limited liability company, joint venture, trust, employee benefit plan, or other enterprise, or as a trustee or administrator under any employee benefit plan of the Corporation or any wholly owned subsidiary thereof, shall be indemnified by the Corporation to the fullest extent from time to time permitted by law in the event he<u>such person</u> is made, or is threatened to be made, a party to any threatened, pending or completed civil, criminal, administrative, investigative or arbitrative action, suit or proceeding and any appeal therein (and any inquiry or investigation that could lead to such action, suit or proceeding), whether or not brought by or on behalf of the Corporation, seeking to hold him<u>such person</u> liable by reason of the fact that he<u>such person</u> is or was acting in such capacity; *provided*, *however*, that the Corporation shall not indemnify any such person against liability or expenses he<u>such person</u> may incur on account of his<u>such person's</u> activities which were, at the time taken, known or believed by him<u>such person</u> to be clearly in conflict with the best interests of the Corporation.

The rights of those receiving indemnification hereunder shall, to the fullest extent from time to time

------

permitted by law, cover (i) reasonable expenses, including without limitation all attorneys' fees actually and necessarily incurred by him<u>such person</u> in connection with any such action, suit or proceeding, (ii) all reasonable payments made by him<u>such person</u> in satisfaction of any judgment, money decree, fine (including an excise tax assessed with respect to an employee benefit plan), penalty, or settlement for which he<u>such person</u> may have become liable in such action, suit or proceeding; and (iii) all reasonable expenses incurred in enforcing the indemnification rights provided herein.

The Corporation shall be entitled to pay expenses incurred by anyone entitled to receive indemnification under this section in defending a proceeding in advance of the final disposition of such proceeding as authorized by the board of directors in the specific case or as authorized or required under any provisions in the bylaws or by any applicable resolution or contract upon receipt of an undertaking by or on behalf of such person to repay such amount unless it shall ultimately be determined that he<u>such person</u> is entitled to be indemnified by the Corporation against such expenses.

The provisions of this section shall not be deemed to preclude the Corporation, in its sole discretion, from indemnifying persons serving as agents or employees of the Corporation, or as agents, employees, partners or members at the request of the Corporation for any other or domestic corporation, partnership, limited liability company, joint venture, trust, employee benefit plan, or other enterprise, to the extent permitted by law.

The board of directors of the Corporation shall take all such action as may be necessary or appropriate to authorize the Corporation to pay all amounts required by this bylaw, including without limitation, to the extent needed, (i) making a good faith evaluation of the manner in which the claimant for indemnity acted and of the reasonable amount of indemnity due him, (ii) making advances of costs and expenses, or (iii) giving notice to, or obtaining approval by, the shareholders of the Corporation. The board of directors may appoint a committee or special counsel to make such determination and evaluation.

Any person who at any time serves or has served in any of the aforesaid capacities for or on behalf of the Corporation shall be deemed to be doing or to have done so in reliance upon, and as consideration for, the right of indemnification provided herein. The rights to indemnification provided in this section are contract rights, and no repeal or modification of these indemnification provisions shall affect any rights or obligations existing at the time of such repeal or modification. The rights provided for herein shall inure to the benefit of the legal representatives of any such person and shall not be exclusive of any other rights to which such person may be entitled apart from the provisions of this bylaw.

The Corporation shall have the power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise or as a trustee or administrator under an employee benefit plan against any liability asserted against him<u>such person</u> and incurred by him<u>such person</u> in such capacity, or arising out of his<u>such person's</u> status as such, whether or not the Corporation or other such enterprise would have the power to indemnify him<u>such person</u> against such liability.

The rights granted herein shall not be limited by the provisions contained in Section 55-8-51 of the Act (or its successor) and shall not limit the power of the Corporation to agree to indemnify its directors, officers, employees or agents by contract or resolution to the fullest extent allowed by applicable law.

------

**<u>SECTION 4. Fiscal Year</u>:** The fiscal year of the Corporation shall be fixed by the board of directors.

**<u>SECTION 5. Amendments</u>:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The board of directors may amend or repeal these bylaws, except to the extent otherwise provided in the Articles of Incorporation, a bylaw adopted by the shareholders, or the Act, and except that a bylaw adopted, amended or repealed by the shareholders may be readopted, amended or repealed by the board of directors if the Articles of Incorporation, the Act or a bylaw adopted by the shareholders authorizes the board of directors to adopt, amend, or repeal that particular bylaw or the bylaws generally.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The board of directors shall have no power to adopt a bylaw:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Changing the statutory requirement for a quorum of directors or action by directors or changing the statutory requirement for a quorum of shareholders or action by shareholders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Providing for the management of the Corporation otherwise than by the board of directors or the committees thereof;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)Increasing or decreasing the number of directors; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)Classifying and staggering the election of directors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The Corporation's shareholders may adopt, amend, alter, change, or repeal any of these bylaws consistent with the provisions of Section 11 of Article III.

**<u>SECTION 6. Emergencies</u>:** In anticipation of or during an emergency, the board of directors may: (i) modify lines of succession to accommodate the incapacity of any director, officer, employee, or agent; and (ii) relocate the principal office or designate alternative principal or regional offices, or authorize the officers to do so.

During an emergency: (i) notice of a meeting of the board of directors need be given only to those directors whom it is practicable to reach and may be given in any practicable manner, including by publication and radio; and (ii) one or more officers present at a meeting of the board of directors may be deemed to be directors for the meeting, in order of rank and within the same rank in order of seniority, as necessary to achieve a quorum.

**<u>SECTION 7. Severability</u>:** Should any provision of these bylaws become ineffective or be declared to be invalid for any reason, such provision shall be severable from the remainder of these bylaws and all other provisions of these bylaws shall continue to be in full force and effect.

**<u>SECTION 8. Waiver of Notice</u>:** Whenever any notice is required to be given to any shareholder or director under the provisions of the Act or under the provisions of the Articles of Incorporation or bylaws of the Corporation, a waiver thereof in writing signed by the person or persons entitled to such notice, whether before or after the time stated therein, shall be equivalent to the giving of such notice.

**<u>SECTION 9. Time Periods</u>:** In applying any provision of these bylaws which requires an act to be done or not done a specified number of days prior to an event or that an act be done during a period of a specified number of days prior to an event, calendar days shall be used, the day of the doing of the act shall be excluded and the day of the event shall be included.

------

**<u>SECTION 10. Exclusive Forum</u>:** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) To the fullest extent provided by law, unless the Corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for all litigation relating to the internal affairs of the Corporation, including without limitation (i) any derivative action or proceeding brought on behalf of the Corporation, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Corporation to the Corporation or the shareholders of the Corporation, (iii) any action asserting a claim arising pursuant to any provision of the Act, the Articles of Incorporation or these Bylaws, (iv) any action to interpret, apply, enforce or determine the validity of the Corporation's articles of incorporation or these bylaws, or (v) any action asserting a claim governed by the internal affairs doctrine, shall be the state courts of North Carolina, or if such courts lack jurisdiction, a federal court located within the State of North Carolina, in all cases subject to the court's having personal jurisdiction over the indispensable parties named as defendants. Any such action filed in a North Carolina state court shall be designated by the party filing the action as a mandatory complex business case pursuant to Section 7A-45.4 of the North Carolina General Statutes. In any such action where the Act specifies the division or county wherein the action must be brought, the action shall be brought in such division or county.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) To the fullest extent permitted by applicable law, any person or entity purchasing or otherwise acquiring any interest in shares of capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this Section 10 of Article IX.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) If any provision or provisions of Section 10 of Article IX shall be held to be invalid, illegal, or unenforceable as applied to any person or entity or circumstance for any reason whatsoever, then, to the fullest extent permitted by law, the validity, legality, and enforceability of such provisions in any other circumstance and of the remaining provisions of this Section 10 (including, without limitation, each portion of any sentence of this Section 10 containing any such provision held to be invalid, illegal, or unenforceable that is not itself held to be invalid, illegal, or unenforceable) and the application of such provision to other persons or entities and circumstances shall not in any way be affected or impaired thereby.

**<u>SECTION 11. Electronic Transactions</u>:** The Corporation may conduct any action or set of actions by any electronic means to the fullest extent permitted by applicable law.

## Exhibit 31.1

**Exhibit 31.1** 

**Certification by Chief Executive Officer** 

**pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as** 

**adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002** 

I, Gregg A. Lowe, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Wolfspeed, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: January 26, 2023

---

| |
|:---|
| /s/ GREGG A. LOWE |
| Gregg A. Lowe |
| Chief Executive Officer and President |

---

## Exhibit 31.2

**Exhibit 31.2** 

**Certification by Chief Financial Officer** 

**pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as** 

**adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002** 

I, Neill P. Reynolds, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Wolfspeed, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: January 26, 2023

---

| |
|:---|
| /s/ NEILL P. REYNOLDS |
| Neill P. Reynolds |
| Executive Vice President and Chief Financial Officer |

---

## Exhibit 32.1

**Exhibit 32.1** 

**Certification by Chief Executive Officer pursuant to** 

**18 U.S.C. Section 1350,** 

**as adopted pursuant to** 

**Section 906 of the Sarbanes-Oxley Act of 2002** 

In connection with the Quarterly Report of Wolfspeed, Inc. (the "Company") on Form 10-Q for the quarterly period ended December 25, 2022 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Gregg A. Lowe, Chief Executive Officer and President of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| /s/ GREGG A. LOWE |
| Gregg A. Lowe |
| Chief Executive Officer and President |
| January 26, 2023 |

---

This Certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed "filed" by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Report, irrespective of any general incorporation language contained in such filing.

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

## Exhibit 32.2

**Exhibit 32.2** 

**Certification by Chief Financial Officer pursuant to** 

**18 U.S.C. Section 1350,** 

**as adopted pursuant to** 

**Section 906 of the Sarbanes-Oxley Act of 2002** 

In connection with the Quarterly Report of Wolfspeed, Inc. (the "Company") on Form 10-Q for the quarterly period ended December 25, 2022 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Neill P. Reynolds, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| /s/ NEILL P. REYNOLDS |
| Neill P. Reynolds |
| Executive Vice President and Chief Financial Officer |
| January 26, 2023 |

---

This Certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed "filed" by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Report, irrespective of any general incorporation language contained in such filing.

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

<br>